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PREFACE
The mission of the N ational Institu te for Occupational Safety 
and H ealth (NIOSH) is to protect the health  and safety of 
working men and women. W ithin the context of its program  are 
NIOSH efforts th a t are directed toward the identification of 
those disease conditions th a t are closely related to or caused by 
the work environm ent as a necessary prerequisite to their pre­
vention.
This guide, originally published in p a rt in  1976, has been 
revised and expanded to reflect new knowledge as well as 
suggestions submitted by users of the guide. The guide is 
designed prim arily as an  aid to sta te  agencies and  others con­
cerned w ith occupational disease com pensation. It presents 
one method for assem bling and evaluating evidence th a t m ay 
be relevant in  determ ining the work-relatedness of a disease in 
an  individual. Inform ation on fourteen disease-producing 
agents is presented to illustrate the decision-making process. It 
should be noted th a t such inform ation m ay not be complete and 
does not necessarily reflect the m ost recent da ta  regarding 
health  s tandards and epidemiologic studies.
NIOSH will welcome suggestions from users of the guide for 
its improvement.
ABSTRACT
This guide discusses various factors associated with es­
tab lishing the relationship between disease and occupation. 
Prepared as an aid to state agencies, physicians, and others 
concerned with workers’ compensation for occupational 
disease, the publication describes a method for collecting, 
organizing, and appraising medical, occupational, and other 
evidence with the aim of determ ining the probable work­
relatedness of a given disease. Illustrative m aterial on fourteen 
disease-producing agents is included. The guide also contains 
a list of occupations with potential exposure to selected 
agents, and other inform ation tha t may be useful to 
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INTRODUCTION
B a c k g ro u n d
U ntil this century, suing the employer was the only way for 
disabled workers or their families to obtain com pensation for 
on-the-job injuries. Under common law, workers had  to prove 
the employer’s negligence in order to be com pensated for work 
injuries. The injured worker, because of this narrow  in terpreta­
tion of law, found tha t com pensation through the courts was 
seldom satisfactory.
By 1920, all but six states had  passed workers’ compensation 
statu tes th a t sought to remedy past deficiencies and  to avoid 
costly litigation by m aking employers responsible for the 
economic loss to workers due to injuries sustained at work.
Although the new laws established a more equitable com pensa­
tion system, the system has not kept pace w ith the substantial 
changes th a t have taken place in the la st h a lf  century in  the 
labor force, in medical knowledge and techniques, and in 
industrial toxicology. In 1970, Congress established a N ational 
Commission on State Workmen’s Compensation Laws to 
reexam ine the adequacy of the com pensation system in light of 
these changes. The Commission's published report to the 
Congress in 1972 lists the objectives of a modern workers’ 
compensation program. Included is a statem ent th a t all work- 
related injuries or diseases should be covered by the com pensa­
tion system. The report also states th a t coverage restricted 
to a list of specified occupational diseases is incom patible w ith 
complete protection.
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D e c is io n -M a k in g
In order for the com pensation system  to trea t both injury and 
disease in a uniform m anner, disease m ust be related to the 
workplace as effectively as injury. For the decision-maker, 
however, establishing the causality  of a disease is often a diffi­
cult task, especially when it becomes necessary to decide if an 
employee’s disease resulted from, or was aggravated by, 
employment-related factors.
In contrast to a traum atic injury, which is readily apparen t to 
the affected employee and to those around him, a cause-effect 
relationship between disease and an  agent or conditions in the 
workplace m ay not be clear. Occupational disease m ay be slow 
to develop. Symptoms of disease m ay be confused with changes 
th a t are due to the aging process, or w ith the effects of smoking 
or alcohol abuse. Additionally, inform ation on p a s t work expo­
sures is often unavailable, inadequate, or incomplete. Not all 
individuals react in the same way to sim ilar exposures to 
disease-producing agents. Off-the-job exposures m ay contri­
bute or be a prim ary cause of illnesses and accidents. These are 
but some of the factors which m ust be considered in the 
decision-making process.
The decision of the person responsible for determ ining the 
work-relatedness of a disease m ust be based on an  evaluation of 
the available information. When appropriate evidence is 
presented in a logical and orderly sequence, w hen m ajor issues 
are identified, and the basis for any presum ption is detined, 
then the decision-making process is facilitated and an  equitable 
decision is likely to result.
The following text outlines and describes a method for the 
collection, presentation, and evaluation of medical, occupa­
tional, and other evidence of occupational disease; presents 
selected inform ation on fourteen disease-producing agents to 
illustrate the methodology; and discusses some problem areas 
associated with decision-making.
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CHAPTER I—AN APPROACH TO 
DECISION-MAKING
R a tio n a le
In  the current workers’ com pensation system, the end result 
of the adjudicatory process is a decision th a t  the claim ant 
(employee) has or has not established th a t he has an  occupa­
tional disease, th a t is, a disease condition resulting from, or 
aggravated by, his employment. In general, a disease is occupa­
tional if:
1. The medical findings of disease are compatible with the 
effects of a  disease-producing agent or agents to which 
the worker has  been exposed;
2. there exists in the worker’s occupational environm ent 
(past or present) exposure to an  agent or agents 
sufficient to have caused the disease; and
3. the w eight of evidence supports th a t the disease is of 
occupational rather than  non-occupational origin.
I t  would be convenient if  a method could be devised which 
invariably  led to a correct and unequivocal descision regarding 
the presence of an  occupational disease. However, it is doubtful 
th a t such a system  could be developed. A case in which the 
relationship of an illness to a documented agent exposure is 
clearly evident is not ap t to be contested or to require the 
m echanism  of a formal claims inquiry. The element of 
judgm ent is m inim al and decision-making is relatively simple.
On the other hand, decision-making m ay be extremely difficult 
in m any contested claims. H onest differences of opinion are 
common, “facts” may be subject to different interpretations,
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and considerable judgm ent is necessary w hen d a ta  are lacking 
or incomplete.
This guide is an  effort to define a step-by-step method for 
assem bling and appraising evidence for the purpose of aiding 
the decision-making process. I t is intended to be of particular 
assistance in cases where the suspected agen t is not generally 
known to produce disease, and in those in which nonoccupa- 
tional exposures m ust be considered.
T h e  M e th o d
This guide presents a suggested approach to decision-making 
th a t consists of six basic steps:
1. Consideration of evidence of disease,
2. consideration of epidemiologic data,
3. consideration of evidence of exposure,
4. consideration of validity of testimony,
5. consideration of other relevant factors, and
6. evaluation and conclusion.
Each of these steps is discussed fully in subsequent chapters. 
The im portance of individual steps will vary according to the 
type of agent, the am ount and quality of medical and occupa­
tional inform ation available, and past experience w ith sim ilar 
situations. Occasionally, one or more steps can be omitted. 
However, with occupational diseases, w hat appears to be 
“obvious” is often subject to controversy, and it is im portan t to 
assemble complete inform ation wherever possible in order to 
assure an  equitable decision.
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CHAPTER II—EVIDENCE OF 
DISEASE
The first consideration in determ ining the probability of a 
cause-effect relationship between an  illness and an  agent a t the 
workplace is to establish:
1. T hat a disease condition does, in fact, exist, and
2. th a t the particular m anifestations of the disease appear 
to be the result of exposure to a specific harm ful agent.
The medical evidence which m ay be elicited in the course of the 
medical evaluation should cover the above points. Generally, a 
m edical evaluation  should include:
1. An analysis of the employee's medical, personal, family, 
and occupational histories;
2. a thorough physical exam ination and clinical evalua­
tion (analysis of signs and symptoms); and
3. a laboratory evaluation (analysis of the results of 
specific tests).
M ed ica l H is to r y
In order to determine the origin of illness, the worker’s past 
medical history m ust be evaluated by the physician. A routine 
medical history includes the dates and details of:
—O nset of present illness,
—all previous illnesses (childhood, physical, mental),
—injuries,
—surgical procedures, and 
—hospital admissions.
In  addition, the medical history should include any details 
specific to a suspected occupational causative agent.
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P e rso n a l H is to r y
This section of the history should give consideration to:
—Age, sex, m arital status, num ber of children,
—nam e and location of all places of residence since birth, 
—areas visited prior to onset of symptoms,
—alcohol and tobacco use (how much and  how long),
—m edications or drug use (past and present),
—recreation and hobbies,
—use of chemicals in the home (cleaning agents, aerosols, 
etc.), and
—details specific to a suspected causative agent.
F a m ily  H is to r y
This section of the history should consider, for each of the 
worker’s parents, siblings, spouse, and children:
—Age, sex, and health  s ta tus (if deceased, cause of death), 
and
—any chronic or occupational disease in the family or in 
persons in the worker’s household.
O cc u p a tio n a l H is to r y
The employee’s complete occupational history, including 
m ilitary service, is also necessary in determ ining the origin of 
illness. The following factors regarding p ast and  present 
occupations should be evaluated:
—Job titles,
—type of work performed (complete listing of actual 
duties),
—duration of each type of activity,
—dates of employment and worker's age for each job 
activity,
—geographical and  physical location of employment, 
—product or service produced,
—condition of personal protective equipm ent used (if any) 
and frequency and duration of periods of use, and 
—nature of agents or substances to which worker is or has 
been exposed, if known. Include frequency and average
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duration of each exposure situation. (See also Evidence 
of Exposure, page 11.)
C lin ica l E v a lu a tio n
This portion of the medical exam ination m ay vary  somewhat 
with the type of illness but should include at least the following:
1. Routine exam ination of all physiological system s—
head and neck







gas troin testin al,
2. observation and evaluation of behavior related to 
emotional status,
3. specific exam ination for health  effects of suspected or 
possible disease agents (seek com petent medical 
consultation),
4. com parison of date of onset of symptoms with 
occupational history,
5. evaluation of results of any past biological or medical 
m onitoring (blood, urine, other sam ple analysis) and 
previous physical exam inations, and
6. evaluation of laboratory tests: routine (complete blood 
count, blood chem istry profile, urinalysis) and specific 
tests for suspected disease agents (e.g., blood or urine 
test for specific agent, chest or other X-rays, liver 
function tests, pulm onary function tests).
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CHAPTER III -  
EPIDEMIOLOGY
Epidemiology is the branch of medical science th a t  deals 
w ith the incidence, prevalence, distribution, and  control of the 
diseases th a t occur amongBt hum an  populations. I t  is the study 
of the distribution and determ inants of disease frequency in 
m an.
Epidemiology is concerned, am ong other things, with m eas­
uring the frequency of illnesses and deaths in certain  popula­
tion groups and  with the study of the relationship between 
exposure and  incidence of disease. Thus, studies of illness in 
groups of workers have made it possible to relate some diseases 
to various substances with which the workers had been in 
contact. Epidemiologic studies point up possible associations 
bu t do not prove cause-effect relationships.
Epidemiologic studies of coal m iners dem onstrated th a t 
prolonged exposure to coal mine dust could produce the 
crippling lung disease, coal workers’ pneumoconiosis (black 
lung). Other studies have show n the relationship between 
workers’ illness and exposure to sugar cane dust (bagassosis), 
cotton dust (byssinosis), silica dust (silicosis), and  various 
fibrous silicates (asbestosis).
Epidemiologic studies have often revealed the carcinogenic 
action of certain substances and chemicals. Some studies were 
simply descriptive accounts of observed effects. Scrotal cancer 
was noted in  English chimney sweeps two hundred years ago, 
and skin cancers in chromium workers a t the turn of the la st 
century. More recent studies have shown the carcinogenic 
properties of arsenic, vinyl chloride, ionizing radiation, and 
other agents.
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Epidemiologic d a ta  docum enting th a t groups of workers and 
other hum an populations exposed to a suspected agent have 
sustained certain types of illnesses m ay be extremely helpful in 
establishing the fact th a t the substance in  question m ay cause 
an  illness of a certain  type. W hatever epidemiologic da ta  is 
available should be included in  the evidence presented.
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CHAPTER IV — EVIDENCE 
OF EXPOSURE
H aving heard evidence th a t establishes the medical condi­
tion of the claim ant and its com patibility with known health 
effects of the suspected agent, and epidemiologic inform ation 
about hum an populations with sim ilar exposure histories, the 
exam iner m ust consider evidence of exposure of the claim ant to 
the suspected agent. Generally, occupational da ta  will be 
presented for each relevant job or duty. The following inform a­
tion would be helpful:
1. Identification of the substances handled or used directly 
in operations in the area or in nearby areas;
2. any inform ation from industrial hygiene studies, 
especially air sam pling data, th a t indicate m agnitude of 
worker exposure for the job or sim ilar jobs (see specific 
guides);
3. da ta  to be accum ulated for work exposure evaluation:
a. inhalation exposure inform ation—expert testimony
should be obtained concerning general environm en­
tal conditions, especially when there are no
industrial hygiene studies available as evidence.
Such testimony should include reference to at least:
(1) E stablishing the precise chemical or physical 
form of the agent (name the "chemical; specify 
type of dust);
(2) a complete description of the operation as 
performed by the worker including m aterials 
h a n d lin g  p rac tice s , accesso ry  equ ipm en t, 
operating procedures, and  protective equipment;
(3) inform ation on the particle size of the agent (for 
dusts) generated by the operation;
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(4) inform ation about the solubility of the agent 
affecting absorption by the body;
(5) possible additional modes of entry of the agent 
in to  the body (inhala tion , ingestion , skin 
absorption);
(6) available ventilation:
—was general exhaust ventilation provided?
—was local exhaust ventilation provided?
—was it properly designed?
—was it installed to design specifications?
—was it properly m aintained?
—was it properly used by the operator?
—was contam inated exhaust a ir recirculated into 
the plant?
(7) general housekeeping:
—was dry sweeping done?
—were spills cleaned up properly? «
—was equipment properly m aintained and 
serviced?
—were all p lan t areas regularly cleaned?
—were m aterials stored properly to prevent spills 
or leaks?
(8) respiratory protection (While respirators are not 
the preferred method of protecting workers from 
inhalation  of airborne toxic agents, they are 
sometimes used until o ther controls can be in s ta ll­
ed. They m ust be used properly to fulfill th is 
function, and  testimony directed tow ard th is 
point should be elicited.):
—was the proper type of respirator used? It 
should have been selected by an  industrial 
hygienist for the specific agent involved, and 
approved by NIOSH or the Mine Safety and 
Health A dm inistration.
—were the respirators fitted properly? Leaks in 
the facepiece negate effectiveness.
—did employee use the repirators?
—were cartriges, filters, etc. changed a t appro­
priate intervals?
—were employees trained  in the proper use, 
purpose, and care of respirators?
—were the respirators periodically inspected and 
m aintained?
b. sk in  contact, sk in  absorp tion , and  ingestion .
Evidence should include inform ation regarding:
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(1) potential for skin contact
—was the operation a “closed system ”?
—was persona] protective clothing used?
—was the proper type of clothing supplied?
—was it used properly? laundered properly?
—were change rooms available? protective skin 
creams? emergency w ashing facilities?
(2) potential for ingestion
—was smoking perm itted in the work area?
—were smoking m aterials permitted in  the work 
area?
—was eating perm itted in the work area?
—was food stored or prepared in the work area? 
—were there separate facilities for storing food 
and eating?
—were proper w ashing facilities available?
E x p o su re  E v a lu a t io n
The best evidence to confirm the exposure of a worker to an 
agent is measurements (such as air samples, noise levels, or 
radiation m easurements) obtained at the worker’s actual job 
stations, past and present. Factors which should be considered 
when evaluating the m easurem ents are:
1. Num ber o f samples (or duration of time covered by 
samples). In most cases, a few (two or three) samples 
covering only a sm all portion of a working day are not 
sufficient to establish degree of exposure. Generally, 
samples or measurements should be obtained covering 
most of a complete working day; covering several non- 
consecutive work days is even better. For very short 
duration samples or readings (less than  15 min.), a 
minimum of seven samples, spaced random ly over the 
workday, is advised.
2. Location o f samples.
The best location for sample taking is in the breathing 
zone (within a few inches of nose and mouth) of the 
employee or a worker doing an identical job, under 
conditions identical to those under which the employee 
worked. Samples obtained a t a sta tionary  point in the 
work environment (area samples) can give an indication 
of possible exposure but can also be very misleading. 
For example, m easuring noise levels a few inches from a
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noisy m achine when the worker is located several feet 
aw ay m ay ind icate  erroneously h igh  exposures. 
O btaining air samples for a solvent a t the center of 
the room, when the worker must lean into a solvent 
tank, would indicate erroneously low exposures.
3. A ir sam pling method.
The methods mentioned in the illustrative agent section 
of th is guide are those commonly used or accepted in the 
industrial hygiene profession. O ther methods m ay exist 
and give satisfactory results. However, expert opinion 
should be obtained concerning their validity. All equip­
m ent used should be accurately calibrated.
A. Laboratory analysis.
Analysis of air sam ples is a difficult science and should 
be performed by experienced, com petent persons. 
Laboratories can be accredited by the American Indus­
trial Hygiene Association for these analyses. In any 
case, the laboratory’s previous experience with the 
specific type of analysis should be ascertained. Certi­
fication of laboratory s ta ff  is another indication of 
competence-
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CHAPTER V — AGGRAVATION 
OF PREEXISTING CONDITIONS
With regard to occupational disease, there is no generally 
accepted medical definition of aggravation. In the current 
system of workers’ compensation, aggravation of a preexisting 
disease or physical im pairm ent m ay be defined as any occupa­
tional occurrence, act, or exposure th a t will make worse, 
intensify, or increase the severity of any physical or m ental 
problem known to exist before the occupational exposure. An 
example of aggravation would be the effects on an employee 
with known allergies exposed to allergens in the workplace re­
sulting in  frequent asthm atic attacks. In another example, a 
recovered alcoholic w ith mild liver dam age is exposed to 
carbon tetrachloride at work, resulting in greater liver damage. 
This definition implies th a t if  there is any occupational contri­
bution to an  existing disease, the disease can become 
compensable. However, this guide is concerned solely w ith the 
causation of disease and whether or not the causes are occu­
pational.
The existence of a condition before exposure does not neces­
sarily m ean before employment. M any companies change 
processes and  products from time to time. When such changes 
occur during an  employee’s period of employment, there may 
be an  aggravation of a condition th a t was not adversely 
affected by prior work in the sam e job or plant.
Any stresg m ay be an aggravating factor and has been so con­
sidered by the courts for such jobs as firefighting and police 
work.
Since most states hold th a t the employer accepts the worker 
"as is,” such factors as age, sex, heredity, and obesity can be 
logically excluded from the list of causative factors. This leaves
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those environm ental (occupational) exposures—m echanical, 
chemical, physical, or biologic—which m ay occur a t work or in 
the non working environm ent, as candidates for discussion of 
the “cause" of an  aggravated disease or condition.
This consideration appears to lead to a very straightforw ard 
decision-making scheme to weigh the “percent contribution” of 
various factors in a specific case with the aim of aw arding 
compensation on a contributory basis. U nfortunately, no such 
single approach is feasible.
A ggravation cases frequently have multiple causes, not all of 
which are kfiown, and m ost of which are poorly understood. 
The table on page 17 lists some agents which may contribute 
to disease and aggravation of disease.
A problem with aggravation of chronic diseases is th a t there 
are m any param eters involved. The causes, courses, and 
eventual outcome of these diseases are usually unknown and 
poorly understood. As chronic diseases progress, they m ay ex­
hibit irregular periods of w orsening and of improvement. This 
factor confounds the role of an aggravating  agent, and it is 
therefore necessary to medically m onitor these employees over 
several of the cycles of improvement-worsening. Furthermore, 
the time of life when symptoms of chronic disease develop often 
contributes to the complexity of the problem, since both the 
degenerative processes of aging and  the appearance of chronic 
diseases are associated with the middle years.
A r th r i t is
A rthritis is a disease th a t is alm ost universally present in the 
older age group. A rthritis can cause effects tha t range from 
nuisance aches to severe incapacity. Certain abbatoir workers 
are required to work in damp, cold conditions. Over the years, 
some of these workers develop a d isabling form of arthritis, but 
some escape it entirely. Are the work conditions responsible for 
the disabling arthritis? The courts have most often held th a t 
they are, but since the cause of arth ritis  is unknown, these 
decisions are based on adjudicatory and adm inistrative 
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C o ro n a ry  A r te r y  D isea se
Coronary artery disease, which m ay lead to a  heart attack, is 
one of the most frequent “preexisting conditions” cited as 
being aggravated by work. There are those who feel tha t heart 
attacks should never be compensable and, since they have 
such complicated etiology (causation), th a t they should be re­
moved from the com pensation system. (N ational Commission 
on Workmen’s Compensation Laws, 1973. Compendium on 
W orkmen’s Compensation. W ashington: GPO.)
In addition to the commonly accepted factors such as age, 
smoking, diet, heredity, etc., there are some chemicals th a t 
have profound effects on the h eart and cardiovascular system. 
Aniline and nitrobenzene are m yocardial (heart muscle) de­
pressants. Ethylene, chloroform, and trichloroethylene are 
m yocardial irritants. The azides produce severe vasodilation. 
Carbon disulfide induces atherosclerosis.
Carbon monoxide, cyanide, and certain insecticides can have 
dam aging effects on individuals with impaired cardiac function 
or reduced cardiac reserve. Pulm onary irritan ts  such as 
ammonia, chlorine, phosgene, and sulfur dioxide can be quite 
hazardous to the person with heart im pairm ent. Silicosis, 
asbestos, and  other pneumoconioses m ay result in right heart 
failure (cor pulmonale). Heat, cold, and electrical shock can 
seriously affect the impaired heart.
H eart attacks seem to occur a t a lower rate  in workers than  in 
the population a t large. This m ay result, in part, from the fact 
th a t the American worker is “selected,” th a t is, he often 
receives a preplacement medical exam ination to place him in a 
job th a t is compatible w ith his health  and physical abilities. He 
m ay also receive periodic follow-up exam inations a t work to 
m onitor his health.
One researcher (Paffenberger, the A merican Journal of Epi­
demiology) studied longshoremen. Those performing heavy 
work h ad  a lower rate of sudden death th an  workers doing light 
work, suggesting th a t perhaps heavy work m ay help to prevent 
sudden deaths from coronary artery disease ra ther th an  to 
cause them. These conclusions have been confirmed by m any 
other studies.
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In  alm ost all heart attacks th a t go to litigation, the problem is 
th a t of causation. To make a  determ ination th a t an  employee 
was subjected to a  stressor “sufficient to b ring about the heart 
attack or reaction,” is extremely difficult because of the lim ita­
tions of medical knowledge as to etiology. Rarely can a 
physician state th a t a heart attack is related to a particular 
stress, nor can he point w ith certainty to the in itia ting  process 
of any heart attack. Although the presence of some athero­
sclerosis m ay be granted, it is not possible to predict when 
particular coronary vessels will occlude and precipitate the 
m yocardial infarction or a fata l arrhythm ia.
The physician does have a  role in  inform ing the court th a t the 
worker did indeed have a heart attack  and  in  presenting sub­
s tan tia ting  data. A final judgm ent m ust be rendered in  
accordance with the adm inistrative and adjudicatory fram e­
work of the state.
Several of the more troublesome areas concerned with deter­
m ination of aggravation of preexisting conditions have been 
discussed above. Causation and the lack of positive medical 
knowledge about causation are the most im portant deficits in  
this determ ination. T hat a specific disease state  can be caused 
or aggravated by more than  one stressor is another im portant 
factor in  determ ination, inasm uch as not all stressors can be 
identified. The other factors in  the determ ination can be identi­
fied and quantified by experts; for example, factors related to 
genetics, physical characteristics, personal habits, work 
exposure, work habits, work processes, contam inants, age, and 
sex. To assist in arriving a t a ju st decision, it is suggested th a t 
qualified medical and other professional advice should be 
obtained during the decision-making process. Consideration 
should be given to:
a. Using this guide, and other m aterial, as sources of 
inform ation which should be obtained to help support 
opinions and decisions; and
b. using the services of an  im partial advisory board made 
up of occupational medical specialists and other physi­
cians and industrial hygienists. Participants should be 
selected by state or local medical societies and profes­
sional organizations.
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O ther measures tha t m ay ultim ately enhance the equitable 
handling  of cases involving possible aggravation of disease 
are:
a. Encourage research on the causes of chronic disease and 
the relative degree of contribution of various factors;
b. encourage research into the possibility o f rem oving cases 
of aggravation from the “ all or nothing” decision realm. 
While th is approach has certain draw backs, it m ay also 
make possible partia l com pensation for diseases not 
previously held compensable. (This is being done through 
second injury funds established in  some states.)
c. encourage preventive medicine through preplacement 
medical exam inations and job selection procedures to 
place workers in jobs which will no t aggravate any of 
their preexisting health  conditions.
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C H A P T E R  VI — V A LID IT Y  O F  
T ES TIM O N Y
Non-professional persons cannot be expected to collect and 
evaluate all of the inform ation needed. In most cases, physi­
cians will provide testimony on medical conditions and 
laboratory and other medical tests; industrial hygienists will 
testify concerning evidence of exposure; epidemiologists give 
testimony on epidemiologic data. These professionals m ust 
consider all pertinent points in their area of expertise in  order 
to present an  accurate and m eaningful evaluation of the avail­
able data. The hearing exam iner, board, commissioner, or 
officer should verify:
1. The professional qualifications of those testifying, and
2. the basis of the testimony, th a t is, the im portance 
attributed to various areas of the inform ation reviewed, 
and the conclusions th a t were drawn.
Medical
The phrase “competent medical person" is frequently used in 
both the lay and professional literature, including th is guide. 
But w hat does it mean? Who is a com petent medical person? 
Board certification (other than  in occupational medicine) and 
academic s ta tus do not in  themselves confer expertise in 
occupational disease. An expert in a specific medical field is 
not necessarily medically com petent to render clinical judg­
m ent on an  entire case, but only on th a t portion which is w ithin 
his or her area of expertise. No rigid rules for judging compe­
tency can be defined. Because of the m any variables, some 
guidelines are offered to aid the decision-maker in judging who 
is or m ight be considered a “com petent medical person.”
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A competent medical person is:
1. A physician, judged competent in one of the several 
disciplines of medicine, and
2. specially trained in the particular expertise required for 
the testimony to be presented. In determ ining occupa­
tional causation of disease, such expertise would 
include in tim ate knowledge of the work environm ent.
For com pensation purposes, a medical specialist—such as an 
internist, pathologist, surgeon, specialist in  chest diseases, or 
an  occupational health  physician—is usually a competent 
medical person, bu t not in all instances.
For example, in  a com pensation case involving a  question of 
occupational lung disease, the chest specialist can certainly 
use his or her expertise to diagnose a chest condition. But 
unless such a specialist is fam iliar w ith the work history and 
exposure of the employee, and has the background to coordi­
nate  and evaluate toxicological, epidemiologic, and  industrial 
hygiene inform ation in term s of the medical condition, th a t 
specialist should not be considered com petent to render an 
expert opinion regarding the occupational origin of the disease 
condition.
Generally, a physician certified in occupational medicine is a 
com petent medical person. Occasionally, however, the physi­
cian’s particular work experience does not include an under­
stand ing  of the exposure issues involved, such as carcinogenic 
factors. In  the examples given, two physicians m aybe required 
to provide the expert opinion.
It is im portant for the medically com petent person to m ain tain  
im partiality  and  to have an  understanding of labor and indus­
try. Almost all persons, medical and  otherwise, who testify in 
com pensation cases have some degree of bias. This does not 
invalidate their testim ony. However, the exam iner should 
consider the extent, nature, and  effect, if  any, of expert bias 
in arriv ing  a t his decision.
It is the duty and  responsibility of a com pensation hearing 
officer, lawyer, or any  interested person to be aw are of the re­
quirem ents for medical competency in order to assure sound 
decisions. The following should be considered in judging 
medical competence:
1. Is the physician certified in occupational medicine by 
the Am erican Board of Preventive Medicine?
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2. Is the medical expert’s specialty directly related to the 
type of disease in  question (cardiologist for heart 
disease, pulm onary specialist for lung disease, etc.)?
3. Does the physician have industrial experience? In  w hat 
industries? Does th is include experience in  diagnosing 
the disease in  question?
4. W hat is the expert’s form al tra in ing  in  occupational 
medicine?
Exceptions: A lthough the competent medical person is a 
physician, there are some instances w hen the 
physician’s testim ony will be supplem ented by 
testimony from a dentist, anatomist, toxicologist, 
occupational health  nurse, or industrial hygi- 
enist concerning special health  issues in  their 
area of expertise. In  such circumstances, these 
professionals are considered "competent experts” 
for the purposes of the particular adjudicatory 
proceedings. The testimony of such non-physicians 
should not be perm itted to be substituted for the 
medical testim ony of a physician. In  addition, 
the qualifications of such individuals should be 
ascertained as is done in  qualifying any expert 
in any court case.
Indus triaI Hygienis t
According to the American Industrial Hygiene Association, a 
professional industrial hygienist is “a person possessing either 
a Baccalaureate Degree in Engineering, Chemistry, or Physics, 
or a Baccalaureate Degree in  a closely related biological or 
physical science from an  accredited college or university, who 
has, in  addition, a minimum of three years of industrial hy­
giene experience. A completed Ph.D or Sc.D. in a related phy­
sical or biological science or an M.D. can be substituted for two 
years of the three year requirem ent.” Further, it is suggested 
th a t all industrial hygienists consulted be professionally certi­
fied by exam ination of the American Board of Industrial 
Hygiene.
The following should be considered when judging an  industrial 
hygienist’a competence:
1. Is the industrial hygienist certified by the American 
Board of Industrial Hygiene or under the direction of a 
certified industrial hygienist?
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2. Is the area of specialty of the industrial hygienist re­
lated to the evidence being given (comprehensive, 
engineering, toxicology, acoustics, a ir  pollution, 
chemistry)?
3. Does the industrial hygienist have experience w ith the 
particular occupation involved?
Whenever possible, reports of past industrial hygiene studies 
pertinent to the case should be relied upon to provide basic 
environm ental evidence. To be credible, personnel conducting 
industrial hygiene studies for use as evidence should be pro­
fessionals trained in industrial hygiene or be under the direction 
of such professionals.
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C H A P T E R  VII —  C O N C LU SIO N S
Evidence presented by qualified professionals according to 
the method described in  the preceding chapters will generally 
be sufficient for the hearing exam iner to answ er the following 
questions to his satisfaction:
1. H as a disease condition been clearly established?
2. H as it been shown th a t the disease can result from the 
suspected agent(s)?
3. H as exposure to the agent been dem onstrated? (by work 
history, sam pling data, expert opinion?)
4. H as exposure to the agent been shown to be of sufficient 
degree an d /o r  duration to result in the disease condi­
tion? (by scientific literature, epidemiologic studies, 
special sam pling, replication of work conditions?)
5. Has nonoccupational exposure to the agent been ruled 
out as a causative factor?
6. Have all special circum stances been weighed? 
Occasionally, special circum stances m ust be considered. Were 
there any unusual events a t work th a t reduced the effectiveness 
of protective equipment? Of ventilation? Of safe work 
practices? I f  the employee is a woman, are there special risks to 
women from exposure to the agent? If so, this factor m ust be 
evaluated.
7. H as the burden of proof been m et—did the evidence 
prove th a t the disease resulted from, or was aggravated 
by, conditions a t work?
If the answ er to all of the above is “Yes,” the decision can be 
m ade th a t the disease is occupational in origin.
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C H A P T E R  VIII —  E X A M P L E S  O F  
T H E  M E T H O D
The following text of the guide presents inform ation on 
fourteen selected disease-producing agents to illustrate the use 
of the decision-making method previously described. The 
examples presented are antim ony, inorganic arsenic, asbestos, 
benzene, carbon monoxide, coke oven em issions, cotton dust, 
inorganic lead, inorganic mercury, nitrogen dioxide, noise, 
crystalline silica, sulfur dioxide, and  toluene diisocyanate.
Different and  additional agents could have been presented, and 
consideration will be given to such publication if  experience 
with the guide indicates a dem and for such agent inform ation. 
As a group, however, the above agents exemplify both acute 
and  chronic effects. They represent different physical forms: 
Solid fibers, physical agents, particulates, fumes, and vapors. 
In  their health  effects these agents involve m any organ 
systems: Respiratory system, central nervous system, hepatic 
system, genitourinary system, blood forming (hematopoietic) 
organs, and  other systemic effects, as well as carcinogenic 
action. The organization of the agent m aterial presented in  the 
following pages can serve as a guide for collecting and record­
ing pertinent inform ation about other disease-producing 
agents.
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A N T IM O N Y  A N D  ITS C O M P O U N D S  
(E X C E P T  STIBINE)
Introduction
Antim ony is a silvery, lustrous m etal or gray lustrous 
powder; its chief ore is stibnite. Antim ony m ay cause adverse 
health  effects through inhalation, ingestion, and  skin 
absorption. D ust and fumes of antim ony and its compounds are 
sources of the hazard.
A ntim ony is frequently encountered as a fine dust in  industry 
w ith inhala tion  being the usual route of entry. D ust m ay be 
ingested by  swallowing accum ulations w hich have been 
deposited in  the upper respiratory tract.
Nonoccupatiorial exposure m ay occur through ingestion (i.e., 
antim ony dissolved from enam el glazed utensils used for 
acidic foods and  fluids such as lemonade) or inhalation  an d /o r 
skin absorbtion (i.e., clothing im pregnated w ith antim ony 
trioxide for flameproofing). However, exposures are low, except 
in industry.
The symptoms of early antim ony poisoning are sim ilar to 
arsenic (NOTE: See Arsenic Guide), and  the two elements are 
often encountered together in  nature. A ntim ony compounds 
are irrita ting  to the skin and mucous m em branes often 
resulting in derm atitis, gingivitis, rh in itis, inflam m ation of 
the upper and lower respiratory trac ts  including pneum onitis, 
gastritis, conjunctivitis, and  ulceration of the n asa l septum  
(cartilage separating  the nostrils) and  larynx. The w eakness 
and fatigue characteristic of the chronic poisoning m ay be due 
to anem ia caused by antim ony. C ardiac injury and  cases of 
sudden death  have been reported in persons exposed to 
antim ony.
Antim ony h as  been found to cause pneumoconiosis in workers 
exposed to the ore stibnite. Anitm ony m ay produce changes in 
the lung detectable by X-ray; lung function m ay also be 
affected.
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“Antim ony spots” is a derm atitis caused by antim ony trioxide 
in which there is intense itching followed by skin eruption. 
Lesions tend to occur in  hot w eather due to dust accum ulating 
on m oist skin areas.
Chromosome dam age in hum an cells has been induced by 
antim ony (Patton and Allison, 1972).
A ntim ony can form m any compounds, m ost of which are less 
toxic than  antim ony. The following is a listing of common 
compounds and some common nam es, followed by a listing of 
occupations with potential exposure to antimony:










antim onyl pyrogallol 
antim ony oxychloride
antim ony black, antim ony 
regulus, stibium
triethyl antim onite 
antim ony thioglycolamide
antim onine, antim ony sa lt of 
lactic acid
algaroth  powder, antim onyl 
chloride, antim ony chloride 
oxide, basic antim ony chloride, 
mercurius vitae
antim ony oxysulfide cathusian  powder, kermes 
mineral, kerm esite.pyrostibnite 
antim ony blend, sulfurated 
antim ony
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C hem ica l Nam e Com m on Names
antim ony pentachloride
antim ony pentafluoride 
antim ony pentaiodide 
antim ony pentasulfide
antim ony pentoxide
antim ony potassium 
dim ethyl cysteino ta rtra te
antim ony potassium oxalate
antim ony potassium 
ta rtra te
antim ony sodium 
dimethylcysteino ta rtra te
antim ony sodium gluconate
antim ony sodium tartra te
antim onic chloride, antim ony 
perchloride, butter of antim ony
antim ony fluoride
antim ony iodide
antim onic sulfide, antim onial 
saffron, antim ony red, antim ony 
persulfide, antim ony sulfide, 
golden antim ony sulfide
antim onic anhydride, antim onic 
acid, antimonic.oxide, antim ony 
pentaoxide, stibic anhydride
potassium -antim ony oxalate, 
potassium  oxalatoantim onate
antim ony potassium  salt of 
ta rta ric  acid, potassium- 
antim ony tartrate , potassium  
antimony! ta rtra te , tartrated  
antim ony, ta rta r  emetic, 
tartarized antim ony
antim ony gluconate complex 
sodium salt, antim ony gluconate 
sodium, gluconic acid antim ony 
sodium derivative, sodium 
antim ony gluconate, sodium 
stibogluconate, triostam, 
T.S.A.G.
antim ony sodium oxide 
L-tartrate, Emeto-Na, sodium 
antim onyl tartrate , stibunal
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C hem ica l Nam e C om m on Names
antim ony sodium 
thioglycollate
antim ony sulfate
antim ony tetroxide 
antim ony tribromide
antim ony trichloride
antim ony trichloride 
solution
an timony trifluoride 
antim ony triiodide 
antim ony trioxide
antim ony triselenide 
antim ony tritelluride 
antim ony trisulfide
antim ony sodium thioacetate, 
mercaptoacetic acid antim ony 
derivative sodium salt
antim ony sa lt of sulfuric acid, 
antim onous sulfate, antim ony 
trisulfate
antim ony oxide
antim onous bromide, antim ony 
bromide
antim onous chloride, antim ony 
chloride, butter of antim ony, 
caustic antim ony,m ineral butter
antim ony chloride solution, 
liquid butter of antim ony
antim onous fluoride, antim ony 
fluoride
antim onous iodide, antim ony 
iodide
antim ony oxide, antim ony 
white, antim ony bloom, 
diantim ony trioxide, Exitelite, 
flowers of antim ony, 
Senarm ontite, sulfuret of 
antim ony, black antim ony, 
V alentinite Weisspiess-glanz
antim ony telluride
antim ony glance, antim ony 
orange, antim ony sulfide, 
antim onous sulfide, antim onite, 
crimson antim ony, gray 
antim ony, needle antim ony, 
stibnite
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C hem ica l Nam e Com m on Names
emetine antim ony iodide
lead antim onate
oxo (tartrato) antim onate 
(1-) aniline
sodium antim onate
sodium antim onyl adonitol
sodium antim onyl D-arabitol
sodium antim ony] biscatechol
sodium antim onyl tert-butyl 
catechol
sodium antim onyl catechol sodium antimonous-3-catechol 
thiosalicylate thiosalicylate, stibsol
sodium antimony] citrate
sodium antim onyl erythritol
sodium antim onyl D-funcitol
sodium antim onyl gluco- 
guloheptitol
sodium antim ony] glycerol
sodium antim onyl 
2,5-methylene D-mannitol
sodium antim onyl 
2,4-methylene D-sorbitol
sodium antim onyl xylitol
antim ony em etine iodide
antim ony yellow, N aples yellow
aniline antim onyl tartrate , 
antim onyl aniline ta rtra te
antim ony sodiate
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O ccupations w ith  P o te n tia l Exposures to  A n tim o n y
antim ony ore smelters 
antim ony workers 
babbitt metal workers 
battery workers, storage 
brass founders 





glass m akers 
glaze dippers, pottery 
gold refiners 
insecticide m akers 
insulators, wire 
lake color m akers 
lead burners 
lead hardeners 
lead shot workers 
lino typers 
m atch makers 















explosives m akers 
fireworks m akers 
pewter workers 
pharm aceutical workers 
phosphor m akers 
pigm ent m akers 





rubber m akers 
semiconductor workers 
solder m akers 
stereo typers 
stibnite miners 








Medical Evaluation and Differential 
Diagnosis
(See also Decision-Making Process)
The following should be considered:
—Inflam m ation of several nerves (polyneuritis) due to 
other industrial poisons (e.g., lead) or in  chronic exces­
sive alcohol intake,
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—diseases of the heart muscles caused by toxins (toxic 
cardiomyopathies),
—diseases of the stomach,
—rashes due to food and  drug sensitivity (urticaria), and 
—jaundice due to phosphorus or arsenic poisoning
Signs and Sym ptom s
Acute Poisoning
Acute poisoning from antim ony seldom occurs as an occupa­
tional exposure. Signs and symptoms of acute antim ony 
poisoning are chiefly gastro in testinal and  include:
—Violent vomiting,
—continuous d iarrhea with mucus,
—hepatitis,
—kidney involvem ent w ith blood in  the urine (hemoturia), 
—shock m ay be associated with slow, irregular respiration 
and a subnorm al tem perature, and 
—death m ay occur in several hours.
C hronic P o isoning
Chronic antim ony poisoning can result from the inhala tion  of 




—num bness and tingling (neuritis),
—m uscular aches,
—loss of appetite (anorexia),
—gastro in testinal sym ptom s such as nausea or constipa­
tion,
—headache,
—dizziness, and  
—chest pain.
Respiratory sym ptom s are:
—Inflam m ation of the larynx  (laryngitis),
—inflam m ation of the trachea (tracheitis),
—cough, and
—difficulty in  breathing (dyspnea).
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Antim ony and  its compounds are generally regarded as 
prim ary skin irritan ts. Lesions usually appear on exposed, 
moist area of the body but rarely on the face. Skin disorders 
include:
—Sores resembling chickenpox (pustular, covered with a 
crust),
—blistering of the lips,
—perforation of the n asa l septum (cartilage separating  the 
nostrils), and
—nodular ulcers on the neck an d /o r m oist areas of the 
body, e.g., axilla or groin.
Other sym ptom s of chronic poisoning are:
—Inflam m ation of the gums (gingivitis),
—inflam m ation of the mouth (stomatitis),
—inflam m ation of the m em brane th a t lines the eyelids and 
the front of the eyeball (conjunctivitis),
—inflam m ation of the cornea (keratitis),
—constipation,
—joint pains (arthralgia), and
—possible diseases of the skeletal, voluntary, or cardiac 
muscles.
E ither liver or kidney failure or both can occur in the la te stages 
of the disease, and death m ay result.
Laboratory and Clinical Evaluations
Additional da ta  which will assist in  arriv ing a t a correct 
diagnosis are:
Blood
—antim ony level above 6.0 m illigram s per deciliter 
—white blood count m ay show a sh ift to the left (a prepon­
derance of less m ature white cells)
Urine
—antim ony level above 1.0 m illigram  per liter 
Liver
—liver function studies m ay reveal hepatic injury 
Elec troca rdiogram
—acute poisoning m ay induce ST and T wave changes, 
auricular fibrillation, and possibly ventricular a rrhy ­
thm ias 
Chest X-ray
—m ay indicate pneum onitis or pneumoconiosis (small 
opacities in all regions of the lung)
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Epidemiology
A great variety of signs and symptom s associated with 
industrial exposure to antim ony has been detailed in the 
scientific literature. Epidemiologic studies have demon­
strated  the relationship between antim ony and m yocardial 
changes, transien t pneum onia, chronic derm atitis, irritation  of 
the mucous membrane, and irritation of the digestive tract 
am ong workers in trades and occupations such as m ining 
antim ony-containing ores, flameproofing, abrasives, and  the 
prin ting industry. The d a ta  dem onstrate th a t worker exposure 
is dependent on the specific antim ony compound present in the 
work environm ent. This should be considered when reviewing 
the following inform ation:
Brieger et a l.1 reported a 2-year study of 12£ workers in an 
abrasives industry  (using antim ony trisulfide) who had  been 
exposed to air concentrations of antim ony rang ing  from 0.58 
to 5.5 m illigram s per cubic meter, w ith m ost values over 3.0 
m illigram s per cubic meter. During the study, 6 workers died 
suddenly in addition to 2 other workers who died of chronic 
heart disease. Four of the deceased were under 45 years of age. 
Since no autopsies were performed, the cause of death was not 
determined definitely but in all but 1 case h eart disease was 
suspected. Fourteen had  a blood pressure of over 150/90 mm of 
mercury, and 24 of under 110/70 mm of mercury. Thirty-seven 
out of 75 showed changes in the electrocardiogram, m ostly of 
the T-waves; 7 out of 111 had ulcers. Irrita tion  of the skin, 
mucous membranes, or respiratory trac t was not found. Urine 
sam ples contained 0.8 to 9.6 m illigram s of antim ony per liter 
of urine. (Elkins suggested th a t 1 m illigram  of antim ony per 
liter of urine is a safe level.) When the use of antim ony trisulfide 
was discontinued, no further deaths from heart disease or 
abnorm al increase of cardiovascular disorders occurred. 
Electrocardiographic changes were reported to persist in 12 of 
56 workers who were re-examined. When unattended, evidence 
showed th a t injury to the heart m ay rem ain undetected during 
the long latency periods.
Cooper et al.2 reported a study of 28 workers who had  been 
engaged in processing antim ony from a  crude ore for 1 to 15 
years. Workers were exposed to dusts of antim ony trioxide and 
antim ony ore; antim ony concentrations in  air ranged  from
0.081 to 138 milligram s per cubic meter w ith the heaviest 
concentration being in  bagging operations. O f the workers
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with abnorm al pulm onary function, 1 had  definite sm all 
opacities, 1 had  very early changes, and  2 h ad  negative chest 
X-rays. TTiree workers w ith either suspicious or definite chest 
X-ray abnorm alities had norm al pulm onary function. Electro­
cardiogram s were obtained from 7 workers (3 had  antim ony 
pneumoconiosis); 6 workers had  norm al tracings; and 1 showed 
a  slight bradycardia. Antimony in  the urine sam ples ranged 
from 0 to 1.02 m illigram s'per liter of urine. These low values 
correspond to the low solubilities of antim ony oxides. In 
contrast, Brieger et al. reported th a t workers exposed to lower 
air concentrations of the more soluble antim ony trisulfide had  
higher urinary levels of antim ony.
Renes3 published a report on a 5-month study of 69 smelter 
workers who were exposed to antim ony trioxide; antim ony 
levels in air ranged from 4.69 to 11.81 m illigram s per cubic 
meter. (Antimony, arsenic, and  caustic soda were present in the 
a ir of the smelter but antim ony w as the predom inating aerial 
contam inant.) Six workers showed definite pneum onitis which 
cleared after removal from exposure and  treatm ent. The 
pathological conditions m ost frequently diagnosed were 
derm atitis and  rhinitis, next in frequency were inflam m ation 
of the upper and  lower respiratory trac t (including pneumo­
nitis), and  less than  4% of the cases had conjunctivitis, gastritis, 
and septal perforations reported.
M cCallum1-5-6 reported a study of 268 process workers. Twenty- 
three workers (8.5%) exhibited simple pneumoconiosis changes 
(Categories 1-3, I.L.O. In ternational Classification, Geneva 
1958); associated defects in lung function were not present. 
One furnace worker with antim ony pneumoconiosis who had 
retired a t age 65 had  0.055 milligram of antim ony per liter of 
urine 7 m onths after leaving work and 0.028 m illigram s per 
liter 4 years after leaving work.
Karajovic et al.7 reported a study of 160 men employed a t an 
antim ony smelter for 5 to 12 years. No symptom s were found 
which could be related to systemic antim ony poisoning but skin 
changes and pneumoconiosis were present. Thirty-one out of 
62 smelter workers had  simple pneumoconiosis. No m assive 
lesions were observed. In  20 workers of the total studied, 8 had 
pneumoconiosis, 13 had  em physem a, and  9 had  chronic 
bronchitis.
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Taylor8 reported a study of 7 workers who were accidentally 
exposed to the fume of antim ony trichloride. Air contained up 
to 73 m illigram s of antim ony per cubic meter when leaks 
developed during the refining of the ore. After 24 hours, 5 men 
had  symptoms of gastro in testinal disturbance including 
abdom inal pain and persistent anorexia (loss of appetite). All 
cases reported an  absence of abdom inal tenderness and a 
return of norm al appetite by the tenth  day. The urine antim ony 
content exceeded 1.0 m illigram  of antim ony per liter of urine 
during the incident and fell rapidly to Jess th a n  0.02 m illigram  
24 hours after exposure. No lung changes or evidence of 
persistan t intoxication were observed after exposure.
Rodier and Souchere9 reported chronic poisoning which 
resulted from occupational exposure in Moroccan antim ony 
mines. Workers complained of mild symptom s including 
headaches, sleeplessness, vertigo, appetite loss, and m uscular 
pains. Antim ony was detected in the urine and  hair. Although 
the blood-cell picture was altered, antim ony was not detected in 
the blood. Gallina. and Luvoni11’ reported cases of antim ony 
poisoning am ong workers exposed to antim ony pentasulfide 
in a Milan glass factory. Among symptom s reported were 
nausea, vomiting, diarrhea, bitter taste  in the mouth, and a 
characteristic leucocyte cojint shift.
Evidence of Exposure
Sampling and Analysis
The NIOSH approved air sam pling method uses mechanical 
filtration- Two methods previously used are:
1. Im pingem ent and
2. electrostatic precipitation.
The NIOSH approved method for a ir sam ple analysis uses 
atomic absorption spectrophotometry. Two methods pre­
viously used are:
1. Rhodam ine B and
2. 9-methyl-2,3,7-trihydroxyfluor-6-one.
The above are not intended to be exclusive, but alternative 
methods should be justified.
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Allowable Exposure Limits
The Federal s tandard  for antim ony and its compounds is 0.5 
milligram  per cubic meter of air based on an  8-hour time- 
weighted average exposure. Occupational exposure to an ti­
mony in am ounts greater th a n  th is is evidence of a possible 
causal relationship between disease and occupation.
Conclusion
Diagnostic criteria for occupational antim ony poisoning are 
based on the following:
1. Confirm ed h is to ry  of occupational exposure to 
antim ony or one of its compounds,
2. clinical findings compatible w ith antim ony poisoning,
3. urine antim ony levels in excess of 1.0 m illigram per liter, 
and
4. blood antim ony levels in excess of 2.0 m illigram s per 100 
grams.
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Inorganic Arsenic (Except Arsine)
Introduction
Arsenic is found is sm all am ounts in soils and w aters and in 
foods, particularly seafoods. For industrial and commercial 
uses, it is removed from ores during dmelting operations as 
arsenic trioxide, which is used in the m anufacture of m ost other 
arsenic compounds.
Exposure to arsenic can be through ingestion (swallowing 
accumulations of dust deposited in the upper respiratory tract), 
inhalation, or percutaneous (absorbed through the skin) as 
arsenic can be widely distributed throughout body tissues. It is 
also found in hair, nails, urine, and feces. N onoccupational 
exposures to arsenic have resulted in average urinary  arsenic 
levels of 0.014 to 0.25 m illigram  of arsenic per liter w ith the 
h ighest reported levels being attributed to probable seafood 
consumption (Dinman, I960). Therefore, when evaluating 
occupational exposure to arsenic, nonoccupational exposure 
of the individual m ust also be carefully examined.
Arsenic is an  irr itan t to the skin and to mucous m em branes and 
can cause acute and chronic poisoning. Acute arsenic poison­
ing rarely occurs in  industry.
The corrosive action of arsenic m ay cause perforation of the 
nasa l septum (cartilage separating  the nostrils). NOTE: There 
can be other causes of perforation.
Chronic arsenic poisoning induces numerous skin m anifesta­
tions which include overgrowth of the horny layer of the 
epidermis (hyperkeratosis), sensitization, and  possibly loss of 
ha ir and nails. In addition, skin cancer m ay be associated with 
chronic arsenic poisoning. These include squam ous cell 
carcinoma, epithelioma which m ay arise a t sites of keratoses 
(most common), basal cell carcinoma, and the chronic precan- 
cerous derm atitis referred to as Bowen’s disease.
Arsenic m ay also have a  depressant effect on bone marrow 
erythropoiesis and myelopoiesis (the process of blood cell 
formation).
40
Epidemiologic d a ta  (experience with groups of people) show a 
relationship between exposure to arsenic and the development 
of cancer in  the lung, lym phatic system, a n d /o r skin.
Arsenic can form m any compounds. The following is a list of 
common compounds and some common nam es followed by a 
listing of occupations w ith potential exposure to inorganic 
arsenic:
_____Chem ical Name_____
am m onium  arsenate
arsenic 
arsenic acid
arsenic acid, m agnesium  salt 
arsenic acid, sodium sa lt
arsenical nickel








am monium acid arsenate, 
diam m onium  sa lt of arsenic 
acid, diam m onium  arsenate, 
dibasic am monium arsenate, 
secondary am monium arsenate
gray arsenic, metallic arsenic
orthoarsenic acid, true arsenic 
acid
m agnesium  arsenate






arsenic bisulfide, arsenic 
monosulfide, arsenic sulfide, 
realgar, red arsenic, red arsenic 
sulfide, red arsenic glass, ruby 
arsenic
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arsenic acid anhydride, arsenic 
oxide, arsenic anhydride, 
arsenic pentaoxide, ZOTOX
arsenic bromide, arsenous 
bromide
arsenic butter, arsenic chloride, 
arsenious chloride, arsenous 
chloride, butter of arsenic, 
caustic arsenic chloride, fuming 
liquid arsenic
arsenic fluoride, arsenious 
fluoride, arsenous fluoride
arsenic iodide, arsenious iodide, 
arsenous iodide
arsenic sesquioxide, arsenious 
ad d , arsenious oxide, 
arsenolite, arsenious trioxide, 
arsenite, arsenous acid, 
arsenous a d d  anhydride, 
arsenous anhydride, arsenous 
oxide, arsenous oxide anhy­
dride, claudite, claudetite, crude 
arsenic, white arsenic
arsenious selenide, arsenous 
selenide
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C hem ica l Nam e Com m on Names
arsenic trisulfide
arsenious acid, monosodium 
salt
arsenious acid, sodium 
salt






arsenic persulfide, arsenic 
sulfide, arsenic tersulfide, 
arsenic yellow, arsenious sul­
fide, arsenous sulfide, 
auripigment, orpiment, p ing’s 
gold, ping’s yellow, yellow 
arsenic sulfide
sodium arsenite, sodium 
m etaarsenite
sodium salt polymers of 
arsenious acid, sodium 
ortho arsenite







orthoarsenate, Chip-Cal, Fen 
Cal, Kalo, Spracal, tricalcium 
ortho-arsenate
acid copper arsçnite, arsenious 
ad d , copper, copper arsenide, 
cupric arsenite, Scheele's green, 
Scheele’s mineral, Swedish 
green
disodium salt of arsenic acid, 
sodium a d d  arsenate, sodium 
arsenate dibasic anhydrous
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acid lead arsenate, arsenate of 
lead, lead sa lt of arsenic acid, 
dibasic lead arsenate, lead 
orthoarsenate, plumbous 
arsenate
lead m-arsenite, lead o-arsenite, 
lead m etaarsenite
mercury arsenate, mercury 
arsenite
acid-true arsenic acid, arsenic 
acid, arsenic acid 75, arsenic 
add  hemihydrate, liquid arsenic, 
meta-arsenic add, orthoarsenic 
a d d  hem ihydrate
nickel o-arsenate, nickelous 
arsenate
disodium sa lt of arsenious acid
Occupations with Potential Exposure to Inorganic Arsenic
acetylene workers 
acid dippers 
alloy m akers 
aniline color makers 
aniline workers 
arsenic workers 
a rtif id a l flower m akers 
babbitt m etal workers 
bleaching powder m akers 
boiler operators 
book binders 
brass m akers 












fertilizer m akers 
fireworks m akers 
flypaper m akers 
galvanizers 
glass m akers 
gold extractors
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candle (colored) m akers 
canners 
carpet m akers 
carroters, felt h a t 
cattle dip workers 
ceramic m akers 





defoliant m akers 
dimethyl sulfate makers 
disinfectant m akers 
drug m akers 
dye m akers 
m etal cleaners 
m etal refiners 
miners 
m ordanters 
nitrocellulose m akers 
ore smelters
organic chemical synthesizers





pharm aceutical m akers
pigm ent m akers
plastic workers
plumbers
preservative m akers 
printing ink wqrkers 
pyrotechnics workers 
rayon m akers 
rodenticide m akers 
sealing wax m akers 
semiconductor compound 
m akers 




ha ir remover m akers 
herbicide m akers 
hide preservers 
ice m akers
illum inating gas workers
ink m akers
insecticide m akers









soil sterilizer m akers
solderers
subm arine workers 
sulfuric acid workers 
tanners 





type metal workers 
varn ish  m akers 
vine dressers 
wallpaper printers 
w arfare gas m akers 










Medical Evaluation and Differential 
Diagnosis
(See also Decision-Making Process)
The following should be carefully evaluated to determine if 
present symptoms are in  fact associated with a previous 
disease or injury:
—History of Addison’s disease,
—hemolytic anemia,
—viral infections,
—upper respiratory trac t infections,
—gastrointestinal irritants,
—gastritis or lower gastrointestinal 
diseases, and 
—non-obstructive kidney failure (anuria) 
from lead or mercury poisoning.
Nonoccupational Exposure
Arsenic poisoning m ay occur from a home hobby or other 
activities such as:
—Farm ing (use of pesticides),
—gardening 
—wine making,
—diets very heavy in seafood (a high in take of lobster, 
oysters, and mussels m ay elevate blood arsenic levels), 
—wood preserving, and




Acute poisoning usually occurs from exposure to arsenic- 
containing dust. However, it rarely occurs in industry. High 
exposure may be tolerated w ithout sym ptom s of systemic 
poisoning.
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In  acute poisoning following ingestion of inorganic arsenic, 
symptom s develop w ithin 1/2 to 4 hours and  are characterized 
by constriction of the th roa t followed by:
—Inability  to swallow or difficulty in  swallowing 
(dysphagia),
—epigastric pain,
—vom iting and abdom inal pain,
—watery diarrhea, and
—shock may occur w ith severe fluid loss, and death m ay 
ensue in  24 hours.
If the acute effects are survived, the following m ay develop:
—Inflam m ation of the skin involving redness and flaki­
ness (exfoliative derm atitis) and 
—inflam m ation of the nerves, m ainly of the hands and feet 
(peripheral neuritis).
Acute poisoning due to inhalation is extremely rare in industry. 
When it occurs, respiratory and central nervous system 
symptoms predominate. G astrointestinal symptoms are less 
frequent and occur later.








Signs and symptoms which m ay occur later include:
—N ausea,
—vomiting, and  
—colic.
C hronic Poisoning
The signs and  symptoms of chronic arsenic exposure re­
semble m any diseases, including early lead poisoning, and are 
characterized by:
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—loss of appetite (anorexia),
—weight loss,
—inflam m ation of the gums (gingivitis) an d /o r mouth 
(stomatitis),
—inflam m ation of the mucous m em brane of the nose 
(rhinitis),
—inflam m ation of the kidney (nephritis), and 
—decreased pulm onary function.
Inorganic arsenical compounds are prim ary cutaneous (skin) 
irritan ts, and signs and symptom s include:
—Redness which m ay be more intense around ha ir follicles 
and give the Bkin a mottled appearance,
—brittle nails,
—loss of nails and hair,
—a broad white transverse line (called Mee’s lines) can also 
be found in association with polyneuritis,
—pustular, ulcerative, or gangrenous lesions,
—overgrowth of the horny layer of the epidermis (hyper­
keratosis) associated with thick, dry, cracking skin, often 
with excessive sw eating of the palm s and soles of the feet 
(hyperhidrosis),
—deposits of black pigm ents in different body parts (mela­
nosis),
—hyperpigm entation of a "rain-drop” configuration (be­
lieved to be a sign of systemic, not local toxicity), and 
—jaundice, which may be secondary to liver involvement.
Signs and symptoms associated with the nervous system are 
less common and occur in fewer than 5% of all cases:
—Inflam m ation of the peripheral nerves (peripheral 
neuritis),
—numbness, tingling, “pins and needles” , heightened 
sensation,
—symmetrical weakness in feet and legs,
—fasciculation and gross tremors, m uscular incoordina­
tion (ataxia), shuffling gait,




In  chronic arsenic poisoning, the liver may be involved resulting 
in:
—Enlargem ent of the liver (hepatomegaly),
—excessive accumulation of serous fluids in the abdom inal 
(peritoneal) cavity, and 
—cirrhosis (liver fibrosis).
Perforation of the nasa l septum (the cartilage separating  the 
nostrils) is common in workers chronically exposed to arsenic.
Persons exposed to chronic arsenic absorption have been re­
ported to develop carcinom a of the lung, larynx, and viscera 
(the abdom inal organs) as well as skin. However, the relation­
ship of arsenic to nonderm al cancer is m uch more of an  open 
issue.
Laboratory and Clinical Examinations
A dditional tests which will assist in  arriving a t a correct 
diagnosis are:
—Electrocardiographic abnorm alities which indicate a 
direct toxic effect,
—liver function studies m ay indicate liver cell injury,
—decreased white blood cell count,
—decreased red blood cell count (anemia),
—basophilic stippling of the red blood cells,
—chest X-ray m ay reveal lung cancer, and 
—pulm onary function m ay be decreased.
The norm al range of urinary  arsenic levels is less th an  0.1 
m illigram  of arsenic per liter in 24-hour specimens. Levels 
greater th an  0.2 m illigram  of arsenic per liter suggest exposure 
to lim its greater than  those stated on page 52. However, 
acquired tolerance m ay allow levels greater th a n  0.2 milligram  
of arsenic per liter w ithout evidence of arsenic poisoning. 
Conversely, persons w ith urine arsenic levels less th an  0.2 
m illigram  of arsenic per liter m ay in  fact have arsenic poison­
ing. An additional test th a t will aid in arriv ing a t a correct 
diagnosis is a bioassay of nails. For fingernails, maxim um  
arsenic levels are 0.82 to 3.5 parts  per million (ppm), and for 
toenails, 0.52 to 5.6 ppm.
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Epidem iology
The relationship between occupational exposure to arsenic 
and chronic poisoning signs and symptoms including malaise, 
abdom inal complaints, anorexia, hyperkeratosis, and pruritis 
has been well documented in scientific literature.
It has been shown th a t arsenic m ay be absorbed through the 
skin, from the tracheobronchial tree, and from the gastro­
in testinal tract. For this reason, nonoccupational exposure to 
arsenic which can be present in the air, water, and  food should 
be reviewed since it can also elicit a toxicological response. 
A rsenic absorption, however, does not necessarily indicate 
poisoning. These facts should be kept in mind when considering 
the epidemiologic data.
Pinto et a l.11 reported a study of 24 sm elter workers who were 
exposed to an  average airborne arsenic concentration range of
0.003 to 0.295 m illigram  per cubic meter with a m ean value of
0.053 m illigram per cubic meter. The workers were exposed to 
arsenic trioxide. Average urinary  arsenic values ranged from
0.038 to 0.539 m illigram  of arsenic per liter of urine with an 
overall average of 0.174 m illigram of arsenic per liter. The 
Pearson correlation factor between airborne arsenic concen­
trations and urinary  arsenic levels over the range studied was
0.530 (P <  0.01) which dem onstrates a statistically  significant 
correlation. There was evidence th a t nonoccupational arsenic 
absorption from the consumption of seafood resulted in 
elevated u rinary  arsenic levels.
The following sections in quotes are from the N ational Institute 
for Occupational Safety and H ealth:12
Butzengeiger13 reported a study of “180 vinedressers and  cellar- 
men who were exposed to arsenical insecticides while tending 
the vineyards and  from consum ing homemade wine believed to 
be contam inated with arsenic. All had  sym ptom s of chronic 
arsenic intoxication, and in  41, there was evidence of vascular 
disorders in the extremities. Of 15 cases described in detail, all 
had varying degrees of hyperpigm entation, and 13 had  palm ar 
and  p lan ta r keratosis; all 15 had cold hands, feet, or both which 
seemed to preceed the development of gangrene on toes or 
fingers in 6 of the 15. U rinary  arsenic levels ranged from 0.076 
to 0.934 m illigram of arsenic per liter with a m ean value of 0.324 
m illigram  per liter. Average arsenic content in  h a ir  was 0.039 
m illigram  of arsenic per 100 gram s of h air.”
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In  a  more recent study of the electrocardiogram s (ECGs) from 
192 vinegrowers suffering chronic arsenic intoxication, 
Butzengeiger14 reported th a t “55 (28.7%) revealed definite 
changes with 36 cases of these hav ing  no possible cause other 
th a n  arsenic poisoning. ECG abnorm alities included Q-T pro­
longation and flattened T-waves. Further study showed a 
decline in ECG abnorm alities associated w ith a ttenuation  of 
other symptom s of arsenic intoxication.”
Lee and  F raum eni15 reported a study of 8047 copper sm elter 
workers who were exposed to arsenic trioxide over a 25-year 
period. Worker exposure da ta  is sum m arized as follows:
1965 S M E L T E R  SU R V E Y  
ATM OSPHERIC A RSENIC CONCENTRATIONS 
(m illig ram s o f  a r s e n ic  p e r  cub ic  m e te r  o f  a ir)
H eav y M edium L ig h t
R a n g e 0.10 to 12.66 0.03 to 8.20 0.001 to 1.20
M ean 1.47 1.54 0.206











(Lee and F raum eni, 1969)
Overall m ortality of the exposed workers was significantly 
higher th an  expected when compared to an  unexposed popula­
tion w ith the cause of excess deaths m ainly due to m alignan t 
neoplasm s of the respiratory system  and diseases of the heart. 
They further reported the excess of respiratory cancer to be as 
high as eight-fold among workers who were employed for more 
th a n  15 years in  “heavy” exposure areas.
Perry et a l.16 reported a 1-year study of 31 chemical workers who 
were exposed to sodium arsenite a t an  English sheep-dip 
factory. Air concentrations of arsenic ranged from 0.110 to 
4.038 milligram s of arsenic per cubic meter with a m ean value 
of 0.562 m illigram  per cubic meter. Twenty-eight workers ex­
hibited hyperpigm entation, and 9 had  wart-like lesions. The
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average u rinary  arsenic concentration was 0.23 m illigram  of 
arsenic per liter; average arsenic concentration in hair w as 108 
parts per million.
B irm ingham  et al.17 emphasized th a t the cutaneous effect of 
exposure to arsenic occurs more frequently than  the rare 
systemic toxicities. M ilham and S trong18 reported a study of 
smelter workers in which “80% of the workers excreted 1.0 to 
3.0 m illigram s of arsenic per liter of urine and  had derm atitis. 




The NIOSH approved air sam pling method uses m echanical 
filtration. Two methods previously used are:
—Im pingem ent and 
—electrostatic precipitation.
The NIOSH approved method for air sam ple analysis uses 
atomic absorption spectrophotometry. Four methods previ­
ously used are:
—Gutziet method,
—silver diethyldithiocarbam ate method,
—iodine m icrotitration, and 
—molybdenum blue method.
The above methods are not intended to be exclusive but other 
methods used should be justified.
Allowable Exposure Limits
A rsenic is a  confirmed occupational carcinogen with the 
target o rgan/tissue being the lung and  skin; it is a suspect 
lym phatic tissue carcinogen (Ket et al., eds., 1977).
The s tandard  adopted by the Occupational Safety and  Health 
A dm inistration (OSHA) establishes a permissible exposure 
limit of 10 micrograms per cubic meter air. This represents 
the lowest level which OSHA believes is feasible. The 
existence of a safe level of exposure to inorganic arsenic has
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not yet been dem onstrated. In  the absence of a dem onstrated 
safe level, OSHA will not assum e th a t one exists because of the 
irreversibility and long latency period for lung cancer.
Conclusion
Diagnostic criteria for occupational arsenic poisoning are 
based on meeting the following:
1. Confirmed history of occupational exposure to arsenicor 
one or more of its compounds,
2. clinical findings compatible with arsenic poisoning, 
and
3. analysis of urine (or nails) for arsenic is of value in  con­




Asbestos is a m ineral fiber, and  is the nam e given to about 
th irty  silicate compounds. Of these, only the following 5 are of 
significance in industry:
Chrysotile (white asbestos) Crocidolite (blue asbestos) 
Amosite A nthophyllite
Tremolite
Chrysotile accounts for about 97 percent of all th e  asbestos used 
in th is country.
Asbestos is widespread in the environm ent because of its exten­
sive use in industry and the home. Over 3,000 products contain 
asbestos.
Because of this wide usage, it m ay be difficult a t tim es to deter­
mine if  a disease arising from asbestos is occupational in 
origin. For example, the air of some relatively new apartm ent 
buildings has been found to contain more asbestos fibers th an  
the m axim um  recommended levels in  industry . The source of 
the fibers in  the apartm ent buildings is the insu la ting  
m aterials used in the ventilation system.
Exposure to asbestos can produce a lung fibrosis called 
asbestosis. The onset of asbestosis is usually gradual, 
developing over a period of 10 to 30 years of exposure to 
significant concentrations of asbestos. Occasionally, from 
very m assive exposures, it m ay develop more quickly.
Asbestos is also a cancer producing agent (bronchogenic 
carcinoma, mesothelioma) and  can cause certain  specific skin 
diseases (asbestotic subcutaneous granuloatosis and  asbesto- 
tic cutaneous verruc a). H eavy exposure to dust containing 
asbestos can cause sk in  irritation . Epidemiologic studies 
(experience with groups of people) and  anim al studies have 
shown th a t increased exposure to any  of the types of asbestos 
increases the risk  of lung cancer (bronchial carcinoma). This 
carcinom a appears to be related to the degree of exposure to 
asbestos, the type of asbestos, and  cigarette smoking. I t  is also
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significant th a t cigarette smoking in men and women greatly 
increases the risk of lung cancer in those who are exposed to 
asbestos. Smoking is a factor th a t should be considered when 
determ ining whether lung cancer is caused, wholly or in part, 
by an occupational exposure to asbestos.
Mesothelioma, a rare  m alignant tumor of the mem brane which 
lines the chest cavity and the abdom inal cavity, is occurring 
with increasing frequency in workers w ith exposure to asbes­
tos. The development of this tumor apparently  is not related to 
the am ount of asbestos inhaled and it is found in persons not 
having  asbestosis, Levels of exposure which are w ithin 
accepted standards for protection against asbestosis m ay not 
protect aga in st mesothelioma.
An increased incidence of m alignancy of the stom ach and 
colon has  been reported am ong insulation workers using 
asbestos.
O ccupations w ith  P o ten tia l Exposure to A sbestos
acoustical product makers 
acoustical product installers 
a ir filter m akers 
asbestos-cement 









asbestos-m ortar m akers 
asbesos-m ortar users 
asbestos millers 
asbestos miners 
asbestos-paper m akers 
asbestos-paper users 
asbesos-plaster m akers 






furnace filter m akers 
gasket m akers
h eat res is tan t clothing m akers
insulation workers
inert filter m edia workers
ironing board cover m akers
laboratory  hood installers
laggers
pain t m akers
pipe insulators
plastics m akers
pump packing m akers
roofers











brake lining m akers 
building demolition workers 
carders (asbestos) 
caulking compound makers 
caulking compound users 








vinyl-asbestos tile makers 
vinyl-asbestos tile installers 
weavers (asbestos)
Medical Evaluation and Differential 
Diagnosis
(Also, See Decision-Making Process)
In addition to the usual medical history, the following should 
be considered:
1. Any history of diseases of the heart or lung or abnornal 
tissue growth should be carefully evaluated to determine 
the relationship between the previous disease and the 
claim ant's present condition.
2. A respiratory questionnaire, a sam ple of which is shown 
in Appendix C, can be useful in evaluating the extent 







Shortness of breath  upon exertion is usually the first 
symptom, frequently accompanied by a dry cough. This 
sym ptom  develops afte r several years of progressive 
pulm onary fibrosis. As asbestosis progresses, the following 
signs and symptoms are observed:
—Cough with production of sputum,
—anorexia (loss of appetite),
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—secondary respiratory infections th a t are difficult to 
control,
—rapid  breathing,
—repetitive end-inspiratory crackles (crackling sounds 
heard in the lower part of the lungs through stethoscope 
when employee completes each of a series of inhaled 
breaths),
—orthopnea (breathing difficulty in a recum bent position), 
—cyanosis (change in skin color to bluish, grayish, slate­
like or dark  purple),
—decrease of chest expansion,
—digital clubbing (rounding of the ends, and swelling of 
the fingers and /o r toes), and 
—sequelae (other re su lta n t d iseases) including  cor 
pulm onale (right h eart failure), bronchogenic carcin­
oma (lung cancer), stom ach or in testinal cancer, or 
pleural carcinoma (cancer of the m em brane lining the 
chest).
Fibrosis results in alveolo-capillary block (impaired ability 
of the lungs to transfer oxygen into the blood). This im pairm ent 
is often more severe than  is indicated by chest X-rays.
M esotheliom a
In cases of mesothelioma, the rare  m alignancy noted above, 
there m ay be a long laten t period, as much as 40 years, between 
in itia l exposure to asbestos and  the development of the tumor.
Mesothelioma of the peritoneum  (mem brane surrounding the 
abdom inal organs) is usually accompanied by abdom inal 
swelling and pain tha t is not concentrated in a particular 
area. Signs and symptoms of th is type of tum or (which m ay  be 
associated with asbestos exposure) include;
—Weight loss,
—obstruction of the bowel, and
—excessive accum ulation of fluid in the abdom inal cavity 
(ascites) is almost always present.
This m alignan t tumor of the peritoneum m ay spread to the 
chest cavity.
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With mesothelioma of the pleura, com plaints include chest 
pain and  breathlessness. Signs and  sym ptom s of pleural 
mesothelioma include:
—Pleural effusion (accumulation of fluid in the space 
around the lungs),
—the tum or m ay grow outward through the chest wall in 
the form of a lump beneath  the skin (subcutaneous lump), 
—the tum or m ay spread to involve bone, lym ph glands 
(nodes), m ediastinum  (area between the righ t and left 
lungs), and pericardium  (the sac enclosing the heart). As 
a result, the supraclavicular nodes m ay become 
enlarged, ribs m ay develop tum ors, and  obstruction of 
the superior vena cava (major vein drain ing  the upper 
portion of the body) m ay occur, and 
—in addition, pericardial effusion (fluid in the h eart cavity) 
m ay occur, causing tam ponade (acute compression 
of the heart).
Laboratory and Clinical Examinations
(See Decision-Making Process)
Additional da ta  which will assis t in arriv ing a t a correct 
diagnosis are:
Chest X-rays
Findings should be classified according to the 1LO/UC 1971 
Classification of the Radiographs of the Pneumoconioses.
F indings for asbestosis vary, but the usual picture shows a 
density in both lungs, w ith the lower one-third of the lungs 
involved. In the affected area there is a “ground g lass” 
appearance.
As asbestosis progresses, more and  more of the lung is involved, 
except the apices (tips of the lungs). The X-rays will show 
gradual obscuring of the border between the lungs and the 
diaphram . It m ay show shadow s from the presence of nodules.
X-ray findings usually will show the following as the asbestosis 
progresses:
—Reduced radiographic volume and 
—form ation of cysts combined with increased size of the 
heart, dilation (enlargem ent) of the proximal pulm onary 
arteries (arteries which lead from the h eart to the lungs).
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Reduced lung capacities and  other lung changes do not differ 
from those resulting from other forms of lung fibrosis, both 
occupational and nonoccupational. Therefore, the results of 
lung function tests alone or chest X-ray findings alone do not 
lead to diagnosis of asbestosis. Asbestos bodies in lym ph nodes 
indicate exposure, but not necessarily asbestosis.
—Asbestosis causes a reduction in the v ital capacity (VC) 
of the lungs and a reduction in to tal lung capacity (TLC). 
These capacities are further reduced as the disease 
progresses.
—The residual volume (RV) of the lungs will be norm al or 
slightly increased.
—The lungs’ diffusing capacity for carbon monoxide (DL) 
will be reduced.
Other lung function test results which are found in asbestosis 
include:
—Increased minute ventilation (am ount of air breathed in 
one minute),
—reduced oxygenation of the arterial blood (arterial 
hypoxemia),
—increased static  transpulm onary pressures, and 
—decreased lung compliance.
An exercise test will result in an  increased am ount of air 
required during physical effort and decreased oxygen in  the 
blood, leading to cyanosis.
Sputum  Exam ination
Asbestos fibers or bodies m ay be found in the sputum . These 
indicate asbestos exposure, but not necessarily asbestosis. 
Where cancer cells are present in the sputum , and  chest X-ray 
findings are norm al? bronchoscopy m ay be necessary to 
confirm and locate the lung tumor.
Skin  Tests
The following tests should be performed by the physician to 
exclude possible infectious diseases:
1. PPD (tuberculin test) 3. histoplasm in
2. blastom ycin 4. coccidioidin
L ung  F unction  Tests
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Ep idemiology
Various epidemiologic studies have dem onstrated the rela- 
tionaship between asbestos and lung disease, including 
mesothelioma, in such trades and occupations as mining, 
insulation installa tion, textiles, paint, electrical industries, 
and m any other occupations as a result of the w idespread use of 
this substance.
The available inform ation indicates evidence of a dose- 
response relationship for asbestos exposure and the risk of 
asbestosis an d /o r  bronchogenic carcinoma. However, much of 
this inform ation is epidemiologic in natu re and  there is little 
correlation between epidemiologic da ta  and  environm ental 
exposure data . For th is reason and others, including the long 
la ten t period for the development of carcinom as, it is difficult 
to develop a specific dose-response relationship. This should be 
taken into consideration when referring to the  following 
m aterial:
Enterline19 has  reported an  exposure-response relationship 
between asbestos exposure (evaluated as millions of particles 
per cubic foot years) and  the risk of m alignan t and  nonmalig- 
n a n t respiratory disease. Enterline’s da ta  indicate th a t the 
risk of respiratory cancer increased from 166.7 (standardized 
m ortality ratio) a t m inim um  exposure to 555.6 a t cum ulative 
exposures exceeding 750 million particles per cubic foot years. 
Enterline’s d a ta  is sum m arized in a table by N IOSH 20.
M urphy21 reported th a t asbestosis w as 11 times more common 
am ong pipe coverers in  new ship construction th an  in  a control 
group. The first asbestosis w as found after 13 years of exposure 
to an  estim ated cum ulative dose of about 60 million particles 
per cubic foot years. A fter 20 years, asbestosis prevalence was 
38%. M urphy reported no asbestosis for men exposed to 60 
mppcf years bu t 20% asbestosis in  men exposed to 75-100 m ppcf 
years. M urphy reports atm ospheric dust concentrations 
ranged from 0.8 - 10.0 mppcf depending on the different 
operations evaluated. Asbestosis was considered present if  thè, 
worker had  a t least three of the following: V ascular rales fn two 
or more sites, clubbing of the fingers, v ital capacity of less th an  
80% predicted, roentgenography consistent w ith m oderately 
advanced or advanced asbestosis, and  shortness of breath  on 
climbing one flight of stairs.
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The Pennsylvania D epartm ent of H ealth22 reported a study of 
asbeBtos dust concentrations in  two p lan ts (one from 
1930-1967 and  the other from 1948-1968). Sixty-four cases of 
asbestosis were reported. In  the two plants, the Btudy indicates 
th a t the air concentrations of particulates were generally less 
than  five mppcf and in  m any cases less th an  two mppcf.
Epidemiologic evidence is also available rrela ting  the 
development of mesothelioma w ith exposure to asbestos. 
Selikoff 23 24 reported 14 deaths from mesothelioma in  532 
asbestos insulation workers from 1943-1968. No deaths from 
mesothelioma would be expected from the sam e num ber of 
individuals in the general population.
Evidence of Exposure
Historically, there have been two air sam pling and  analysis 
methods to determine the quantity  of asbestos in the workplace 
environm ent. The earlier light field im pinger count method 
allowed only a m easure of the overall dust level in  the air ra ther 
than  focusing on the am ount of asbestos fibers in  the air. The 
current fiber count method satisfactorily determines the 
am ount of asbestos fibers in the air. I t is performed by 
collecting airborne m aterials on a m em brane filter and  then 
counting the fibers using a phase contrast microscope a t a  400 
to 450 times m agnification ratio (400X-450X).
Asbestos fibers occur in varying lengths and diam eters. As of 
the publication of the guide, the O ccupational Safety and 
H ealth  A dm inistration (OSHA) establishes m axim um  allow­
able lim its for asbestos fibers greater th a n  five micrometers 
(um) in length. OSHA lim its such asbestos fibers to no more 
than  2 fibers per cubic centimeter of air (based on an  eight- 
hour time-weighted average exposure).
OSHA further requires th a t no workers be exposed to more than
10 asbestos fibers (greater th an  five um in  length) during any  
one 15- minute period of time.
For sam ples collected by the field im pinger count method, 
results m ay be compared to the pre-1970 lim it (TLV) of five 
million particles per cubic foot of air.
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Occupational exposure to asbestos fibers five um in length or 
greater, at quantities averaging more than 2 fibers per cubic 
centimeter of air or frequent exposures to more than 10 such 
fibers during a 15-minute period of time is evidence of a possible 
causal relationship between disease and occupation.
Toxicological 
(See References 19-24 Appendix A)
Conclusion
The diagnosis of occupational asbestosis is based on meeting 
the following criteria:
1. Confirmed history of occupational exposure to asbestos.
2. X-ray findings compatible with those indicating asbes- 
tosis according to ILO/UC 1971 "Classification of Radio­
graphs of the Pneumoconioses.”
3. Pulmonary impairment, particularly a decrease in lung 
diffusing capacity and an increase in alveolar-arterial 
oxygen difference, as demonstrated by lung function tests.
The diagnosis of occupational mesothelioma is based on 
meeting the following criteria:
1. Confirmed history of occupational exposure to asbestos.




Benzene, an aromatic organic compound, is a colorless liquid 
that is a good solvent for many other organic compounds. It is 
commonly called benzol and in high doses exerts an acute nar­
cotic action on the body. Because of benzene’s extreme toxicity, 
less toxic substances are now being substituted for it in indus­
tries such as artificial leather manufacture, rubber products 
manufacture, and printing.
Absorption of benzene through inhalation is the most impor­
tant route of entry in industrial exposures. Benzene interferes 
with the body’s blood forming system and can cause such dis­
turbances as leukopenia (reduction in the number of white 
blood cells), aplastic anemia (a drastic reduction in the number 
of red blood cells), thrombocytopenia (reduction in the number 
of platelets), and leukemia. Prolonged or repeated skin ex­
posure can result in the development of blisters, erythema 
(localized redness), and a dry, scaly dermatis.
Long latency periods of 10 to 15 years from the time of exposure 
to the development of disease are possible. In addition, signs 
and symptoms of toxicity may persist after treatment.
The following is a listing of common names for benzene 



















O ccupations w ith  P o te n tia l Exposures to  Benzene
adhesive makers 
airplane dope makers 
alcohol workers 
aniline makers 
art glass workers 







































































































window shade makers 
wire insulators
Medical Evaluation and Differential 
Diagnosis
(See also Decision-Making Process)
The following should be carefully evaluated to determine if 
present findings may be associated with a previous disease: 
—History of blood disease,
-^bleeding abnormalities,




—serious bacterial, viral, or protozoan infection of the 
colon, and
—inflammation of several nerves (polyneuritis) due to 
other industrial poisons (e.g., lead) or in chronic 
excessive alcohol intake.
Nonoctupational Exposure
Consider also that exposure to benzene may be from a hobby 




—use of dry cleaners and spot removers, and 
—use of gasoline, paint, wax, lacquer, or leather preser­
vatives.
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In addition, the following should be considered:
—Any known exposure to benzene or any other poisonous 
substances affecting the blood or blood-forming tissues 
(hemotologic toxins),
—ionizing radiation exposures (which also affect the blood- 
forming organs), and 




Acute benzene intoxification occurs following exposure to 
high levels of benzene vapor. Signs and symptoms include:
—Feeling of exaggerated well-being (euphoria),
—excitement,
—exhilaration followed by drowsiness, fatigue, vertigo, 
nausea, and headache,
—respiratory irritation and pulmonary edema,
—gastrointestinal irritation, with vomiting and colic,
—localized redness (erythema), blistering of the skin, 





—paresthesia of hands and feet (numbness, prickling, 
tingling),
—staggering gait,
—incoherent speech, and 
—flushed face.
Continued exposure can result in unconsciousness and death 
from respiratory paralysis. The course of the intoxication may 
be enhanced by muscular exertion, emotions, and fear.
The clinical effects of accidental ingestion of benzene include: 
—Local irritation of the mucous membranes of the mouth, 
throat, esophagus, and stomach, and 
—bronchitis, pneumonia, and collapse may ensue.
Ingestion of benzene results in blood absorption and may 
proceed to systemic intoxication.
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Chronic P o ison ing
Chronic benzene poisoning can occur from daily inhalation 
of benzene. The clinical manifestations of chronic benzene 
poisoning tend to be insidious in onset and are nonspecific. 
They resemble those of many other diseases:






—tiredness, lassitude, weariness, fatigue and weakness.
Other symptoms may include:
-P allo r,




—excessive bleeding at the time of menstruation 
(menorrhagia).
Benzene exposure predisposes to leukemia of the following 
types: Chronic myeloid, chronic lymphatic, and acute 
myeloblastic.
Laboratory and Clinical Evaluations
Additional data which will assist in arriving at a correct 
diagnosis are:
Blood
—arterial blood benzene level
—red blood cells destroyed at a rapid rate (hemolysis) 
—elevated young red blood cell count (reticulocytosis)
—reduced platelet count (thrombocytopenia)
—reduced white blood cell count (leucopenia), an early sign 
—drastic reduction in red blood cells (aplastic anemia)
—increased mean corpuscular volume (average volume of 
red blood cells)
—reduced hemoglobin (that part of the red blood cell that 
carries oxygen)
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—increased plasma bilirubin (orange-colored or yellowish 
pigment in bile)
—hemosiderosis of the liver, spleen, kidneys, or bone 
marrow (a condition characterized by the deposition of 
an iron-containing pigment in these sites)
—the bone marrow may have reduced capacity to produce 
blood cells (hypoplasia); this may be seen in persons with 
short- or long-term exposure to benzene and is more 
common in females 
—the bone marrow may have increased capacity to 
produce blood cells (hyperplasia); this may be seen in 
persons with long-term exposure and is more common in 
males
—chromosome aberrations in peripheral and bone marrow 
cells occur and may persist after exposure.
U rine
—increased urobilinogen
—increased phenol — less than 75 milligrams per liter is 
normal
—ratio of inorganic to total sulfates—normal limits are0.05 
to 0.1 milligram per liter. NOTE: Sample must be 
collected and test begun within one hour after workday 
exposure.
In workers exposed to benzene, hematologic teats should be 
conducted monthly, while urine sulfate testa should be 
conducted every week. Liver and kidney function studies 
should also be evaluated.
Epidemiology
The relationship between benzene and the blood-forming 
tissues of the body has been demonstrated in many epidemio­
logic studies. However, the National Institute for Occupa­
tional Safety and Health has reported that “symptomatic 
effects associated with benzene poisoning often do not correlate 
with objective findings. Even in Berious cases of chronic 
benzene poisoning, symptomatic effects may be completely 
absent.” '* For this reason, a dose-response relationship has not 
been established. These facts should be considered when 
referring to the following material. Sections in quote are from 
NIOSH:^
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Aksoy et al.26 reported a study of 217 workers exposed to 
benzene for periods of 3 months to 17 years in small shops 
manufacturing shoes under poorly ventilated conditions. 
Benzene exposures ranged between 30 and 210 parts per million 
(ppm). Fifty-one (23.5%) of the workers showed hemotological 
abnormalities, consisting of leucopenia, thrombocytopenia, or 
pancytopenia. No cases of leukemia were observed.
In a 7-year study of 28,500 shoeworkers who were chronically 
exposed to a range of 150*650 ppm benzene for from 4 months to 
20 years, Aksoy et al.27 reported on 34 workers who had various 
types of leukemia. Acute myeloblastic leukemia was the most 
frequent type (14 workers, 41.1%), followed by preleukemic (6 
workers, 17.6%), acute erythroleukemia (6 workers, 17.6%), and 
acute lymphoblastic leukemia (4 workers, 11.7%). Among 31 
shoeworkers, the incidence of leukemia of 13.5 per 100,000 
was significantly greater (P<0.001) than the overall 
incidence of leukemia in the general population which was 6 
per 100,000. It was reported that there was a decline in the 
number of cases in the last year of the study which may be 
attributed to the prohibition of the use of benzene.
Forni et al.20 and Hartwick and Schwanitz29 reported benzene- 
induced chromosome changes in peripheral blood lymphocytes 
or bone marrow. In followup studies, Forni observed signifi­
cantly increased rates of “unstable" and “stable” chromosome 
aberrations which persisted several years after exposure to 
benzene had ceased and clinical recovery from the poisoning 
had occurred.
From the data Greenberg30 collected, he concluded that cases 
showing less than 5,000 white blood cells per cubic millimeter 
should be considered positive; 7,500 to 9,000 was considered the 
normal count.
Hardy and Elkins31 reported “that levels of benzene exposure 
ranging from 40-80 ppm with an estimated average of 60 ppm in 
the artificial leather industry had produced deviations in more 
than 1 blood element in 16 out of 52 workers exposed.”
Juzwiak32 reported a study of “585 workers in 13 shoe plants 
who had been exposed to benzene in a glue mixture. Mean 
concentrations of benzene fluctuated from 31-156 ppm. 
Reduced red blood cell counts, white blood cell counts, and 
hemoglobin levels were reported. Ninety-one percent (91%) of
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the workers had reduced hemoglobin levels but only 8.5% had 
reduced white blood cell counts." Environmental data were 
inadequately documented, so it is difficult to correlate 
medical findings with the airbqrne exposures in this study.
In a report of an 11 plant study of 162 workers in the rubber 
coating industry, Pagnotto et al.33 concluded that the urinary 
phenol determination test provides a “good index of benzene 
exposure.” The following table from NIOSH presents air- 
urinary correlation data:
URINARY PHENOL LEVELS WITH 
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Sherwood34 cites the following guidelines for monitoring 
benzene exposure using routine assay of phenol in urine:
1. Values over 100 milligrams per liter—significant risk 
indicated,
2. values over 30 milligrams per liter—probability of 
benzene exposure indicated, and




The NIOSH approved air sampling method uses absorption 
on activated charcoal. Four methods previously used are:
1. Absorption in anhydrous methanol,
2. absorption in nitrating solutions,
3. direct collection of whole-air samples, and
4. absorption on silica gel.
The NIOSH approved method for air sample analysis uses gas 
chromatography. Two methods previously used are:
1. Colorimetric evaluation, and
2. ultraviolet spectrophotometry.
These methods are not intended to be exclusive but other 
methods should be justified.
Various types of direct-reading field instruments are also avail­
able to measure benzene concentrations in air. They include 
detector tubes, combustible gas meters, flame ionization 
meters, portable gas chromatographs, and portable infrared 
analyzers.
Allowable Exposure Limit
The Federal standard for benzene is 1 ppm based on an 
8-hour time-weighted average exposure, with 5 ppm as a 
maximum peak above the acceptable ceiling for a maximum 
duration of 15 minutes. If initial exposure measurements show 
that concentrations are below l/i of the permissible level, or 0.5 
ppm, periodic monitoring will not be required. Above that level, 
however, monitoring and routine medical surveillance as well
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as other practices will be triggered. Benzene has been classed 
as a suspect leukemogen by OSHA. NIOSH has identified 
benzene as a confirmed occupational carcinogen for blood- 
forming tissue and a suspect carcinogenic agent for lymphatic 
tissue (Key et al., eds., 1977). NOTE; This standard is 
currently being litigated in the U.S. Court of Appeals for 
the 5th Circuit. (American Petroleum Institute et al. vs. 
OSHA.)
Conclusion
Diagnostic criteria for chronic occupational benzene 
poisoning is based on meeting the following:
1. Confirmed history of occupational benzene exposure,
2. clinical signs and symptoms consistent with benzene 
poisoning, and
3. findings from blood studies consistent with aplastic 
anemia and/or leukopenia and/or thrombocytopenia 
and/or leukemia.
It is possible to have the signs and symptoms of chronic 
benzene poisoning with a normal blood picture.
Post-mortem findings in acute benzene poisoning via 
inhalation include extensive petechial hemorrhages in the 
brain, pleurae (lining of the chest cage and lungs), pericardium, 
urinary tract, mucous membranes, and skin.
Urine, phenol, and sulfate levels are not diagnostic by them­




Carbon monoxide is a colorless gas produced by incomplete 
burning of carbon-containing materials. On inhalation, it acts 
as an asphyxiant, causing a decrease in the amount of oxygen 
delivered to the body tissues. Carbon monoxide combines with 
hemoglobin (the oxygen carrier in the blood) to form carboxy- 
hemoglobin, which reduces the oxygen carrying capacity of the 
blood.
The two main sources of carbon monoxide exposure are the 
internal combustion engine and cigarette smoking.
The .blood of cigarette Bmokers contains between 3 and 10 
percent carboxyhemoglobin (COHb) deppnding on the number 
of cigarettes smoked and the manner of smoking, inhaling or 
not inhaling. During smoking, the individual is being expo&ed 
to the equilvalent of400-500 parts per million carbon monoxide. 
The COHb of non-smokers is approximately 0.5-0.8 percent. 
Thus, in evaluating occupational exposure to carbon monoxide, 
the smoking habits of the individual must be carefully 
evaluated.
An exposure to carbon monoxide is usually sudden and the 
BymptomB are acute and rapid in onset. Headache and 
dizziness may rapidly progress to unconsciousness depending 
on the rate of buildup of COHb in the blood. Once the person is 
removed, from the carbon monoxide exposure, the process iB 
reversible and no permanent damage is known to occur.
Prolonged exposure and. unconsciousness may cause brain 
damage and result in neurological disturbances.
If chronic carbon monoxide poisoning exists, it is not a 
clearcut, identifiable entity that can be diagnosed. Toxicologic 
and .epidemiologic studies have not yielded adequate infor­
mation to establish any physical impairment from chronic 
exposure to carbon monoxide.
Carbon monoxide is especially serious for persons with chronic 
heart or lung disease. The reason for this is that the carbon 
monoxide in the blood reduces the amount of oxygen available 
to an already damaged heart muscle.
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Occupations w ith  P o ten tia l Exposures 
to C arbon Monoxide




artificial abrasive makers 
artificial gas workers 
automobile users 
bakers



































gas workers (illumination) 
gasoline engine testers 
gas station attendants 
heat treaters 
iron workers
Kraft recovery furnace workers 
laundry workers 
lift truck operators (propane 
and gasoline) 
lime kiln workers 
mercury smelters 








organic chemical synthesizers 
oxalic acid makers 
patent leather makers 
police
producer gas workers 
















Medical Evaluation and Differential 
Diagnosis
(See also Decision-Making Process)
In the medical history, the following should be considered: 
—Neurological diseases, and
—it is important to note that persons with anemia, cardio­
vascular disease, and chronic lung disease have a 
decreased ability to resist the effects of carbon monoxide.
Occupational History
Potential non occupational sources of carbon monoxide 
include:
—Air pollution (particularly in areas of high motor vehicle 
use),
—cigarette smoking,
—cooking with charcoal in enclosed areas,
—burning carbon-containing materials in enclosed space, 
—hobbies involved with the operation of automobiles or 
gasoline engines,
—working as a volunteer fireman,
—malfunctioning stove, furnace or heater, and 
—faulty auto exhaust system.
Signs and Symptoms







Initially, there is lack of color in the skin (skin pallor). Later, 
the skin and mucous membrane may be cherry red due to 
carboxyhemoglobin formation. Breathlessness upon exertion, 
rapid throbbing or fluttering of the heart (palpitation), and pain 
on the surface of the chest in the heart area (precerdial pain) 
may be present. Excess fluid in the lung tissues (pulmonary 
edema) may also occur, or the victim may develop pneumonia.
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It is important to ascertain the circumstances associated with 
carbon monoxide poisoning since the action of carbon 
monoxide is favored by conditions of heat, humidity, and a 
greater amount of muscular activity.
Chronic Carbon Monoxide Poisoning
There is conflicting opinion concerning the chronic effects of 
carbon monoxide. Other than increased carboxyhemoglobin 
levels in the blood, there are a few objective signs. Persons 
with chronic exposure to low levels of carbon monoxide develop 
a tolerance for it. However, the following have been described 
as characteristic symptoms of chronic carbon monoxide 
poisoning: .
—loss-of muscular strength and mental alertness,,
—persistent headache,
—constant dizziness and light headedness, and 
—auditory nerve damage.
Exposures to low levels of carbon monoxide may cause or 
enhance itiyocardial alterations (heart changes) in persons 
with coronary heart disease.
Laboratory and Clinical Examinations
(See Decision-Making Process)
Additonal data which will assist in arriving at a correct 
diagnosis are:
—Blood carboxyhemoglobin of 10 percent or more, 
—hemoglobin value may be increased,
—electrocardiogram may show sinus tachycardia and ST 
segment changes, and 
—electroencephalogram may show focal and diffuse 
epileptiform (resembling epilepsy) changes which 
later disappear.
Epidemiology
Acute carbon monoxide poisoning from inhalation is well 
documented in the scientific literature. It is the most common 
poisoning in industry and may occur wherever internal com­
bustion engines are in use. However, the question of whether 
chronic carbon monoxide poisoning exists has not been resolved 
in spite of numerous studies conducted by various researchers.
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Many of the reports dealing with carbon monoxide (CO) 
toxicity are in terms of carboxyhemoglobin (COHb) percentage 
in blood. The percent of COHb depends on many factors in­
cluding CO concentrations in air, total time of exposure to 
various air concentrations of CO, diffusion rate of CO through 
the lungs, ventilation rate, type of activity being done, meta­
bolic rate, barometric pressure, and temperature. NIOSH35 
recommends an allowable level for CO of 35 ppm based on an 
8-hour time-weighted average exposure so that COHb percent 
does not exceed five. The current allowable limit of 50 ppm CO 
based on an eight-hour time-weighted average exposure is de­
signed to maintain COHb less than 10%.
SYMPTOMS CAUSED BY VARIOUS AMOUNTS OF 
CARBON MONOXIDE HEMOGLOBIN IN THE BLOOD* 
BLOOD SATURA-




Tightness across forehead, possible 
slight headache, dilation of cutaneous 
blood vessels.
20-40 Headache and throbbing in temples. 
Severe headache, weakness, dizziness, 
dimness of vision, nausea, vomiting, 
collapse.
40-50 Same as previous item with more 
possibility of collapse and syncope. 
Increased respiration and pulse.
50-60 Syncope, increased respiration and 
pulse, coma with intermittent 
convulsions and Cheyne - Stokes 
respiration.
60-70 Coma with intermittent convulsions. 
Depressed heart action and respiration 
and possible death.
70-80 Weak pulse and slow respiration, 
respiratory failure and death.
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TIME FOR VARIOUS CONCENTRATIONS OF 
CARBON MONOXIDE TO PRODUCE 80% 
EQUILIBRIUM VALUE OF BLOOD SATURATION












1,600-2,000 61-64 1-1 Vi
2,100-3,000 64-68 Vi-Vx
3,100-5,000 68-73 20-30 Min.
5,000-10,000 73-76 2-15 Min.
There have been a number of reports showing evidence of 
behavioral effects in man on exposure to low levels of CO. The 
results of these studies indicate that exposure to low concen­
trations of CO could affect a worker’s ability to work safely. 
McFarland37 reported difficulties in visual discrimination at 
5% COHb (similar results were reported by Halperin38). 
Horvath39 reported significantly impaired vigilance at 6.6% 
COHb. Schulte40 indicated various physiological and 
behavioral tests were effected by COHb levels as low as 5%. 
Beard4142 in two reports showed exposure to CO in concen­
trations ranging from 50-250 ppm caused a deterioration in the 
ability to discriminate auditory stimuli and exposures to 50 
ppm caused impairment in time discrimination. Trouton43 
reported impairment in muscle limb coordination at COHb 
levels of approximately 5%. There have been a number of 
studies made relating carbon monoxide exposures to cardio­
vascular ramifications. NIOSH44 concludes that the results of 
these studies provide sufficient evidence so that “based on 
cardiovascular alterations which could prove to be of severe 
physiological consequences for persons with CHD (coronary 
heart disease), a significant portion of who are in the worker 
population, it seems advisable that levels of COHb (carboxy- 
hemoglobin) in excess of 5% should be avoided.”
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Evidence of Exposure
Air Sampling and Analysis
There are a variety of direct-reading field instruments 
for the evaluation of carbon monoxide in air including 
Hopcalite-type carbon monoxide meters and detector tubes. 
Air samples can also be collected for carbon monoxide by 
techniques including adsorption on silica gel. Analysis may be 
performed by calorimetric, infrared spectrophotometric, and 
gas chromatographic techniques.
These methods are not intended to be exclusive, but other 
methods should be justified.
Allowable Exposure Limits
The Occupational Safety and Health Administration 
(OSHA) limits carbon monoxide to 50 parts per million parts of 
air by volume based on an eight-hour time-weighted average 
exposure.
See Reference 29-38, Epidemiologic Data, Appendix D.
Conclusion
Diagnosis of occupational carbon monoxide exposure is 
based on the following:
1. Confirmed history of occupational exposure to carbon 
monoxide,
2. carboxyhemoglobin in excels of 10 percent, and
3. clinical findings compatible with carbon monoxide 
poisoning.
One medical researcher (Hunter, D. 1969. The Diseases of 
Occupations, 4th ed. Boston: Little, Brown and Co.) states 
that claims of impaired health from exposure to carbon 
monoxide are unjustified unless three conditions can be 
established:
1. At least a 50 percent saturation of the blood with carbon 
monoxide (not carboxyhemoglobin) or evidence of 
enough carbon monoxide in the air to produce it,
2. an exposure of at least three hours, and
3. continuous and complete unconsciousness for at least 




Coke oven emissions are a complex mixture of particulates, 
vapors, and gases that result from the destructive distillation 
of bituminous coal in the production of coke. (Coke finds its 
major application in the production of steel.)
Coke oven workers have an increased risk of developing cancer 
of the lung, urinary tract, and skin. This risk has been shown to 
be related to the area of employment (i.e., workers employed at 
the top of the oven have the greatest risk followed by part-time 
topside and side oven jobs) and the length of employment. 
Epidemiologic stuides have also shown that exposure to coke 
oven emissions increases the risk of nonmalignant respiratory 
diseases such as bronchitis and emphysema. It should be noted 
that smoking habits, previous exposure in a dusty industry or 
environment, and oven work area have been identified as 
significant factors in the development of these diseases. These 
factors should be considered when determining whether 
nonmalignant diseases are caused wholly or in part by occupa­
tional exposure to coke oven emissions.
Long latency periods of 15 to 25 years from the time of exposure 
to the development of carcinoma have been observed.
The following is a list of occupations with potential exposures 
to coke oven emissions:
O ccu p a tio n s  w ith  P o te n t ia l  E x p o su re s  to  C oke O ven  
E m issio n s
coke oven door cleaners - lu term an
coke oven door machine operators
coke oven heater
coke oven larry car operators
coke oven lidmen-larrymen
coke oven maintenance men
coke oven patcher
coke oven pusher operators
coke oven quench car operators
coke oven tar chaser
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M ed ic a l E v a lu a t io n  a n d  D iffe r e n tia l  
D ia g n o s is
(See also Decision-Making Process)
The following should be considered:
—Any history of skin, genitourinary, or pulm onary disease 
should be carefully evaluated to determine the relationship 
between the previous disease and  the c laim ant’s present 
condition, and
—a respiratory questionnaire, (Appendix C), can be useful 
in  evaluating respiratory symptoms.
S ig n s  a n d  S y m p to m s  o f  C a n cero u s  
C o n d itio n s
Lungs
The early signs and symptom s of lung (bronchogenic) cancer 
are nonspecific and include:
—Cough
—coughing up mucous or phlegm (expectoration),
—coughing up blood (hemoptysis),
—weight loss which m ay not be associated w ith symptom s 
until late in  the course of the disease,
—collapsed or airless condition of a section of the lung 
(atelectasis),
—wheezing respiration,
—segm ental em physem a (trapping of air in  a part of the 
lung) or fibrosis (scar tissue formation),
—pneum onitis,
—abscess formation, and
—signs of m etastasis (spreading of the cancer from one 
organ to another).
Genitourinary
The signs and  symptom s associated w ith the kidney, 
bladder, and urinary  trac t include:
—Blood in the urine w hich m ay be in term itten t (hem a­
turia),
—pains between the rib and  pelvis area (loin pains),
—an  abdom inal m ass,




—An ulcer th a t does not heal,
—a sm all m ass on the skin,
—a lesion th a t bleeds easily or may ooze fluid and  form a  
scab, and
—pain  over the area exposed (the infiltration  site).
S ig n s  a n d  S y m p to m s  o f  N o n c a n c e ro u s  
C o n d itio n s
Respiratory - Bronchitis, Pulmonary Fibrosis, Chronic 
Obstructive Pulmonary Disease
Signs and  sym ptom s can include:
—Cough,
—coughing up mucus or phlegm,
—frequent upper respiratory infections,
—shortness of breath, and
—the use of extra-respiratory muscles to ass is t breathing.
The following g rading  system  has been devised to classify the 
degree of bronchitis according to symptomatology:
BRONCHITIS GRADING SYSTEM
GRADE LABEL SYMPTOMS
0 Asym ptom atic
1 Probable acute 
bronchitis
2 Acute bronchitis
No positive responses or 
only rare  respiratory 
symptom s
Cough OR sputum  
production present occasion­
ally, bu t for less th a n  3 
m onths of the year and  for 
less th a n  2 years.
Cough AND sputum  with 
the sam e frequency and 











Symptoms as in  Grade 2 
plus dyspnea on exertion
Cough OR sputum  present 
for 3 m onths each year and  
for a t least 2 years
Cough AND sputum  with 
some frequency and 
duration as in Grade 4
Symptoms as in  Grade 5 
plus dyspnea on heavy 
exertion (i.e., hill climbing)
Symptoms as in  G rade 5 
plus dyspnea on slight 
exertion (i.e., slow pace on 
level)
(Mittman et al., 1974)
NOTE: C igarette smoking has been associated with increasing 
the severity of symptoms and  should be considered when 
reviewing each case.
Skin
Signs and symptoms which m ay be present include:
—The skin reacts abnorm ally to ligh t (photosensitization) 
w ith resultant:
-diffuse redness (erythema),
-sw elling of body tissues (edema), and 
-burn ing  of the skin with hyperpigm entation developing 
later.
—acne and  blackheads (comedones),
—thickening of the skin (keratosis),
—contact derm atitis,
—form ation of benign tumors or w arts (papillomas), and 
—inflam m ation of follicles.
Systemic




—Inflam m ation of the m em brane th a t lines the eyelids and  
the front of the eyeball (conjunctivitis).
L a b o ra to ry  a n d  C lin ic a l E x a m in a t io n s
A dditional da ta  which will assist in  arriv ing a t  a correct 
diagnosis when cancerous conditions are being evaluated are:
L u n g s
—Chest X-ray,
—exam ination of sputum  for cancer cells (sputum 
cytology),
—visual exam ination of the bronchi (bronchoscopy),
—microscopic exam ination of a scalene node (scalene 
node biopsy),





—X-ray exam ination of the  kidney and ureters (in tra­
venous pyelogram),
—visual exam ination of the bladder (cystoscopy), 
—kidney biopsy,
—abdom inal X-ray, and 
—exam ination of the urine for cancer cells.
Skin
—Total rem oval of lesion, and microscopic (histological) 
exam ination.
A dditonal tests w hich will a ss is t in  arriv ing  a t a correct 
diagnosis w hen noncancerous conditions are being evaluated 
are:
Respiratory
—C hest X-ray and 
—pulm onary function test.
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Skin
—Exam ination under Wood’s ligh t for fluorescence of 
residual tar.
E p id e m io lo g y
The disease response to coke oven emissions has been shown 
to be related to length of employment and exposure level. 
Various studies have indicated th a t coal carbonization workers 
have a high riBk of developing cancer of the skin, lungs, and 
urinary  tract. These workers have also dem onstrated an 
increase in m ortality from cancer of the lungs and kidneys.
A causal but unproven relationship has been reported for 
carcinom a of the larynx, the n asa l sinuses, pancreaB, stomach, 
and blood-forming organs (leukemia). Evidence of an elevated 
risk of nonm alignant diseases such as bronchitis or 
emphysema has also been presented.
It has been shown th a t topside coke oven workers experience a 
higher rate  for carcinom a of the lung than  other coke oven 
workers, and nontopside workers have a higher rate for car­
cinoma of the kidney.
The reporta of disease response in parenthesis are from
NIOSH:45
Doll4B reported an  “81% excess of lung cancer deaths 
am ong gas works pensioners (gas retort workers) in compar­
ison with the general population.” Lloyd47 reported th a t “coke 
oven workers had an average lung cancer m ortality rate  of 2V* 
times th a t predicted by the experience of all steelworkers.”
Lloyd47 and Redmond et al.4H reported th a t “men employed a t 
the Allegheny County coke ovens for 5 or more years exhibited 
a lung cancer rate  th a t was 3.5 tim es the expected rate .” Also, 
men employed full time topside of the coke ovens had  a lung 
cancer m ortality rate  which was 9 times the expected rate, for 
partia l topside it is almost 2Vi times the expected rate, and for 
side oven only i t  is more than  l'/z times the expected m ortality . 
(All of these rates are based on 5 or more years exposure in the 
job category.)
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Henry et al.<9 reported an  "excess risk of bladder cancer am ong 
men employed a t coal carbonization processes.” Redmond 
et al.4B did not observe an  excessive incidence of bladder cancer 
in 4,661 coke oven workers; however, when it is considered th a t 
this is a com paratively rare cancer site with a long la ten t period 
and the study population has an extremely h igh risk for cancer 
of several other sites, the possibility of excess m ortality 
cannot be ruled out.
Over a 43 year period, Henry also reported 84 cases of 
epitheliomatous ulceration (cancer of the skin) including 40 
scrotal cancers. Among men with prior coke oven employment,
11 fatal scrotal cancers were reported.
The United Steelworkers of America™ reported a study of 112 
coke oven employees in which over 50% were diagnosed as 
h av ing  some lung im pairm en t (i.e., pneum oconiosis, 
emphysema, fibrosis, and chronic bronchitis).
E v id e n c e  o f  E x p o su re
Air Sampling and Analysis
The NIOSH approved air sam pling method uses mechanical 
filtration.
The NIOSH approved analytic method uses gravim etric 




The above methods are not intended to be exclusive but other 
methods should be justified.
A llo w a b le  E x p o su r e  L im its
The standard  adopted by the Occupational Safety and 
H ealth A dm inistration (OSHA) provides th a t no employee in 
the regulated area hiay be exposed to coke oven emissions in 
excess of 150 micrograms per cubic meter of air for an 
eight-hour period. For the purpose of the S tandard, coke 
oven emissions as defined as the benzene-soluble fraction
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of total particulate m atter present during the destructive 
distillation or carbonization of coal for the production 
of coke. The regulated area is the coke oven battery, 
including  top side, punchside, coke side and  th e ir  
m achinery, the wharf, and  screening station. Beehive 
ovens have also been established as a regulated area.
C o n c lu sio n
Diagnostic criteria for occupational carcinom a due to expo­
sure to coke oven emissions are:
1. Confirmed history of occupational exposure to coke 
oven emissions and
2. diagnosis of carcinom a as determined by laboratory 
evaluation and clinical findings.
NOTE: As carcinom a also occurs in  the population which is not 
occupationally exposed to coke oven emissions, the decision 
w hether a claim ant’s carcinom a is work related is most 
difficult.
C riteria for diagnosing occupational noncancerous conditions 
due to exposure to coke oven emissions include the following:
1. Confirmed history of occupational exposure to coke 
oven emissions and
2. clinical findings of respiratory, genitourinary, or skin 
exam ination as outlined above and  medical history.
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C o t t o n  D u s t
In tro d u c tio n
Among workers in cotton mills particularly where there 
exist high levels of dust exposure, for example in breakdown, 
opening, and  card rooms, the pneumoconiosis, byssinosis, has 
been found to be highly prevalent. The term  “pneumoconiosis” 
applies to conditions casued by accumulation of a variety of 
dusts capable of inducing a tissue reaction in the lung. 
Inhala tion  of cotton dust results in a type of pneumoconiosis 
which is known to cause decreases of the ventilatory capacity of 
the lungs as well as symptoms of chest tightness and dyspnea 
(labored or difficult breathing). Symptoms become progressive­
ly more severe during the work week, and  workers experience 
relief over the weekend. However, there is a critical point when 
irreversible pulm onary (lung) changes occur.
No specific cause has been found for byssinosis. There is suffi­
cient evidence to suggest th a t cotton dust itself, as well as an 
agent in the bracts (a major component of cotton trash), can 
lead to the liberation of excess h istam ine (a natura lly  occurring 
broncho-constrictor) when either or both come into contact 
with the bronchial mucosa (mucous membrane). Airway 
constriction m ay be induced by the deposition of cotton dust 
in the airw ays in the absence of an  immunological reaction.
It has been proposed th a t a polyphenol extracted from the 
cotton p lan t causes a Type III or A rthus reaction (a severe local 
inflam m atory reponse) which in tu rn  causes the disease. 
Though an  antibody to cotton antigen  was found in workers 
with byssinosis, this m ay represent a nonspecific immune 
(allergic) reaction.
The lungs of byssinotic workers contain an excessive am ount 
of reticulin and  collagen (connective tissue). Rounded yellow 
dust bodies w ith a  central black core are visible. Em physe­
m atous changes and  pathological evidence of chronic 
bronchitis are also seen.
The severity of reaction depends on a num ber of factors: 
D uration of exposure to cotton dust, individual susceptibility, 
the composition of the cotton dust fiber or particle size, and
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concentration. Smoking has been found to be significantly 
associated w ith byssinosis for workers in opening, picking, and 
carding operations.
Byssinosis is sim ilar in m any respects to nonoccupational 
bronchitis and  em physem a and  is often confused with it, 
especially in  advanced stages when sym ptom s of shortness of 
breath and  tightness of the chest are severe every day.
The following is a listing of occupations with potential 
exposure to cotton dust:
O c c u p a tio n s  w ith  P o te n t ia l  E x p o s u re  to  C o tto n  D u s t
beam ing operators openers (cotton mill)
(cotton mill)
carders (cotton mill) pickers (cotton mill)
carding m achine operators press box operators
(cotton mill) (cotton mill)
cleaner operators roving fram e operators
(cotton mill) (cotton mill)
cleaners (cotton mill) slash ing  operators (cotton mill)
combining m achine operator spindle pickers (cotton)
(cotton mil))
draw ing fram e operators spinners (cotton mill)
(cotton mill)
dryer operators (cotton mill) spooling operators (cotton mill) 
gin stand  operators Btripper operators (cotton)
(cotton gin)
ginners stripper operators (cotton mill)
grinders (cotton mill) tw isters (cotton mill)
handpickers (cotton) weavers (cotton mill)
lin t cleaneT operators 
(cotton mill)
M ed ic a l É v a lu a t io n  a n d  D iffe r e n tia l  
D ia g n o s is
(See also Decision-Making Process)




—other diseases of the cardiopulm onary system, and 
—smoking.
09
A worker having  a positive history for any  or all of the above is 
a t increased risk from occupational exposure to cotton dust.
A respiratory questionnaire, such as th a t in  the NIOSH 
Criteria Document on cotton dust, can be useful in  evaluating 







S ig n s  a n d  S y m p to m s
These m ay be shown as  soon as after a few hours of exposure 
or m ay even first appear as long as after 10 years of exposure to 
cotton, hemp, or flax dust.
The following clinical grading (or staging) system  has been 
devised to classify the degree of byssinosis according to 
symptomatology:
Grade 1/2: Occasional chest tigh tness on the first
day of the working week.
Grade I: Chest tightness an d /o r difficulty in
breathing on every first day of the 
working week.
Grade II: Chest tightness and  difficulty in
breathing on the firs t and  on other days 
of the working week.
Grade III: Grade II symptom s, accom panied by
perm anent (irreversible) pulm onary 
incapacity (i.e., chronic respiratory 
sym ptom s and  decreased ventilatory 
capacity  not relieved by appropriate 
drugs).
Although early symptoms of byssinosis are reversible if 
exposure to cotton dust ceases, a point is reached where 
perm anent, irreversible airw ay obstruction persists.
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When the disease is classed as  Grade II, continued exposure to 
cotton dust can induce episodes of bronchitis an d /o r asthm a.
In  Grade III, chronic lung disease can be accompanied by the 
following symptoms:
—Chronic bronchitis and  progression to em physem a and 
—cough with m ucopurulent (consisting of mucus and  pus) 
sputum.
The chest X-ray m ay be norm al in Grade III.
Though byssinosis was originally thought to be related to 
bronchial asthm a, there are  several im portan t differences 
between them. The onset of the sym ptom s of byssinosis occur 
gradually, while asthm a develops soon after exposure to an  
antigen.
Other conditions which m ay result from cotton dust exposure 
are as follows: “Weaver’s cough,” “mill fever,” “m attress 
m aker’s fever,” “stripper’s as th m a,” “grinder’s asthm a,” and 
“cotton card room asthm a.”
O ther acute illnesses resulting in  fatigue, loss of appetite 
(anorexia), headache, nausea, and  vomiting, have occurred 
from the utee of low grade or stained  cotton. The aerobacter 
cloacae bacteria m ay be a cause.
L a b o ra to ry  a n d  C lin ic a l E v a lu a t io n s
Pulm onary function tests are not conclusive but are 
generally necessary in m aking a correct diagnosis:
—A significant decline in one second forced expiratory 
volume (FEVi) from the m orning of the first day of the 
working week to the afternoon of the sam e day. The 
decrem ent is greater on the first day of the working 
week th a n  la ter in  the week.
—decreased forced vital capacity (FVC). This m easure­
m ent is less sensitive th an  FEVi and more dependent 
upon subject cooperation.
NOTE: The findings of these tests (i.e., FEVi and  FVC) have a 
greater validity when performed together ra th e r th a n  separate­
ly. However, these values are  usually obtained from the sam e 
test record.
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The following grading system  which uses one second forced ex­
piratory volume (FEVi) has  been devised to classify ventilatory 
im pairm ent. The m ean of the two highest values of FEVi is 
com pared to s tandard  norm al values. The acute effect of dust 
exposure is measured before and  after the first full workday 
after a  weekend. The difference between the values before and 
after cotton dust exposure is utilized w ith the following guides:
Function (F) 0: No dem onstrable acute effect of the dust on 
ventilatory capacity; no evidence of chronic 
ventilatory im pairm ent; FEV] is greater th an  
80% of the predicted value,
Function (F) 1/2: slight acute effect of dust on ventilatory 
capacity; no evidence of chronic ventilatory 
im pairm ent; FEV] is greater than  80% of the 
predicted value,
Function (F) 1: definite acute effect of dust on ventilatory
capacity; no evidence of chronic ventilatory 
im pairm ent; FEVi is greater than  80% of the 
predicted value,
Function (F) 2: evidence of a  slight to m oderate irreversible
im pairm ent of ventilatory capacity; FEVi is 
60 to 79% of the predicted value, and  
*
Function (F) 3: evidence of a m oderate to severe irreversible
im pairm ent of ventilatory capacity; FEV] is 
less th an  60% of the predicted value.
(F) 0 are norm al workers w ithout evidence of perm anent venti­
latory im pairm ent or acute response to the dust. (F) 1/2 and  (F)
1 are workers who are showing an  acute response to the dust but 
have a t present no evidence of perm anent im pairm ent of venti­
latory capacity. The more severe (F) 1 grade should be accepted 
as indicating th a t  further exposure to textile dust is likely to 
cause perm anent ventilatory im pairm ent in the worker. Grades 
(F) 2 and  (F) 3 include those workers who have some perm anent 
im pairm ent of ventilatory capacity (Bouhoys et al,, 1970).
NOTE: There are no characteristic changes in chest X-ray.
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E p id e m io lo g y
Population studies in  the cotton spinning industry have 
shown that the occurrence of the symptom of chest tightness on 
the first day of the working week (a specific symptom of 
byssinosis) depends upon workplace, type of exposure, length 
of exposure, and the quality of the raw cotton being processed. 
The symptom m ay be accompanied by detectable loss of venti­
latory capacity and  increased breathlessness.
In a 14-plant study of the records of 6,631 employees, M artin and 
H iggins51 reported a significant association between byssino- 
sis and bronchitis, and between smoking and byssinosis for 
employees in opening, picking, and carding. Three percent (3%) 
had  subjective symptoms (by history) of byssinosis; 0.8% indi­
cated both symptoms and  objective signs by a 10% or greater 
drop during the working day of the one-second forced expira­
tory volume (FEVi). M artin and Higgins also reported the 
anatom y of the mouth to be an im portan t factor related to pul­
m onary function testing. Due to an  obstructive phenomenon 
unrelated to the lower pulm onary system, ill-fitting or loose 
dentures were reported to cause a considerable drop in the 
forced expiratory volume in  one second a t the end of eight hours 
of work (FEVU).
Shilling et al.52 reported a study of 190 cardroom and blowroom 
workers. Thirty-nine percent (39%) of the workers were normal, 
35% h ad  Grade I byssinosis, and  25% had Grade II byssinosis. 
I t was further reported th a t 45% of the carders and  65% of the 
strippers and  grinders and  blowroom workers had  byssinosis.
Shilling53 reported a survey of 28 mills spinning the coarser 
grades of raw  cotton th a t dem onstrated a “geography” of 
disease. The h ighest prevalence of disease was found in  groups 
working the nearest to carding engines. This finding could not 
be explained by age differences or in years of exposure to dust.
Zuskin et al.54 reported a study of 120 men and  38 women work­
ers in two air-conditioned cotton mills. The average length of 
employment in these mills was 16 years, and the average age 
was 43. The following table from the report summarizes chronic 
respiratory symptoms and  illnesses:
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BYSSINOSIS GRADES
N um ber o f  W orkers
G rade G rade
Ib
G rades I Ie 
and  I I Id
T otal N um ber 
o f W orkers
C ard ers  M (59) 4 6 5 15 (25%)







T otal (158) 9 11 7 27 (17%)
(Zuskin et al-, 1969)
a - Cough on the first day of the working week or chest tightness sometimes
on the first day of the working week, or both, 
b - Chest tightness every first day of the working week, or both, 
c - Chest tightness on the first day of the working week and other work days, 
d - Chest tightness on all days.
E ight carders from Mill A w ith a history of byssinosis had  an 
average FEV] decrease o f 0.82 liter. In  6 m en in both mills who 
had worked for less th an  1 year, the reduction of FE Vj on the 
first working day of the week ranged from 0.09 to 0.43 liter. 
FEV] decreased significantly during the work sh ift on the first 
working day of the week for all workers in  both mills. The fol­
lowing table from the report summarizes total dust concentra­
tions in all work areas:
DUST CONCENTRATIONS AT D IFFER EN T SITES 
OF WORK IN HILLS A AND B 
(in m illig ram s p e r cubic m eter)
“ R esp irab le” T o ta l
Work P lace N* R ange M ean R ange M ean
. C arders Mill A « .S p inners
3 0.76 to 1.05 0.87 1.47 to 1.92 1.63
3 0.80 to 1.07 0.92 1.79 to 2.15 1.91
C arders 4 0.43 to 0.54 0.50 1.23 to 1.70 1.55
Mill B c  .S p inners 4 0.50 to 0.60 0.55 1.25 to 1.75 1.54
•Num ber of sam ples in  each location.
(Zuskin et al., 1969)
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In a study of 509 cotton textile workers, Schrag and Gullett55 
classified 63 (12%) as having byssinoais. Twenty-nine percent 
(29%) of cardroom workers, 10% of weavers, and 9% of spinners 
had byssinosis. Dust concentrations ranged from 0.3 milligram 
per cubic meter to 5.8 milligram per cubic meter. The table 
on the next page, taken from the report, summarizes respira­
tory symptoms among the workers studied.
Workers with byssinosis had a significantly lower average 
FEVi than did workers without byssinosis when this measure­
ment was made in the middle of the week. Schrag and Gullett 
concluded that a single measurement of FEV{ would not 
identify all symptomatic workers.
Molyneux and Tombleson56 report a 3-year study of1,359cotton 
workers and 227 man-made fiber workers in 14 cotton spinning 
and 2 man-made fiber spinning mills. Total dust levels aver­
aged 3.1 milligram per cubic meter in cotton fiber coarse mills 
and 1.2 milligram per cubic meter in cotton fiber medium mills. 
The total prevalence of byssinosis, 26.9%, was higher in coarse 
fiber than in medium fiber cotton mills. [The count of yarn spun 
in the medium mills ranged from 10 to 50 (60 to 12 Tex) and 1 to 
24 (600 to 25 Tex) in the coarse mills.] In the coarse mills, symp­
toms developed in some men and women within the first 4 years 
of exposure;-in medium mills, symptoms developed between 5 
and 10 years’ exposure. Symptoms similar to those of byssino­
sis occurred in 10 (4.4%) of the total population of the man-made 
fiber mills; however, all 10 had a previous history of exposure 
to cotton dust.
In a study of 10,133 workers employed in 19 plants that process 
raw cotton in the manufacture of yam, Imbus and Suh57 found 
a marked relationship between the incidence of byssinosis and 
bronchitis and lowered pulmonary function. Cigarette 
smoking appeared to further increase the incidence of bron­
chitis and lower pulmonary function. A drop in FEVi during 
the working day, though associated with, was often present 
without byssinosis symptoms.
Merchant et al.58 reported a study of 441 workers employed in a 
modern cotton-synthetic blend mill in which 20% of those work­
ing in preparation areas, 2% of those in yarn processing areas, 
and 6% of all employees were diagnosed as byssinotic. Among 
men, the byssinosis index increased with smoking, and the 
bronchitis index increased with smoking plus dust exposure. 
Byssinotic workers were found to have more chronic bronchi­
tis and dyspnea than matched control workers.
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RESPIRATORY SYMPTOMS IN  MALE CARDERS, SPIN N ERS,
AND WEAVERS WITH BYSSINOSIS AND IN THOSF WITHOUT BYSSINOSIS
Number
o f P e rs is te n t P e rs is te n t




th e  L ast 









W orkers Cough (%) Phlegm  (%) <%) <%) (%) <%)
C arders
With byssinosis 28 71 57 50 17 25 10
W ithout byssinosis 67 37 32 24 9 4 1
Total 95 47 40 32 12 10 4
W eavers
With byssinosis 11 91 82 64 36 27 18
W ithout byssinosis 76 36 26 15 12 8 7
T otal 87 44 33 21 15 11 8
Spinners 
With byssinosis 7 43 71 14 0 0 14
W ithout byssinosis 52 25 23 15 14 10 6
T otal 59 27 29 15 12 8 7
(Schrag and Gullett, 1970)
E v id e n c e  o f  E x p o su re
Sampling and Analysis
The N10SH approved air sampling method uses mechanical 
filtration.
The NIOSH approved method for air sample analysis requires 
the reweighing of a preweighed filter after collection of the 
sample. An additional analysis method is based on beta- 
radiation counting of a size selective sample.
The above methods are not intended to be exclusive, but other 
methods should be justified.
A llo w a b le  E x p o su r e  L im its
The standard adopted by the Occupational Safety and Health 
Administration (OSHA) provides that no employee in the 
textile industry shall be exposed to greater than 200 
micrograms per cubic meter air of lint-free respirable 
cotton dust averaged over an eight-hour work shift, unless 
these employees are engaged in slashing or weaving, in 
which case they shall not be exposed to greater than 750 
micrograms per cubic meter air of lint-free respirable 
cotton dust averaged over an eight-hour work shift. 
In all of the other industries where employees are exposed to 
cotton dust, no employee shall be exposed to greater than 500 
micrograms per cubic meter air of lint-free respirable cotton 
dust averaged over an eight-hour work shift. OSHA has treated 
cotton gins separately and has not imposed a numerical per­
missible exposure limit. OSHA has, however, established re­
quirements for work practices, respirator usage, medical sur­
veillance, and recordkeeping. NOTE: This standard is current­
ly (1978) being litigated in a number of U.S. Courts of Appeal.
C o n c lu s io n
Diagnosis of occupational byssinosis due to exposure to 
cotton dust is based on the following:
1. Confirmed history of occupational exposure to cotton 
dust over a period of years,
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2. chest tightness and dyspnea which appear on the first 
workday following absences from exposure to cotton 
dust, and
3. a reduction of ventilatory capacity following return to 
work on the first workday and during the workday as 
demonstrated by lung function test.
NOTE: Although most persons with Grade I, II, or III byssino- 
sis have a moderate to marked decrease in FEVi, absence of 
this decrement does not rule out the diagnosis of byssinosis in 
persons with symptoms.
Chronic bronchitis may or may not be associated with byssi­
nosis. The person with chronic bronchitis will usually exper­
ience chest tightness when exposed to any dusty atmosphere, 
whereas the early byssinotic is affected only by cotton dust 
and is worse on returning to work on the first working day or 
after several days absence.
Older females without byssinosis employed in mills for many 
years while rearing families and performing usual household 
duties will show a significant drop in the difference in before 
and after-shift (FEVi) tests. It has been concluded that physi­
cal work causes extreme fatigue in these women, and already 
lowered pulmonary function should be interpreted as muscular 
fatigue rather than a significant increase in bronchial resist­
ance (Martin and Higgins, 1976).
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I n o r g a n i c  L e a d
In tro d u c tio n
Lead, a very soft malleable blue-grey metal, has many in­
dustrial applications. It is naturally deposited underground 
and has been mined and spread throughout the environment 
by emissions of motor vehicle exhausts and airborne emissions 
from smelters. Lead is one of the most common contaminants 
of the environment. It accumulates in bone and other tissues 
with age.
The important routes of absorption of lead in man are the gas­
trointestinal tract and the lungs. Dermal absorption is rela­
tively insignificant in most cases.
The effects of lead poisoning are cumulative and result in a 
large variety of health problems beginning with nonspecific 
symptoms such as fatigue, dizziness, cramps, and headaches 
and eventually leading to a variety of disorders that can end in 
paralysis, brain damage, and death.
Serious cases of lead poisoning are rare in industry today be­
cause of more efficient material handling methods and bio­
logical monitoring. Intestinal colic (colon spasms accompanied 
by pain throughout the abdomen) preceded by several days of 
constipation is the most common manifestation of lead poison­
ing (Hunter, 1975).
Stresses such as an accident, operation, pneumonia or other 
infection, physical exertion, or alcohol ingestion can cause 
accumulated body lead to be released into the body and produce 
symptoms of lead poisoning in workers whose metabolism of 
lead is in delicate balance (Key et al., eds., 1977, and Plunkett, 
1976).
Among female workers exposed to excessive lead levels, an 
increased number of miscarriages and stillbirths, menstrual 
disorders, and sterility are recogni2ed risks. Lead poisoning 
as well as moderate increased absorption of lead decreases 
the fertility of men.
Blood lead, free erythrocyte protoporphyrin (FEP), and zinc 
protoporphyrin (ZP or ZPP) have been shown to be indicators of
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absorption while urinary coproporphyrin (CP) (nitrogen- 
containing organic compounds) and delta-aminolevulinic acid 
(ALA) are reliable indicators of effect (Benson, 1976).
Lead and its compounds have numerous chemical and common 
names:













lead chloride, basic 
lead chloride fluoride 
lead chlorite 
lead, chocolate
C om m on N am es
C.I. Pigment Metal 4, C.1.77575, 
lead flake, plumbum, lead S2, 
SI, KS-4
antimony yellow, Naples yellow
galena, blue basic lead sulfate 
lead metaborate
cerussete, cerussite, white lead
BCWL, ceruse, hydrocerussite, 
lead flake, lead subcarbonate, 
white lead
cotunite

















lead salt of chromic acid, chrome 
yellow, cologne yellow, crocoite, 
deep chrome, Leipzig yellow,- 
lemon chrome, lemon yellow, 
midle chrome, pale chrome, 
Paris yellow, permanent yellow, 
primrose chrome, primrose yel­
low, yellow ultramarine
American vermillion, Austrian 
cinnabar, basic lead chromate, 
Chinese red, chromate red, 
chrome orange, chrome red, C.I. 
Pigment red, derby red, lead 
chromate oxide, Persian red, red 
lead chromate, Victoria red
C.I. 77610, C.I. Pigment Yellow 
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C.I. 77580, lead brown, lead 
oxide brown, lead peroxide, lead 
superoxide, Plattnerite, 
anhydrous plumbic acid



















lead p-period ate 
lead-m-phosph a te
basic lead hydroxide, hydrated 
lead oxide, lead hydrate
wulfenite
C.I. 77577, C.I. Pigment yellow 
46, lead monoxide, lead oxide 
yellow, lead protoxide, lead 
oxide, litharge, litharge yellow 
L-28, massicot, massicotite, 
plumbous oxide
lead salt of nitric acid




Cassel yellow, laurionite, 
matlockite, Mendipite
lead perchlorate hexahydrate, 
















lead sulfate, basic 
lead sulfate, blue basic
lead orthophosphate, normal 
lead orthophosphate, lead 
phosphate, perlex paste 500, 
perlex paste 600À, plumbous 
phosphate, lead salt of 
phosphoric acid, pyromorphite. 
trilead phosphate
Clausthalite
lead trioxide, plumbous 
plumbate






Auglisite, C.I. 77630, C.I. 
Pigment White 3, fash white, 
Freeman’s white lead, lead 
bottoms, milk white, Mulhouse 
white, lead salt of sulfuric acid
sublimed white lead















C.I. 77640, galena, galanite, 




C.I. 77578, C.I. Pigment Red 105, 
gold satinobre, lead ortho- 
plumbate, lead oxide red, 
mineral orange, mineral red, 
minium, minium nonsetting 
RL-95, orange lead, Paris red, 




lead-m-titanate, lead salt of 
titanic acid






O ccupations w ith  P o te n tia l E xp o su res  to  In o rg an ic  L ead
acid finishers chemical equipment makers
actors chippers
artists, commercial chlorinated paraffin makers
auto body shop workers cigar makers
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babbitters




































junk metal refiners 
labelers, paint can 
lacquer makers 
lead burners
lead counterweight makers 
lead flooring makers 





































pottery glaze dippers 











lead pipe makers 
lead salt makers 
lead shield makers 
lead smelters 





linseed oil boilers 
lithographers 













vanadium compound makers 
varnish makers
rubber reclaimers 
scrap metal workers 
semiconductor workers 
service station attendants 



















vehicle tunnel attendants 
wallpaper printers 
welders
M edical E va lu a tio n  a n d  D iffe ren tia l D iagnosis
(See also Decision-Making Process)
The following should be considered:
—Acute appendicitis,
—chronic gastric or duodenal (first part of the small intes­
tines) ulcer,
—carcinoma of the stomach, and
—pernicious anemia (severe form of blood disease) or 




Lead is bo widely used that a careful inquiry into hobbies and 
recreation is especially important. Chronic exposure to in­
organic lead in hobbies can produce the same signs and 
symptoms as occupational lead poisoning.
Common nonoccupational lead exposure sources include:
—Foods (bread, meat, canned foods and vegetables),
—hobbies (ceramics, pottery),
—consuming illicit liquors distilled using lead or lead- 
based tubing, soldered condensers (such as automobile 
radiators),
—use of lead-glazed earthenware,
—artists using lead paintB,
—lead toys
—lead dust in shooting galleries, and 
—fumes from burning batteries or painted furniture.
S ig n s  a n d  S y m p to m s
The early signs and symptoms of lead poisoning are non­
specific and may resemble many diseases including influenza. 





—anemia, hemolytic (red blood cells being destroyed) in 
type but not usually severe,
—irritability,
—aching muscles and bones,
—headache,
—decreased appetite, and 
—nausea and vomiting.
These symptoms are reversible, and complete recovery is pos­
sible.
In more advanced cases of lead poisoning, the above signs and 
symptoms progress and frequently involve the gastrointestinal 
and neuromuscular systems (both nerves and muscles).
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Central nervous system symptoms are:
—Brain dysfunction (encephalopathy) which may mimic 
bacterial meningitis. However, cerebrospinal fluid glu­









—rarely, accumulation of cerebrospinal fluid within the 
brain (hydrocephalus),
—blindness may occur from optical atrophy (wasting away 





—loss of appetite, and 
—constipation.
Signs and symptoms associated with the blood and blood- 
forming tissues are:
—Anemia, in which the red blood cells have a reduced 
hemoglobin content (hypochromic normocytic type) and 
—increased serum iron.
The marrow also reveals increased production, and specific 
structural (morphological) changes in nucleated red corpuscles 
(erythroblasts) such as:
—Basophilic stippling and 
—deformed nuclei.
The iron content of the marrow is increased, and increased 
siderocytes, sideroblasts and reticuloendthelial cells are noted. 
Some investigators believe the basic effect lead has on the bone 
marrow is first hyperstimulation, followed by delayed matura­
tion.
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Kidney (renal) symptoms are:
—An abnormal amount of uric acid in the blood (hyper­
uricemia,
—inflammation (nephritis),
—the presence of glucose in the urine (glycosuria),
—an abnormal amount of amino acids in the urine 
(hyperaminoaciduria), and 
—progressive increase in blood urea.
Additional signs and symptoms which may be present are:
—Gum lead line (black or purplish line on gum margin), 
—skin pallor (ashen gray),
—loss of weight, and
—weakness of extensor muscles (such as wrist or foot drop).
Cortical atrophy (reduction in size of brain tissue) has also been 
described but this is not a common finding.
L a b o ra to ry  a n d  C lin ic a l E x a m in a t io n s
Signs pertaining to lead’s effect on the blood-forming organs 
(hemopoietic system) are determined by laboratory analysis. 
These signs occur early with excess lead absorption — usually 
before the outward symptoms of poisoning appear. These tests 
are useful in the routine biological monitoring of persons 
exposed to lead.
NOTE: In studies of lead excretion, satisfactory figures cannot 
be obtained unless specimens of stools and urine are collected 
for at least 3 days. Normal persons excrete lead in feces and 
urine because lead is present in soil and therefore in vegetation 
and animal food sources.
Results of blood and urine laboratory analyses for lead are 
subject to a 10 to 15% error factor. The normal values for the 
laboratory performing the tests should be ascertained. Blood 
lead determinations must be corrected for the mass of circula­
ting red cells (hematocrit), and urinary lead determinations, for 
the specific gravity of the urine.
Parameters which will be useful in the laboratory diagnosis of 
lead poisoning are presented along with abnormal laboratory 
values that may be found in lead poisoning:
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B lood
—decreased hemoglobin — less th an  13 gram  %
—increased blood lead (PbB) — greater th a n  60 to 80 
micro gram s per deciliter 
—decreased red blood count 
—stippled basophilia and reticulocytosis 
—increased free erythocyte protoporphyrin (FEP) and zinc 
protoporphyrin (ZP or ZPP)
U rin e
—increased u rinary  lead — greater th an  0.15 milligram per 
liter
—increased urinary lead after Ca-EDTA treatm ent — 
greater than  2 m illigram s in 24 hours 
—increased urinary  coproporphyrin (CP) — greater than  
80 micrograms per 100 milligram s creatinine 
—increased urinary  delta-am inolevulinic acid (ALA) — 
greater th an  2.0 milligram s per 100 m illigram s creati- 
ine
—increased u rinary  porphobilinogen — greater than  0.15 
milligram per 100 milligram s creatinine
C e n tra l  N e rv o u s  S y stem  
—decreased peroneal nerve conduction velocity
E p id e m io lo g y
Extensive studies have been conducted around smelters, 
battery  factories, soap reclaim ing facilities, chemical plants 
producing lead salts, and gasoline refineries. Neuropathies, 
nephropathy, and blood changes are well documented. How­
ever, lead absorption does not necessarily indicate poisoning.
Feldm an et a l .59 reported a study of subacute low level exposure 
to lead which occurred when a demolition com pany dism antled 
an  elevated tra in  network. The old steel structure was heavily 
coated with several coats of lead paint. R espirators were in use. 
D ata from the report are presented in  the following table.
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(m icrogram  per 




(m /s)ran g e  m ean
B urners 32 4.36 44-100 79.5 41.4 1134' 43.2e
N onburners 12 0.23 24-75 48.8 44.0 714d 49.0'
N orm al Value 46.9 ± 14.9 54.09 ± 5.%
(Feldman et al,, 1977)
a. Free erythrocyte protoporphyrin
b. Peroneal motor-nerve conduction velocity
c. Measured in 13 burners
d. Measured in 5 nonbum ers
e. Measured in 6 nonbum ers
N onbum ers included laborers and  supervisory personnel who 
had been on the job for 4 to 10 m onths and  offered no 
com plaints. Burners with as little as 1 m onth on the job before 
symptom s and other signs of increased body burden of lead 
appeared reported experiencing nausea, abdom inal discom- 
fort, mood change and  irritability , sleeplessness, fatigue, 
headache, and  num bness and  tingling of the extremities. Four 
of the burners had  no com plaints. Workers hav ing  abnor­
m alities in  2 of 3 variables (blood lead, F.E.P., or M.N-C.V.) and 
com plaining of some symptoms were considered to have intox­
ication and  were referred for chelation therapy.
(Blood lead levels greater th a n  60 m icrogram s of lead per 100 
gram s whole blood are indicative of unacceptable lead absorp­
tion; urine lead levels of 0.20 m illigram  lead per liter of urine or 
greater are indicative of unacceptable lead absorption.60)
Elkins61 assembled da ta  available on lead in  air and  lead in 
urine and  reported th a t a urinary  lead level of 0.2 m illigram s 
lead per liter of urine would correspond to an  a ir concentration 
of 0.2 m illigram s lead per cubic meter of air.
The data in the table on the next page relating average and median 
blood lead content with exposure and duration of employment 
have been adapted from Dreesen et al.62, the Committee on 
Biological Effects of Atmospheric Pollu tants,63 and the 
N ational Institu te for Occupational Safety and H ealth60.
Tola and N ordm an64 reported a  study of 335 men representing 
the general population and 2,209 men occupationally exposed 
to lead. No association between blood lead concentrations and 
smoking was dem onstrated in the m en from the general 
population. A dose-response relationship was found between 
the am ount of smoking and  the blood lead concentrations of 
workers occupationally exposed to lead with smokers having 
statistically  significant higher blood lead levels than  
nonsmokers.
Sakurai e t al.G5 reported a study of 218 m ale workers in a rubber 
hose and automobile tire factory who had  an  overall m ean 
duration of occupational lead exposure of 5.0 years (the range 
w as 6 m onths to 21 years). Lead exposure had  been so low th a t 
in the p as t the p lant physician had diagnosed no cases of 
clinical lead poisoning; average 8-hour lead in air concen­
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trations were below 60 m icrogram s per cubic meter. Sakurai. 
et al. concluded tha t subjective symptoms are not likely to be 
induced by lead when the blood level is 50 micrograms per 100 
gram s and less.
AVERAGE AND MEDIAN BLOOD LEAD CONTENT IN  
MILLIGRAMS P E R  100 GRAMS O F BLOOD IN  
STORAGE BATTERY W ORKERS, BY EX PO SU R E 
AND D URATIO N O F EM PLOYM ENT
Dura Lion of 
Lead Exposure
Air Lead C ontent 
(milligram s per cubic meter)

































































(Dreesen et al., 1941, National Academy of Sciences, 1971, and NIOSH, 1972)
L ancranjan  et al.e6 reported a study of the reproductive ability 
of 150 men occupationally exposed to lead in a storage battery 
plant, One hundred men (Group A) had  an average exposure of 
8.5 years (the range was 1 to 23 years) in the p lant; 50 
technicians and office workers (Group B) worked in  annex 
workrooms in  a lead-polluted environm ent for 1 to 27 (mean 6) 
years. Environm ental m easurem ents were not given. Workers 
displaying moderately increased absorption of lead or lead 
poisoning showed a highly significant fertility decrease. 




MEAN VALUES OF LEAD IN BLOOD AND URINE OF COPROPORPHYRIN 
AND DELTA-AMINOLEVULINIC ACID
Group
Lead in Blood 
(m icrogram  per 
100 m illiliter)
Lead in U rine 
(m icro^ram  
per liter)
C oproporphyrine 
(m icrogram  
per liter)
delta-A m ino- 
levulinic Acid 
(m illigram  p e r liter)
A. (a) Lead-poisoned 
w orkm en, 23 74.50 ± 26 385 ± 71 394 ± 116 56.52 ± 20
(b) Lead w orkm en 
w ith m oderate­
ly increased 
absorp tion , 42 52.00 ± 21 251 ± 106 295 ± 132 22.44 ± 8 J
(c) Lead w orkm en 
w ith slightly  
increased 
absorp tion , 35 41 ± 12 100.6 ± 41 80 ± 44 7.7 ± 4.2
B. Men w ith  
physiologic 
absorp tion  o f lead 
w ork ing  in a 
polluted env iron ­
m ent, 23 23 ± 14 92 ±34 35+ 16 4.4 ± 2.2
(Lancrenjan et al., 1975)
Cooper and Gaffey67 reported a m ortality study of 7,032 men 
who had  been employed in  6 lead production facilities and  10 
battery p lants for 1 or more years over a 23 year period. Lead 
absorption in m any of the men was greatly in  excess of 
currently acceptable s tandards based upon urinary and  blood 
lead concentrations available for a portion of the group. 
Although the workers had  high levels of exposure, only sm all 
deviations from expected m ortality were reported. Cooper and 
Gaffey predicted no detectable effect on the m ortality of male 
adults from occupational exposure to lead controlled in 
conformity to currently recommended environm ental and 
biological standards80.
E v id e n c e  o f  E x p o su re  
Air Sampling and Analysis
The NIOSH approved air sam pling method uses m echanical 
filtration. Two methods previously used are:
1. Electrostatic precipitator and
2. impingement.
The NIOSH approved method of analysis is atomic absorption 
spectrophotometry. Four methods previously used are:
1. Polargraphic,
2. spectrographic,
3. dethizone procedure, and
4. titrim etric-extraction.
These methods are not intended to be exclusive but other 
methods should be justified.
A llo w a b le  E x p o su r e  L im its
The Federal s tandard  for lead and  its inorganic compounds 
(except lead arsenate) is 0.2 m illigram  per cubic meter of air 
based on an  8-hour time-weighted average exposure. Lead is a 
suspected occupational carcinogen with the lung and kidney 
being the target organs (Key et al., eds., 1977) (NOTE: A re­
duction in the s tandard  to less th an  50 micrograms of lead per 
cubic meter of air has been proposed by NIOSH.)
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C o n c lu sio n
Diagnostic criteria for occupational lead poisoning are based 
on meeting the following:
1. Confirmed history of occupational exposure to lead,
2. findings compatible w ith lead poisoning, and
3. increased lead in blood an d /o r urine.
NOTE: A diagnosis of lead poisoning does not necessarily 
m ean th a t it is occupational in origin. Further, lead intoxi­
cation with symptoms can exist with norm al laboratory test 
findings.
The medical literature has extensive references to the trea t­
m ent of lead toxicity. Basically, there are 3 types of drugs 
currently known to be effective in trea ting  lead toxicity: 
calcium -ethylenediam inetetra-acetic acid (Ca-EDTA), British 
anti-lewisite (BAL), and Penicillam ine (PCA). Treatm ent 
usually depends upon the severity of sym ptom s and  available 
laboratory data. Because the chemicals used in  the treatm ent of 
lead poisoning are not w ithout their own toxicities, their use in 
exposed workers should be followed closely with repeat blood 
levels and urinalysis.
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I n o r g a n i c  M e r c u r y
In tr o d u c tio n
Mercury, a chemically stable element which is liquid a t room 
tem perature, is found everywhere—in rocks, soils, plants, 
anim als, water, air. I t  is found in  food in  the range o f0.005 milli­
gram  to 0.02 milligram daily and is not considered toxic a t this 
level. However, it is becoming increasingly significant as a 
potential hazard  in the environm ent. For industrial and 
commercial uses, it is removed from the ore, cinnabar, in re­
duction plants.
Exposure to mercury can be through percutaneous (skin) ab­
sorption, ingestion, or inhalation  with the principal source of 
poisoning being mercury vapor. N onoccupational exposure to 
mercury has resulted in u rinary  excretions of 0.5 m illigram per 
day in  urine and  10 m illigram s in feces.
M ercurialism m ay be the result of chronic excessive exposure to 
inorganic mercury, and is characterized by 1 or more of the 4 
classical signs of poisoning: G ingivitis (inflam m ation of the 
gums), sialorrhea (excessive flow of saliva), tremors (affecting 
fingers, eyelids, lips or tongue), and erethism  (emotional in s ta ­
bility). Mercury vapor has been reported to cause fibrotic 
lesions in  the lung. M any of the symptoms associated with 
exposure are very general and  have no connection w hatever 
with such exposure: tiredness and drowsiness a t work, with in ­
somnia, a feeling of weakness, and  exhaustion. Because of the 
many nonspecific signs and symptoms which can be associated 
with mercury, occupational exposure levels a t which no effects 
are observed have not been established.
Acute intoxication from inhaling  mercury vapor in  high con­
centrations was common in the past among those who extracted 
mercury from its ores; now, it is relatively infrequent. Acute 
severe exposures are characterized by metallic taste, nausea, 
abdom inal pain, vomiting, d iarrhea, headache, and  sometimes 
album inurea (usually a sign of renal impairment).
The latency period for signs of toxicity to be produced can vary 
from 1 to 30 years.
117
Mercury and its compounds have numerous chemical and 
common names:
C h em ica l N am e C om m on N a m e s






mercuric bromide ammobasic 
mercuric bromide diammine 
mercuric bromide iodide 
mercuric chlorate 
mercuric chloride
mercuric chloride diammine 
mercuric chloride iodide 
mercuric chloroiodide 
mercuric chrom ate
mercury am ide chloride, 
mercury am m onium  chloride




barium  mercury iodide, 
mercury-barium iodide
mercury bromide
bichloride of mercury, caloch- 
lor, corrosive mercury chloride, 
corrosive sublim ate, MC, 
mercuric bichloride, mercury 
bichloride, mercury 










mercuric iodide am monobasic









m e r c u r ic - c u p r o u s  io d id e
fulm inate of mercury, mercuric 
fulm inate, mercury fulm inate
mercury cyanide
mercuric dichrom ate, mercury 
bichrom ate
mercury fluoride
c o p p e r - m e r c u r y  io d id e ,
m e rc u ry - c o p p e r  io d id e
mercury iodate
mercuric biniodide, mercury 
biniodide, yellow mercury 
iodide, red mercuric iodide, red 
mercury iodide
mercury nitrate, mercury perni- 
trate, mercury sa lt of nitric a d d
mercuric oxide, red mercury 
oxide, red oxide of mercury, red 
precipitate
yellow mercury oxide, yellow 
mercuric oxide, yellow oxide of 
mercury, yellow precipitate
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m e r c u r i c  o x y c y a n id e m e r c u r y  c y a n id e  o x id e ,








phosphate, neutral mercuric 
phosphate, norm al mercuric 
phosphate, tertiary  mercuric 
phosphate, trim ercuric ortho­
phosphate
mercury-potassium cyanide
C hann ing’s solution, M ayer’s 
reagent, mercury-potassium 
iodide, Nessler’s reagent, 
potassium  mercuric iodide, 
potassium  tetraiodom ercurate, 
potassium  triiodomercurate, 
solution potassium  iodohydra- 
gyrate









mercury-silver iodide, silver- 
mercury iodide
basic mercuric sulfate, mercu­
ric dioxysulfate, tu rb ith  
m ineral, turpeth m ineral
mercury bisulfate, mercury per­
sulfate, mercury sulfate, mer­
cury sa lt of sulfuric acid
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mercuric sulfide, black black mercury sulfide, ethiops
mineral
mercuric sulfide, red artificial c innabar, Chinese ver­
milion, cinnabar, quicksilver 
vermilion, red mercury sulfide, 
red mercury sulfurel, vermilion
mercuric sulfocyanate mercuric sulfocyanide, m er­
cury rhodanide, mercury sul­
focyanate, mercuric thiocy- 
anate, mercury thiocyanate
mercuric tellurate 
mercuric thallium  iodide 
mercuric tungsta te  
mercuric cyanam id
mercurous arsenite mercury arsenite
mercurous azide 
mercurous bromate
mercurous bromide mercury bromide
mercurous carbonate
mercurous chlorate mercury chlorate
mercurous chloride calogreen, calomel, calosan,
cyclosan, mercury monochlo­
ride, mercury protochloride, 
mild mercury chloride, precitite 
blanc, subchloride of mercury









mercurous n itrate, 








mercury am m oniated
mercury iodide, mercury proto­
iodide, yellow mercury iodide
hydrated  mercurous n itrate, 
mercury nitrate, mercury sa lt 
of nitric acid
am m oniated mercury nitrate, 
black precipitate, Hahnemann's 
soluble mercury
black mercurous oxide
neutral mercurous phosphate, 
norm al mercurous phosphate, 
mercury phosphate, tertiary  
mercurous phosphate, trim er­
curous orthophosphate
mercury sulfate
hydrargyrum , quick silver
aminomercuric chloride, 
ammono-basic mercuric chlo­
ride, am m oniated mercuric 
chloride, am m oniated mercury 
chloride, am moniated mercury, 
fusible white precipitate, 
Lam ery’s white precipitate, 
mecuric ammonium chloride, 
mercury am ine chloride, m er­
cury ammoniated, mercury cos­
metic, white precipitate
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mercury antim ony aulfide 
mercury nitride
The following is a listing of occupations with potential ex 
posure to mercury:
O c c u p a tio n s  w ith  P o te n t ia l  E x p o su re  to  M ercu ry
am algam  m akers 
bactericide m akers 
barom eter m akers 
battery m akers, mercury 
boiler m akers 
bronzers
calibration instrument makers 
cap loaders, percussion 
carbon brush makers 
cauBtic soda makers 
ceramic workers 
chlorine m akers 
cinnabar ore processors 
commercial artists  
dental am algam  makers 
dentists





electric apparatus makers 
electroplaters 
embalmers 
explosive m akers 
pharm aceutical workers 
photoen gravers 
photographers 









fireworks m akers 






ink m akers 
insecticide m akers 
investm ent casting workers 
jewelers
laboratory workers, blood 
laboratory workers, chemical 
lam p makers, fluorescent 
lam p makers, mercury arc 
m anometer m akers 
mercury workers 
miners, mercury 
neon light m akers 
pain t m akers 
paper m akers 





therm om eter m akers 
vacuum pump m akers 
vapor tube m akers 
vinyl chloride m akers 
wood preservative workers
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M e d ic a l E v a lu a t io n  a n d  D iffe r e n tia l  
D ia g n o s is
(See also Decision-Making Process)
The following should be considered:
—History of blood disease,
—hem orrhages into the skin or mucous membrane,
—syphilis,
—reddening of the skin,
—scurvy, and
—inflam m ation of several nerves (polyneuritis) due to 
other industrial poisons (e.g., lead) or in chronic 
excessive alcohol intake.
Nonoccupational Exposure
Potential nonoccupational sources of mercury include:
—Air pollution (particularly in  industrialized areas 
burning fossil fuels),
—use of mildew proofing and  antifouling paint,
—use of m edicinals of mercurical compounds,
—broken home thermometers, barometers using mercury 
columns, and
—consum ption of fish (ocean fish, swordfish, tuna, cod, 
halibut, mackerel) NOTE: Local E nvironm ental Protec­
tion Agency (EPA) standards should be checked to 
determ ine the applicability of th is potential source.
S ig n s  a n d  S y m p to m s
A cu te  P o is o n in g
Acute industria l toxicity is rare, and  associated signs and 
symptom s are:
—Inflam m ation of the gum s (gingivitis),
—salivation,
—loss of teeth,
—gastro in testinal upset (diarrhea),
—kidney failure (toxic nephrosis),
—cardiac function abnorm alities, and 
—trem or m ay exist as an  isolated finding.
124
C h ro n ic  P o is o n in g
In chronic poisoning, all acute symptom s m ay occur but the 
onset m ay be slower and  insidious. Additional oral symptoms 
associated with ingestion or inhalation  which m ay occur are: 
—C haracteristic “blue line” on the gums, sim ilar to lead 
poisoning,
—upper respiratory trac t inflam m ation, and 
—inflam m ation of the m em brane th a t lines the eyelid and 
the front of the eyeball (conjunctivitis).
“Erethism ”, a form of anxiety neurosis and personality 
changes first described in the felt h a t industry, m ay occur. The 
triad  of gingivitis, tremor, and em otional instab ility  described 
m ay be practically specific. E rethism  m ay be accompanied by: 
—Self-consciousness,
—timidity,
—inappropriate em barrassm ent,
—anxiety indecision,
—inability  to concentrate,
—dependency,
—depression,
—resentm ent of criticism, and 
—irritability  on excitement.
Headache, fatigue, weakness, drowsiness, or insom nia m ay 
follow. In  advanced cases, hallucination, memory loss, and 
intellectual deterioration m ay occur.
Circulatory disturbances m ay be linked to emotional d istur­
bances and  result in:
—Blushing,
—excessive perspiration, and
—derm ographia (ability to sketch figures on skin).
C entral nervous system symptom s are:
—Personality disorders as described above,
—tremor, one of the m ost prom inent signs. I t  is the fine 
intention type and  can be seen in the face and arm s but 
rarely in the legs; it m ay progress to the coarse type and 
convulsions. Tremor also affects handw riting.
—speech disorders such as “scanning speech” (hesitancy, 
slurring of words, and  difficulty in pronunciation). This 
m ay be more severe in organic mercury poisoning.
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—motor and sensory deficits such as:
--Unsteady walk, m ay be spastic,
-a ta x ia  in severe casfes, m ay affect both arm s and  legs, 
-hyperactive tenddh reflexes,
-toes extend when foot is stim ulated (p lan tar extensor 
response),
-n u m b n e s s , p rick lin g , a n d  tin g lin g  s e n sa tio n s  
(paresthesias),
-severe nerve pain (neuralgia),
-decreased sensitivity  to taste and smell,
-postural sensation loss (loss of position sense), and 
--muscle pain and  cram ps.
Signs and symptom s associated w ith the eye are:
—Constriction of visual fields, seen in severe cases,
—fíne punctate opacities in lens (mercuria lends),
—defects in accommodation and eye m uscular balance, 
—lens reflex; slit-]amp exam ination reveals brownish 
colored lusterless reflex from the anterior capsule of the 
lens. This m ay be due to mercury deposits in the anterior 
capsule and may depend on the duration of exposure; 
visual clarity is not affected.
—continuous involuntary movement of the eyeball in  any 
direction (nystagmus),
—eye muscle paralysis (paralysis of external rectus),
—dim ness of vision (amblyopia), and 
—blind spots or areas in  the field of vision (scotomas).
E ar symptoms are:
—Possible loss of hearing,
—vertigo, and
—hypo-excitability of vestibular function (middle ear 
insensitivity).
Skin symptoms are:
—A pallor th a t is unassociated with anem ia and 
—allergic hypersensitivity m ay occur.
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L a b o ra to ry  a n d  C lin ic a l E x p o su re s
A dditonal da ta  tha t will assis t in arriv ing a t a correct 
diagnosis are:
B lood
—excess lym ph cells (lymphocytosis)
—increase in the num ber of cells th a t s ta in  readily with 
the acid stain  eosin (eosinophil count increase)
—electrophoretic pattern  of serum proteins are consistent 
w ith nephrosis 
—increased blood urea in nitrogen (BUN)
—increased quantités of creatinine 
—increased uric acid (with or w ithout gout)
U r in a ly s is
—urine mercury levels above 300 m illigram s per day are 
likfely to be associated with sym ptom s 
—proteinuria
—changes associated with nephrosis (hyaline casts)
F eces
—mercury levels above 10 m illigram s per day
K id n ey
—evidence of nephritis
There m ay be no correlation between u rinary  mercury 
excretion and clinical evidence of mercury poisoning, since 
prolonged exposure m ay induce kidney (rena) injury and 
decreased urinary  excretion. Also, u rinary  mercury m ay be 
increased in  workers exposed to mercury, but who m ay or m ay 
not exhibit symptomatology. However, urinary  values are 
useful guides to early exposure.
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E p id e m io lo g y
Scientific literature has well documented the fact th a t 
chronic exposure to mercury can result in complex alterations 
to a w orker's physiological state. The prim ary effects are on the 
central nervous system. These effects m anifest themselves in 
varied signs and  symptoms, as well as altering the worker’s 
performance capabilities.
In  the studies th a t follow, oropharyngeal changes, other than 
those of the  teeth and gums, showed some dose-response 
relation; abnorm alities of the teeth and  gum s were shown no tto  
be dose-related however.
In  an  18-month study of 142 workers from 4 p lan t groups (3 
p lan ts were engaged in chlor-alkali m anufacturing, and 1 p lan t 
m anufactured m agnetic materials), Miller et al.68 reported 
changes in  neuromuscular indices of trem or and electromy­
ography (EMG) in a  significant num ber of workers when blood 
concen tra tions of m ercury exceeded approx im ate ly  0.1 
m illigram  of mercury per liter. The duration of chronic 
exposure to metallic mercury vapor ranged from 6 m onths to 20 
years w ith a m ean of approxim ately 9 years.
S handar and Simson69 reported a study of 334 workers in a  
variety of occupations or industries with mercury in  air levels 
rang ing  from approxim ately 0 to 2.0 m illigram s per cubic meter 
and  exposure periods rang ing  from 1 m onth to 38 years. 
Symptoms including bleeding gums, tremor, metallic taste, 
and insom nia were associated with urine mercury values 
greater th an  0.3 m illigram of mercury per liter. Symptoms 
including headache, nervousness, tiredness, and  abdom inal 
upset were associated with a  urine mercury content of 0.1 to 0.3 
m illigram  per liter.
Rentos and Seligm an70 reported a  study of 9 mercury mine and 
mill locations. Average work area air concentrations between
0.08 and  0.73 milligrams of mercury per cubic meter were 
associated with clinical evidence of mercury poisoning found in 
18 out of 83 workers examined. Symptom s included loss of 
teeth, sore gums, loose teeth, salivation, headaches, person­
ality  changes, and  tremor. Workers exposed to average a ir 
concentrations less than  0.03 m illigram  of mercury per cubic 
m eter displayed no symptoms.
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The following table relating By mp to me and  exposure d a ta  has 
been adopted from T urrian  et a l.71 and N IO SH 72:
SYM PTO M S O B S E R V E D  IN  58 
M ER C U R Y  W O R K ER S
A ir  C o n c e n tra t io n  (m illig ra m s
o f  m e rc u ry  p e r  cub ic  m e te r)
0 .0 1 -0 .0 6 0 .0 5 -0 .2 3 0 .3 -0 .6
N u m b e r o f  w o rk e r s 26 15 17
A v e ra g e  e x p o su re , 
y e a rs 9.1 16.7 7.4
T re m o r 19% 20% 29%
E re th is m 8% 33% 29%
Im p a ire d  m e m o ry 0% 13% 18%
D e m o g ra p h ia 8% 27% 18%
G in g iv itis 42% 40% 35%
B ad  te e th  o r  
d e n tu re s 46% 67% 41%
(Turrian et al., 1956, and NIOSH, 1973)
McGill et al.™ reported a study of 58 workers in a mercury-cell 
chlorine p lant where mercury vapor levels ranged between 0.08 
and  0.10 m illigram  of mercury per cubic meter. No signs or 
symptoms of poisoning were detected. Urine mercury sam ples 
were usually between 0 and  0.157 m illigram  of mercury per 
liter; blood mercury levels were between 0 and  0.003 m illigram  
of mercury per liter.
Sm ith et al.74 reported a  1-year study of 567 workers exposed to 
mercury in 21 chlor-alkali p lan ts where air concentrations of 
vapor ranged from less th an  0.01 to 0.27 m illigram  of mercury 
per cubic meter w ith a m ean of 0.065 m illigram  of mercury per
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cubic meter. Sm ith concluded th a t loss of appetite, w eight loss, 
and  objective tremors were dose-related. Also, when exposure 
was greater th an  0.10 m illigram  of mercury per cubic meter, 
there was an  appreciably higher incidence of abnorm al 
reflexes.
The following da ta  relating mercury exposure to blood levels 
and urine levels have been reported by Sm ith et a l.74 and are 
taken in table form from NIOSH.72
RELATIONSHIP OF MERCURY EXPOSURE 
TO BLOOD MERCURY LEVELS*
TWA** E x p o su re  P e rc e n ta g e  o f  G ro u p
L ev e l G ro u p s  N u m b e r w ith in  B lood  L ev e l R a n g e  
(m illig ra m s  p e r  o f  (m ic ro g ra m s p e r
cub ic m e te r)  W o rk e rs  _____ 100 m illi lite rs )______
<1 1-5 6-10 >10
C o n tro ls  0 .0 0 117 69.3 30.7 0.0 0.0
< 0 .01 27 33.3 63.0 3.7 0.0
0 .0 1 -0 .05 175 20.6 74.9 4.0 0.6
0 .0 6 -0 .1 0 77 10.4 81.8 6.5 1.3
0 .1 1 -0 .14 53 3.8 22.6 26.4 47.2
0 .2 4 -0 .2 7 26 0.0 19.2 26.9 53.9
(Smith et al., 1970 and NIOSH, 1973)
•Expressed as percentage of each exposure level group with 
designated ranges of blood mercury levels.
**Thne-weighted averages
The d a ta  support E lkins’ suggestion of a “biological threshold 
value,” a urine level of 0.25 m illigram  of mercury per liter. 
Sm ith reports a  corresponding blood level of about 6 micro- 
gram s of mercury per 100 milliliters.
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R E L A T IO N S H IP  O F  M E R C U R Y  E X P O S U R E  TO  
M ER C U R Y  L E V E L S IN  U R IN E , U N C O R R E C T E D  F O R  











Percentage of Group 
:hin Urine Level Range 
(milligram per liier)
-11-.30 .31-.60 .81-1.0 >1.00
C o n tro ls  0 .00 142 35.2 62.7 2.1 0.0 0.0 0.0
< 0 .0 1 29 6.9 86.2 6.9 0.0 0.0 0.0
0 .0 1 -0 .0 5 188 6.9 66.0 24.5 2.7 0.0 0.0
0 .0 6 -0 .1 0 91 0.0 62.6 30.8 6.6 0.0 0.0
0 .1 1 -0 .1 4 60 3.3 18.3 31.7 16.7 23.3 6.7
0 .2 4 -0 .2 7 27 0.0 14.3 29.6 44.5 7.4 3.7
(Smith et al., 1970, and NIOSH, 1973)
•Expressed as percentage of each exposure level group w ithin 
designated ranges of urine mercury levels
*+Time-weighted averages
The following sections in quotes are from the N ational 
Institu te for Occupational Safety and  H ealth:72
In  a study of the records of 1,173 hatters, Baldi et al.75 reported 
“300 cases of mercury poisoning resulting from exposure to 
concentrations rang ing  from 0.5 to greater th an  2.0m illigram s 
of mercury per cubic meter. One hundred of these cases resulted 
in  perm anent disability. Although some cases were reported a t 
exposure levels below 0.5 m illigram  of mercury per cubic meter, 
there were no cases reported for workers exposed to less 
th an  0.1 m illigram  of mercury per cubic m eter.”
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NIOSH concludes th a t the results of the epidemiological 
surveys on mercury exposure “dem onstrate th a t the higher the 
concentrations of mercury in air the greater the likelihood th a t 
an  exposed worker will develop signs or symptom s of mercury 
intoxication although it cannot be assured th a t toxicity will 
develop a t high exposure levels.”
E v id e n c e  o f  E x p o su re
Air Sampling and Analysis
The NIOSH approved a ir sam pling method uses adsorption 
on a  two section tube containing silvered Chromosorb P  in one 
section and carbosieve B in  the other section. In  addition, the 
suspect a ir is screened with a portable mercury meter or 
detector to determ ine the airborne mercury concentration. The 
direct-reading instrum ent determines the length of time th a t 
the air is sam pled with the adsorption tube. Five m ethods 
previously used are:
1. Mercury vapor meters or detectors,
2. gold chloride on silica gel,
3. selenium sulfide coated paper,
4. im pingem ent, and
5. length of stain  detector tubes.
The NIOSH approved analysis m ethod uses cold vapor atomic 
absorption. Six analysis methods previously used are:
1. Visual reading of length of s ta in  detector tubes,
2. direct-reading meters or detection instruments,
3. visual color determ ination of gold chloride on silica gel,
4. visual color determ ination of selenium sulfide coated 
paper,
5. dithizone colorimetric method, and
6. Barnes method.
These methods are not intended to be exclusive but other 
methods should be justified.
A llo w a b le  E x p o s u r e  L im its
S tandards adopted by the Occupational Safety and  Health 
A dm inistration (OSHA) lim it mercury (inorganic) exposure to
0.1 m illigram  of mercury per cubic meter of air as a ceiling
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value. The NIOSH recommended s tandard  is 0.05 milligram 
of mercury per cubic meter of air as an  8-hour time-weighted 
average.
C o n c lu sio n
Diagnosis of occupational mercury poisoning is based on the 
following:
1. Confirmed h istory of occupational exposure to mercury,
2. mercury in the blood and  urine (level m ay not correlate 
well with the severity of disease), and
3. clinical findings compatible w ith mercury poisoning.
NOTE: H unter states th a t a high u rinary  excretion of mercury 
is of diagnostic significance only when the signs and 
symptoms of mercury poisoning can be dem onstrated.
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N i t r o g e n  D i o x i d e
In tro d u c tio n
Nitrogen oxides include nitrous oxide, nitric oxide, nitrogen 
dioxide, n itrogen  trioxide, n itrogen  tetroxide, n itrogen  
pentoxide, n itric  acid, and  nitrous acid. A thorough discussion 
of the chemical and  toxic properties of each oxide can be found 
in the NIOSH Criteria Document on the oxides of n itrogen75. 
This chapter is concerned with the chemical agent nitrogen 
dioxide (N 02) which exists in equilibrium w ith nitrogen 
tetroxide (N2 O4 ) a t body temperature.
Exposure to nitrogen dioxide is through inhalation. There is 
often only mild irritation  of the  upper respiratory tract, 
apparently  because little of the inhaled gas enters into solution 
until it reaches the moist alveolar (air cell) spaces of the lungs. 
Therefore, a t the tim e of exposure, there m ay be little pain  or 
shortness of breath, and a seriously dam aging dose can be 
delivered to the lungs while a worker is not im m ediately aware 
of the danger.
Depending upon the concentration and duration of exposure, 
toxic reactions to nitrogen dioxide can range from mere 
mucosal irritation  to chemical pneum onitis, acute pulm onary 
edema (excess fluid in  lung tissue), or death. There is a la ten t 
period of from 3 to 30 hours from the time of in itia l exposure to 
the onset of potentially fata l pulm onary (lung) symptoms.
Chronic exposure to low levels of nitrogen dioxide (5 to 20 ppm) 
m ay result in mild irritation to the eyes, nose, and throat, con­
tinued pulm onary irritation, coughing, and  possible lung 
dam age, especially to the alveolar tissue. Chronic bronchitis 
and  a clipical condition in  which the blood’s ability to tra n s ­
port oxygen is reduced (methemoglobinemia) m ay result.
The following is a  listing of common nam es for nitrogen 
dioxide followed by a  listing Qf occupations with potential 










Occupations w ith Potential Exposures to Nitrogen 
Dioxide
acid dippers 
aniline m akers 
arsenic acid makers 



































n itrate workers 
nitric acid workers 
nitrite workers 
nitrogen dioxide workers 
nitrous acid workers 
nurses
organic chemical synthesizers 
oxalic acid m akers 
oxidized cellulose compound 
m akers 
pharm aceutical m akers 
phosphoric acid m akers 
photoengravers 




plasm a torch operators 
raw  silk bleachers 
rocket fuel m akers 
silo fillers
sulfuric acid m akers 




M e d ic a l E v a lu a t io n  a n d  D iffe r e n tia l  
D ia g n o s is
(See also Decision-Making Process)
The following should be considered:
—smoking history,
—periodic chest X-rays,
—periodic pulm onary function tests such as 1 second 
forced expiratory volume (FEVi) and forced vital 
capacity (FVC), and 
—methemoglobin studies.
The differentail diagnosis includes:
—Pneumonia,
—acute bronchitis, and 
—X-ray findings m ay mimic tuberculosis.
A respiratory questionnaire (Appendix C) can  be useful in eval­








I t  should also be considered th a t exposure to nitrogen dioxide 
can be from a  home hobby or activity such as:
—Automotive and related hobbies,
—welding, especially arc, and 
—use of a  gas heater or stove.
Air pollution m ay also be a factor, especially in  cities 
w ith heavy vehicle use.
NOTE: N itrogen dioxide is contained in both tobacco smoke 
and  smog. Smokers in  smoggy areas are likely to be a t 
increased risk of developing chronic obstructive pulm onary 
disease.
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S ig n s  a n d  S y m p to m s
Local
—irritation  of eyes
—irritation  of mucus m em branes of upper respiratory trac t 
—yellowish or brownish stain ing  of skin and  teeth (may 
indicate nitric acid exposure)
Systemic
Nitrogen dioxide fumes can cause 2 types of upper 
respiratory trac t injuries:
—Severe pulm onary irritation, progressing to pulm onary 
edema, which m ay occur w ithin 24 hours of prolonged 
an d /o r concentrated exposure 
—insidious bronchiolar dam age, causing life-threatening 
respiratory trac t obstruction in  1 to 4 weeks after only 
mild to moderate exposure to the toxic gas.
M ethemoglobinemia m ay also occur.
Acute Exposure
—discomfort, uneasiness, or indisposition, often indicative 
of infection (malaise)
—bluish or grayish  discoloration of the skin (cyanosis)
—cough
—expectoration of blood (hemoptysis)
—rapid breath ing  (tachypnea)







—collapse and death from respiratory failure 
—bronchial irritation, a 5- to 12-hour symptom-free period, 
followed by sudden onset of acute pulm onary edema m ay 
also occur
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Nitrogen oxides formed from green silage m ay produce "silo- 
filler’s disease” and or bronchiolitis fibrosa obliterans. I t m ay 
develop w ithin a  few days or 6 weeks and is accompanied by: 
—Fever,
—severe and  progressive dyspnea, and 
—cyanosis.
Silo filler's disease m ay also progress to chronic pulm onary 
obstruction.
Chronic Exposure
—pulm onary dysfunction 
-decreased vital and  breathing capacities 
-decreased lung compliance 
-increased residual volume 
—low arterial oxygen saturation  
—dyspnea on exertion 
—m oist rales and wheezes
—sporadic  cough w ith  m ucopurlen t expectoration  
(consisting of mucus and pus)
—m ethem oglobinem ia, usually  m ild and  tran s ien t. 
Persons with genetic susceptibility m ay develop toxic 
levels of methemoglobin
L a b o ra to ry  a n d  C lin ic a l E x a m in a t io n s
Additional da ta  th a t will assist in arriv ing  a t a correct 
dignosis are:
—Chest X-ray of acute exposure shows diffuse, reticular 
fine, nodular infiltration, or numerous scattered nodular 
densities (1 to 5 millimeters in  diameter),
—decreased blood pH,
—decreased serum proteins, and
—ihcreased urinary  hydroxyproline and  acid mucopoly­
saccharides.
E p id e m io lo g y
When considering exposure to nitrogen dioxide, both concen­
tration and  exposure tim e m ust be evaluated. There is sufficient 
da ta  to conclude th a t the prim ary irritan t effects of nitrogen 
dioxide are dose-related.
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It should be noted th a t the acute and usually delayed effects 
of higher concentrations of nitrogen dioxide are well estab­
lished but the critical concentration needed to produce either 
acute or pulm onary edema or bronchiolitis fibrosa obliterans is 
not known. In addition, subacute and chronic responses to low 
levels of exposure to nitrogen dioxide are no t well-established 
or defined in the hum an.
Muller77 reported a study of 7 workers or guests who were 
exposed to nitrogen dioxide during the final b last w hich would 
connect 2 parts of a tunnel under construction. No environ­
m ental m easurem ents are available. Two of them were 
hospitalized shortly after the explosion, and the third was 
hospitalized 12 days la ter after exposure during a second 
explosion. After the acute disease, the m ost common 
com plaints Were bronchitis, cough, sputum, and exertional 
dyspnea. Seven m onths after the accident, 4 of the exposed 
group had  a  1 second forced expiratory volume (FEVi) of less 
than  70%. W ithin 7 to 14 m onths after the accident, 5 recovered 
completely; 2 who suffered from a mild bronchitis previous to 
the accident had  a worsening of symptoms afterw ards and  were 
unable to carry out norm al duties. The following table from the 
report presents latency periods and  bridging symptoms.
LA TEN C Y  P E R IO D S  A N D  B R ID G IN G  SYM PTO M S 
FROM  7 CA SE S T U D IE S  O F A C C ID E N T A L  
N IT R O G E N  D IO X ID E  E X P O S U R E
C A SE L A T E N T  P E R IO D BR ID G IN G  SYM PTOM S
1 4 weeks Dull pressure in chest 
Fatigue, m oderate dyspnea 






(gradual worsening of 
respiration)
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3 18 days Fatigue, dyspnea 





4 4 days Tem perature 
Bronchitis and  cough 
Moderate dyspnea 
a few days 
sick a t home
5 2-1/2 days Sanguinolent sputum  





7 14 hours Pressure in chest
Vomiting
D yspnea
1 week sick 
a t home
(Muller, 1969)
NOTE: Case 2 became gradually short of breath but never was 
seriously sick. Case 6 had  neither a la ten t period nor 
bridging symptoms, although he had  respiratory 
symptom s for about 6 months.
The following report of a dose-response relationship in quotes 
has been taken from the N ational Institu te for O ccupational 
Safety and H ealth:60
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In a study of 70 workers, “aged 26 to 48, exposed for 6 to 8 hours 
daily for 4 to 6 years in a chemical p lan t to w hat was described 
as oxides of nitrogen, Kosider et al.7B reported concentrations 
between 0.4 and 2.7 ppm as nitrogen dioxide. Sam pling and 
analysis methods were not reported. A control group of 80 
workers of sim ilar ages who were not exposed to nitrogen 
oxides w as selected, and  workers smoking more than  10 
cigarettes daily were excluded from both groups. Workers 
exposed to nitrogen dioxide complained of sporadic cough with 
m ucopurulent expectoration and  dyspnea on exertion. Fine 
bubbling rales and ‘w histling’ sounds were heard  in some men, 
prim arily over the lower lungs. There were no chest X-ray 
abnorm alities noted.”
Over a period of 18 m onths, Tse and Bockm an79 observed 4 
firemen with acute toxic reactions due to accidental inhalation  
of nitrogen dioxide which originated from a leak in a chem ical 
plant. Environmental measurements were not made but reports 
indicated the presence of dense, reddish brown fumes. 
Pulm onary function da ta  for the firemen who experienced 
every phase of the illness including the eventual development 
of chronic pulm onary insufficiency follow:





V ita l C a p a c ity  (ml) 3,943 3,000 2,750 2,650
RV /TLC* (3%) 23 45 46 53
F E V ,b (% o f  v i ta l  
cap a c ity ) 79 51 61 70
F E V 3C (% o f  v ita l  
cap a c ity ) 95 73 87 100
M axim um  M id- 
E x p ira to ry  F lo w  
( l i te r s /m in ) 130-395 45 60 65
M ax im al B re a th in g  
C a p a c ity  




A rte r ia l  pH 7.35-7.45 7.40 7.44 7.48
O x y g en  S a tu ra t io n
(%) 99.5 94.3 94.3 86.8
P a o 2d (mm Hg) a i r 90-100 75 75 55
100% o x y g en 550 560 550 550
P a c o 2e a ir 40 29 35 35
D iffu s in g  C ap ac ity  
(DLCO)r
m l/m in /m m  H g 23.2-39.2 30.7 32.3 24.0
(Tse and Bockman, 1970)
a - Residual volum e/total lung capacity
b - Forced expiratory volume in 1 second
c - Forced expiratory volume in 3 seconds
d - Arterial oxygen pressure
e ■ Arterial carbon dioxide pressure
f  - Diffusing capacity of the lung for carbon monoxide
All 4 firemen experienced respiratory discomfort of varying 
degrees with or w ithout abnorm al X-ray findings about 4 to 6 
weeks after exposure. No correlation between individual 
response and smoking was made; however, it was noted th a t 
the 1 firem an m ost severely affected had stopped smoking 14 
years prior to exposure. The others who smoked about */z 
package of cigarettes per day a t the tim e of the accident event­
ually became asym ptom atic.
The probable results of excessive single exposures to nitrogen 
dioxide as determined by the Am erican Industrial Hygiene 
Association are as follows:80
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PROBABLE RESULT OF SINGLE 
EXPOSURE TO NITROGEN DIOXIDE
Exposure
Time C oncentration Expected Effect
(min) in Air (ppm) in  Hum ans
5 400
15 200 Pulmonary edema and
30 150 death
60 100
5 200 Pulmonary edema with
15 100 possible subacute or
30 75 chronic lesions in the
60 50 lungs
5 100
15 50 Respiratory irritation,
30 40 chest pain
60 25
(Emergency Exposure Limits, AIHA J, 1964)
Lowry and Schuman01 reported a study of 4 workers who were 
exposed to nitrogen dioxide after entering a silo or silo chute. 
Exposure occurred within 48 hours of filling of the silo. 
Although actual environmental measurements were not avail­
able, observed concentrations of nitrogen dioxide obtained 
during research experiments in agricultural science have 
ranged from 200 to 4,000 ppm. Irritating fumes were noted by 
all 4 workers who also experienced respiratory symptoms of 
varying degrees of severity and developed bronchiolitis fibrosa 
obliterans. Two of the workers died, 1 on the 27th and the other 
on the 30th day. One of the surviving 2 was hospitalized for 
about 1 week, the other for 3 weeks. Both were able to resume 
normal duties but tiny nodular densities throughout both lung 




The NIOSH approved air sampling method uses a solid 
sorbent tube (packed column). Two previous methods used are:
1. A commercially available field kit and
2. impingement.
Direct-reading indicator tubes are still in use for spot sampling 
and analysis.
The NIOSH approved method for air sample analysis uses gas 
chromatography. Three methods previously used are:
1. A lpha-naphthylam ine-nitrate spectrophotometry 
analysis for the field kit method,
2. colorimetric intensity measurement, and
3. phenol-disulfonic method.
The methods are not intended to be exclusive but other methods 
should be justified.
Allowable Exposure Lim its
The Occupational Safety and Health Administration 
(OSHA) has adopted standards that limit exposure to nitrogen 
dioxide to 5 ppm (or 9 milligrams per cubic meter) of air by 
volume, based on an 8-hour time-weighted average exposure. 
(NOTE: A reduction in the standard to 1 ppm as a ceiling value 
has been proposed by NIOSH to prevent acute irritant effects 
in the lungs of workers exposed to nitrogen dioxide. In addition, 
the prevention of repeated acute episodes of irritancy should 
lessen the risk of developing chronic obstructive lung disease.)
The American Conference of Governmental Industrial 
Hygienists recommends an exposure limit to nitrogen dioxide 
of 5 ppm (or 9 milligrams per cubic meter) expressed as a 
Ceiling Limit which should never be exceeded.
Conclusion
There are no specific tests for diagnosing nitrogen dioxide 
poisoning. Diagnostic criteria for occupational nitrogen 
dioxide poisoning are based on meeting the following:
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1. Confirmed history of occupational exposure to nitrogen 
dioxide,
2. clinical findings as outlined in this guide,
3. blood platelet may increase 10 to 100% above normal,
4. methemoglobin determination may be helpful,
5. carbon dioxide in the blood may be increased,
6. X-rays may show chemical pneumonitis or pulmonary 
edema, and
7. pulmonary function tests.
X-ray findings and lung function tests results are of diagnostic 
value but diagnosis cannot be based on these findings alone.
The clinical findings or effects of inhalation exposure to 
nitrogen dioxide may simulate other diseases such as 
pneumonia, acute bronchitis, or even cerebral hemorrhage. 
These entities can usually be excluded by an accurate medical 
history.
The history of acute nitrogen dioxide exposure is characteristic: 
initial symptoms subside upon termination of exposure, 
followed by a sudden onset of pulmonary edema (excess fluid in 
lung tissue) after a latent period of 3 to 30 hours.
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N o i s e
Introduction
Occupational hearing loss is a slowly induced deafness 
produced by loud sound in the workplace, over a period of time 
varying from months to years. Hearing loss may also be 
immediate, such as that caused by a sudden, loud explosion.
Exposure to intense noise for an extended period of time causes 
hearing loss which is either temporary, permanent, or a 
combination. Hearing loss is referred to as temporary thres­
hold shift (TTS) or permanent threshold shift (PTS).
Temporary hearing loss means that the person’s ability to hear 
will return to normal when he is absent from the source of the 
noise for a period of time. In cases of permanent hearing loss, 
there is never a return of hearing to the previous threshold.
Disability from hearing loss results from the decreased ability 
to identify spoken words or sentences. Speech is composed of 
frequencies between the range of 250 and 3,000 Hertz (Hz). 
Hertz is a unit of measurement of the frequency, sometimes 
referred to as cycles per second (cps).
The hearing level for speech is a simple arithemetic average of 
the hearing levels at frequencies of 500, 1,000, and 2,000 Hz. 
(Sataloff, J.; and Michael, P. 1973. Hearing Conversation 
Springfield, Illinois: Charles C- Thomas Co.) Healthy young 
ears are able to hear sounds through the frequency range from 
20 to 20,000 Hz.
Hearing loss from repeated exposure to excessively loud noise 
usually occurs in the 4,000 Hz. area. Since this is above the 
frequency range of the normal spoken voice, an individual may 
suffer a decrease in hearing and not be aware of it.
A person's ability to hear high frequencies decreases with age 
just as his ability to read fine print decreases with age. The 
hearing deficiency is called presbycusis. The effects of age on 
hearing and vision are not the same for all individuals. This 
adds to the problem of determining if a hearing loss is occupa­
tional in origin, or the result of the aging process. However,
146
presbycusis tends to start in the 8,000 Hz. frequencies, whereas 
hearing loss due to noise is usually in the 4,000 to 6,000 Hz. 
range. Recruitment is present in early cases of deafness due to 
excessive noise, but not in presbycusis. Recruitment is the 
inability to understand speech in the presence of surrounding 
noise. The louder the words are spoken, the more difficult it is to 
understand them. Noise induced hearing loss usually is 
bilateral (exists in both ears).
In cases of occupational hearing loss, any accompanying 
hearing loss due to presbycusis is usually accounted for by 
allowing a reduction of lh  decibel (dB) for each year of age over 
the age of 40. The decibel (dB) is a unit for measuring 
the loudness or intensity of sound. For example, the sound 
pressure level (loudness) of conversation is between 60 or 70 
dBA, a compressor is in the range of 120 dBA, and a turbojet 
engine 160 dBA. Because noise is not one frequency but is 
composed of a mixture of many frequencies, the so-called A- 
weighted technique is used for measurement of intensity. It is 
an average of the intensity of the different frequencies and is 
expressed as dBA.
Excessive noise can cause physiological problems other than 
hearing loss. It can have an effect on emotions, produce 
irritability, increase blood pressure and heart rate, and produce 
nausea. These effects on the worker in a noisy environment are 
not well defined as an occupational illness, but may have an 
affect on the quality and efficiency of the work performed.
Occupations With Potential Exposures to Noise
boiler rooms paper manufacture
chemical products paper products manufacture
manufacture petroleum refining
construction plastics manufacture
corrugated paper manufacture plastic products manufacture 
demolition power plant operators
earth moving equipment printing
opera tore primary metal processing
electrical equipment quarrying
manufacture rubber manufacture
engine rooms rubber products manufacture
fabricated metal product shipbuilding
manufacture steel making
farm equipment operators stone products industries









mining — open pit 









Medical Evaluation and Differential 
Diagnosis
(See also Decision-Making Process)
In the Medical History, the following should be considered:
1. Any previous history of diseases or injury involving the 
auditory nerve, capable of causing hearing loss, either 
as a direct result of disease or injury, should be evaluated 
to determine if present findings are associated with 
previous disease or injury.
2. In cases of possible occupationally induced hearing 
loss, it is important to evaluate the claimant’s medical 
history pertaining specifically to diseases and condi­
tions of the ear and auditory nerve. Included are the 
following considerations:
—Previous ear trouble and disease,
—extent of known hearing loss,
—dizziness,
—tinnitus (ringing in the ears),
—treatment with drugs (ototoxic drugs),
—head injury, and
—estimate of subject's own hearing ability.
In the occupational history, consider also that exposure to 




—loud music in any form from any source,
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—auto repair,
—operating noisy equipment (tractors, lawn mowers, etc.), 
—traffic,
—pistol, rifle, or shotgun firing,
—auto racing, and
—operating motorcycles, snowmobiles, or boats.
Signs and Sym ptom s
Early signs of hearing loss are:
—Inability to understand spoken words in a noisy 
environment,
—need to look at the person speaking to understand words, 
—familiar music may not sound the same, and 
—changes occur in routine audiometric examination.
NOTE: The American Academy of Opthalmology and Oto­
laryngology Guide for Determining Hearing Impairment is a 
useful guide for assessing handicaps due to hearing loss.
Laboratory and Clinical Evaluations
Other Tests
A thorough clinical examination of the ear should include 
the following:
—External ear examination for scars or malfunctions,
—otoscopic examinations of ear drum (typanic membrane) 
for any abnormalities,
—examination of nose, throat, and nasopharynx for any 
abnormalities,
—eye reflexes are noted (pupil and cornea),
—examination with tuning fork,
—pure tone audiometric examination,
—bone conduction studies,
—speech reception testing for threshold and 
dis crimin ation,
—recruitment and tone decay studies, and 
—other tests may be conducted.
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If baseline and/or periodic audiometrie examinations were 
conducted by the emloyer, these test results should be obtained 
for comparison with present audiometrie test results.
In addition, the following should be considered:
The audiometrie (pure tone) examination is one of the best 
clinical means of measuring hearing loss, although other 
examinations as referred to above should also be completed. 
The audiometrie examination should be administered only by 
trained, competent personnel, and the test results interpreted 
by a competent otologist or audiologist.
The frequencies monitored by audiometry should cover the 
range of 250 Hz through 8,000 Hz. Factors which may alter 
audiometrie test results include the following:
—Faulty or maladjusted equipment,
—inaccurate or misunderstood instructions from the test 
operator,
—wax in the ears,
—head cold or allergy, and
—exposure to intense noise 18 hours or less prior to the test.
Epidemiology
The sources of hearing loss and other auditory damage are 
well documented in the scientific literature, and many studies 
have shown the levels and durations of noise that are liable to 
cause such effects.
The following reports of dose-response relationships are taken 
from NIOSH82. NIOSH summarized audiometric surveys 
carried out between 1960-1970 in the United States and other 
countries. The following sections in quotes are all from NIOSH:
Coles and Knight80 reported a study of workers in diese 1-engine 
testing. “Maximum noise level 116 dB. Of six men who worked 
continuously in the intense noise of the two-stroke test-house 
(average period 3l/2 years) all had losses of 45-60 dB in one or 
both ears at 3.4 and 6 KHz, and none could be accounted for by 
an aging factor.”
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Yaffe and Jones84 reported a study of Federal penitentiary 
workers (textiles, wood products, sheet metal, brush, shoe and 
clothing manufacture, and printing) where octave band noise 
levels ranged from 75-110 dB. “Those levels which exceeded 
octave band criteria produced significant hearing threshold 
shifts at 3, 4, and 6 KHz after 24 months exposure. The loca­
tions producing the largest shifts were cotton mill twist and 
weaving departments, woolen mill weaving departments, and 
furniture mills."
Schneider85 reported a study of 294 jobs in chemical works 
involving 691 individuals. “Data divided into 4 noise exposure 
groups based on octave band criteria indicated that the group 
exceeding criteria more than 10% of the time experienced a 
permanent threshold shift of 1 dB per year at 2, 3, and 4 KHz. 
For the group near criteria exposure, most of the hearing loss 
occurred within the first five or so years.”
Brohm and Zlamal06 reported a study of noise in the cabs of 
heavy trucks ranging from 90-110 dB. Examinations were 
made of 51 truck drivers and in each case a loss of hearing was 
determined.”
Mancini and Stancari87 reported a study of 50 fettlers. “Men 
working in 9 foundries with noise levels of 92-100 dB. In men 
who had been working for more than 5-6 years in noisy 
conditions almost all frequencies were involved; those who had 
worked less than 2-3 months in noisy conditions showed a loss 
varying from 30 to 50 dB at 400 Hz." Chadwick88 reported a 
study of 12 men exposed to noise from industrial gas-turbine 
engine noise. “Noise levels reached as high as 113 dB fla t... the 
low-tone loss in just over two years was in the region of 10 dB 
and from 2,000-4,000 Hz was in the order of 20 dB ... the average 
loss for the speech frequencies was . . . eight times more than 
that to be expected in a more conventional industry with a 
known noise hazard.
Filin09 reported a study of drivers of self-propelled jumbos in 
underground ore mining. “Noise levels of 127 dB at frequencies 
between 1,000 Hz and 8,000 Hz. Hearing loss in 91 of 135 miners 
examined; after 10 years’ work, 28 dB loss at 4,000 Hz.”
Weston90 reported a study of agricultural tractor drivers. “53 
drivers of tractors of different horsepower; audiograms showed 
greater impairment in inland drivers where the tractors are of
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higher power and exposure is for longer periods than on coast- 
plain farms. Noise levels ranged from 92 dB to 106 dB, occa­
sionally as high as 114 dB.*’
Cohen91 reported a study where “hearing levels for heavy 
earth-moving equipment operators, paper bag workers, and 
airport ramp workers were compared with those of non-noise 
exposed groups. Noise encountered ranged from 80-120 dB 
(A-weighted sound level). The hearing loss levels of the heavy 
earth equipment operators were found to be significantly 
higher than the non-noise exposed groups. The paper bag 
workers had higher hearing loss levels but not as high as the 
earth equipment operators. The airport ramp personnel, 
however, had the lowest hearing loss levels, probably due to the 
intremittency of their exposures.
Bums92 reported a study of 759 employees in 32 various 
industrial factories with noise levels ranging from 78 to 109 
dBA. "A relationship between noise level, exposure duration 
and hearing level was defined with two parameters: audio­
metric frequency and percentage of persons expected to exceed 
a specific hearing level. A-weighted sound level was found to be 
adequate for estimating hearing level for the industrial noises 
measured.”
Stone93 reported a study of “3,116 employees of 9 steam electric 
generating plants and 2 hydroelectric plants were tested. Noise 
levels from assorted equipment ranged from 91 to 127 dBA, the 
more intense values associated with coal hoppers, turbine 
generators and pumps, and forced draft fans. Prevalence of 
hearing impairment (defined by hearing levels averaging more 
than 15 dB (reASA 1951) at test frequencies of 0.5,1, and 2 KHz) 
varied from 4.7 percent for the younger workers having less 
than two years of service to 31.9 percent for the oldest workers 
with 26 years or more experience. Boilermakers, heavy equip­
ment operators, and conveyor car operators as classes had high 
incidences of hearing impairment.”
Evidence of Exposure 
Measurement Methods
The current basis for evaluating continuous industrial noise 
exposures is the A-weighted sound level measurement. The A- 
weighted network is one of the several standardized frequency
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weighting networks on most sound measuring equipment. The 
A-scale is thought to rate noise in a similar manner as the 
human ear. Measurements are A-weighted, slow response for 
the evaluation of continuous noise. If only octave band 
analyses are available, equivalent A-weighted levels can be 
calculated for comparison to current standards.
There is a wide variety of instrumentation available for the 
evaluation of noise from very simple equipment to extremely 
sophisticated equipment used by acoustical engineers and 
consultants. The Occupational Safety and Health Administra­
tion (OSHA) proposes that noise level measurements for steady- 
state or continuous noise be made “with a sound level meter 
confirming as a minimum to the requirements of the ANSI 
Zl.4-1971, Type 2, and set to an A-weighted slow resonse or with 
an audio-dosimeter of equivalent accuracy and precision.” 
Measurements should be taken as clo6e as possible to the 
hearing zone of the worker whose noise exposure is being 
evaluated.
For the measurement of impact noise (such as that from a drop 
hammer), an impact noise meter with peak hold capability 
should be used. This type meter should conform to the require­
ments of ANSI Zl.4-1971, Type 1.
Sound level measuring instrumentation should be calibrated 
with an acoustical calibrator the day of the study, preferably 
before and after the noise measurements.
Allowable Exposure Limits
The OSHA allowable limits for continuous noise are as 
follows:
DURATION PER  DAY 
HOURS










XA or less 115
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OSHA indicates that “when the daily noise exposure is com­
posed of two or more periods of noise exposure of different 
levels, their combined effect should be considered, rather than 
the individual effect on each.
“If the sum of the following fractions C l/T l + C2/T2 +... Cn/Tn 
exceeds unity, then the mixed exposure should be considered to 
exceed the limit value. Cn indicates that the total time of 
exposure at a specified noise level, and Tn indicates the total 
time of exposure permitted at that level.”
The OSHA allowable limit for impact noise should not exceed 
140 dB peak sound pressure level. NOISE ABOVE these limits 
may cause damage, and the exact level of safety has not yet 
been determined.
C o n c l u s i o n
A careful otologic examination and hearing evaluation as 
outlined above are necessary for an accurate diagnosis. 
Criteria for diagnosing occupational hearing loss due to 
exposure to noise include the following:
1. Time and nature of onset of the loss,
2. pattern of hearing loss for different frequencies,
3. confirmed history of occupational exposure of many 
months or years to noise level in excess of accepted 
standards, and
4. clinical findings of otologic examination and medical 
history.
Functional hearing impairment exists when there is no organic 
cause for the apparent deafness, and the inability to hear 
results chiefly from psychological or emotional factors.
Acoustic trauma is hearing loss resulting from a loud noise, 
such as an accidental explosion. If the causative noise occurs 
on the job, the hearing loss would be occupational.
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C r y s t a l l i n e  S i l i c a
Introduction
The crystalline form of silica, silicon dioxide, is widely 
distributed in nature and constitutes a major portion of most 
rocks and their products such as soils and sands. Silica occurs 
in three principal crystalline forms: Quartz, tridymite, and 
cristobalite. During many industrial operations such as 
drilling blast holes and grinding stone objects, a dust of silica 
particles can be formed. Inhalation of these very sharp, 
insoluble particles into the lungs can produce the disease 
silicosis, which is a form of pneumoconiosis characterized by 
the formation of small, discrete fibrous nodules in the lungs.
The silicosis nodule is composed of circular bundles of collagen 
(a fibrous insoluble protein) resulting in fibrous nodules 
measuring 1 to 10 millimeters in diameter. The nodules are 
found in lymphatics around blood vessels, beneath the pleura 
(the membrane covering the thoracic cage and lungs), and in 
groups of lymph nodes within the chest cavity. The upper lobes 
and hilar lymph nodes are more severely affected than the lung 
bases. The nodules may fuse to become “progressive massive 
fibrosis.”
Silicosis may be of an acute or chronic nature. Acute silicosis 
refers to a rapidly developing lung disease which may occur in 
workers exposed to high levels of respirable free silica over a 
relatviely short period ranging from a few weeks to 4 or 5years. 
Eight to 18 months may lapse from the time of first exposure to 
the onset of symptoms which include progressive dyspnea 
(labored or difficult breathing), fever, cough, and weight loss. 
After development of symptoms, survival time is likely to be 
short. This disease has been most often reported in 
manufacturers and packers of abrasive soap powders, in sand- 
blasters working in enclosed tanks, and in high-power drillers 
of tunnel rock.
Chronic pulmonary silicosis, the type commonly encountered 
in industry, iB similar to acute silicosis but usually develops 
after many years of exposure to Bilica dust and may take many 
more years to progress. This disease occurs most frequently in 
the mining industry but is also seen in other industries such as
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potteries, foundries, stone cutting and finishing, tile and clay 
producing, and glass manufacturing.
Both acute and chronic silicosis have a definite tendency to 
progress whether or not the worker remains exposed to dust. 
Tuberculosis is a common complication of silicosis. Silicosis is 
also associated with pulmonary hypertension and cor 
pulmonale (hypertrophy or failure of the right ventricle).
Lung function tests and chest X-rays classed according to the 
ILO U/C system (international classification of radiographs of 
the pneumoconioses) are useful in diagnosing and following 
the progression of silicosis.
Exposure to crystalline silica can result in the occupational 
dermatosis, silica granuloma (a granular tumor or growth 
usually of lymphoid and epitheloid cells).
The common names of some minerals that contain varying 

















The following is a list of trade names of products that either 
consist of or contain silica:
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Positive Sol 130M Tokusil TPLM
Positive Sol 232 U 333
Pregel Ultrasil VN 3
Protek-Sorb Ultrasil VH 3
Quso G 30 Ultrasil VN 2
Quso 51 Verticurine
RD 8 Vitasil 220
Santocel CS Vulcasil S
Santocel 62 Wessalon S





Occupations w ith  P o ten tia l Exposures to
C yrystalline Silica
abrasive blasters cement mixers
abrasives makers ceramic workers
agriculture chemical glass makers
auto garage workers chippers
bisque-kiln workers coal miners
brick layers construction workers
brickmakers cosmetics makers
buffers cutlery makers
buhrstone workers diatomaceous earth calciners
carborundum makers electronic equipment makers
casting cleaners, foundry enamellers
cement makers farming
fertilizer makers quartz workers
fettlers refractory makers
flint workers road constructors
foundry workers rock crushers
furnace liners rock cutters
fused quartz workers rock drillers
glass makers 
glaze mixers, pottery 
granite cutters 
granite workers 
grinding wheel makers 
grindstone workers 


























optical equipment makers 
paint mixers 
polishing soap makers 
porcelain workers 
pottery workers 
pouncers, felt hat 
pulps tone workers 
quarry workers
Medical Evaluation and Differential 
Diagnosis
(See also Decision-Making Process)
The following should be considered:
—Other pneumoconioses,
—sarcoidosis (a chronic granulomatous disease),
—tuberculosis,
—fibrosing alveolitis (hardening of lung tissue),
—carcinomatous lymphangitis (spread of cancer via 
lymph channels), and 
—pulmonary hemosiderosis (iron deposits in lung tissue).
A respiratory questionnaire, such as that in Appendix C, can be 
useful in evaluating the extent and importance of respiratory 
symptoms.
scouring soap workers 
silica brick workers 



















Potential nonoccupational sources of silica dust include:
—Ceramics, pottery and related hobbies,
—work with plasters, mortars, or cements having a high 
silica content, and 
—rock working hobbies (carving, cutting, chiseling).
Signs and Sym ptom s—Simple Silicosis
Simple silicosis may be nonspecific early in the course of the 
illness and have little effect on ventilatory capacity. Generally, 
the only finding is nodulation of the lungs as seen on a chest X- 
ray. Approximately 20 to 30% of the persons with simple 
silicosis go on to develop complicated silicosis despite removal 
from a silica environment.
Signs and Sym ptom s—Complicated 
Silicosis
—Cough and sputum (productive cough),
—labored or difficult breathing (dyspnea),
—wheezes (rhonchi),
—crackling sound (crepitations), on examination of the 
lungs,
—chest pain,
—bluish or grayish discoloration of the skin (cyanosis), 
—decreased pulmonary function, and 
—chest X-ray shows nodulation of the lungs.
Progression of involvement is related to continued exposure, 
increasing age, smoking, and pulmonary infections. Severe 
pulmonary fibrosis may occur in 20 to 30% of workers who 
develop silicosis. In advanced cases, the following may occur:
—Chronic bronchitis,
—obstructive pulmonary disease (emphysema),
—cardiac failure may occur, and 
—death may occur from respiratory failure.
Silicosis may also co-exist with tuberculosis. It should also be 
noted that silicosis favors the growth of the tubercle bacillii. 
However, silicosis may suppress the usual features ofepitheloid 




Laboratory and Clinical Examinations
Additional data that will assist in arriving at a correct 
diagnosis are:
Pulm onary Function
—reduced forced vital capacity (FVC)
—decreased 1 second forced expiratory volume (FEVi)
—reduced diffusing capacity 
—reduced maximal breathing capacity
NOTE: These test results indicate impairment of lung function; 
there are no lung function tests which specifically assay for 
silica.
Pulmonary impairment including oxygen desaturation on 
exercise progresses rapidly in complicated silicosis. Associated 
chronic bronchitis may be a key factor in the decreased 
pulmonary function.
C hest X-Ray
The following classifications are used in charting the 
possible progression of silicosis:
—Simple silicosis: multiple opacities of various sizes and 
densities (from less than 1.5 to 10 millimeters) may be 
diffused over the entire lung field; the opacities may be 
calcified. Hilar nodes may develop “egg shell” calcifica- 
tion.
—Complicated silicosis: conglomerate masses are greater 
than 1 centimeter in diameter and are usually found in 
upper and middle zone. Large sausage-shaped masses 
which may be surrounded by emphysematous bullae 
may appear in advanced cases.
—Caplan’s syndrome: occurs when larger nodules appear 
against the background of simple silicosis; rheumatoid 
disease may be associated.
Radiographs should be classified by the ILO U/C scheme.
161
NOTE: Because silicosis shares the X-ray appearance of at 
least 20 other chest diseases, X-ray findings alone cannot be the 
basis of diagnosis. However, most workers’ compensation 
insurance acts use X-ray criteria for compensation purposes.
Acute, high exposure can result in death without any X-ray 
evidence of silicosis. It should also be noted that nodular 
densities can be induced by silica, iron, tin, and barium without 
associated fibrosis.
Epidemiology
The relationship between crystalline silica and respiratory 
impairment, including silicosis, has been demonstrated in 
various epidemiologic studies. The available information 
indicates that 1 or more of the following factors may have 
important etiologic significance in the development of lung 
disease: The particle size of the crystalline silica dust, the 
concentration of the free crystalline silica, possible synergistic 
action of other ions present, differences in individual 
susceptibility, and the presence of a concomitant infection 
(especially tuberculosis). This should be taken into 
consideration when interpreting the following studies:
Musk et al.94 reported a 4-year study of 688 granite shed 
workers who were exposed to mean silica dust concentrations 
less than the threshold limit value of 100 micrograms per cubic 
meter for respirable free silica. Excessive average yearly 
decrements in pulmonary function were observed: 75 to 84 
milliliters per year for forced vital capacity (FVC) and 53 to 67 
milliliters per year for 1 second forced expiratory volume 
(FEVi). Observed decrements were independent of exposure 
group (i.e., cutter, sculptor, polisher, sandblast area worker, 
etc.) and could not be accounted for by cigarette smoking. In 528 
additional granite shed workers, decrements in ventilatory 
capacity were measured for 1, 2, or 3 years and were of the same 
order of magnitude.
Prospective studies of lung function in working populations 
and in the general population have shown that FEVi and FVC 
in healthy men decrease at a rate of less than 40 milliliters per 
year after the age of 25 years with a greater rate of decline for 
cigarette smokers than for those who have never smoked. 
Subjects with chronic obstructive pulmonary disease exhibit a 
rate of decline of FEVi and FVC of approximately 80 milliliters 
per year.94
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In a study of 727 mine workers from a representative group of 
metal mines, Dreessen et al.95 reported an incidence of silicosis 
in 25% of the workers exposed for more than 6 years to silica 
dust concentrations of 10 to 23 million particles per cubic foot 
(mppcf) having a free silica content of 20 to 40%. No cases of 
silicosis were observed in workers whose exposures did not 
exceed an average of 18 mppcf and whose employment 
exposure did not exceed 10 years. The severity of pulmonary 
fibrosis among cases of silicosis increased greatly with 
increasing length of employment.
Flinn et al.9fi reported a study of 2,516 workers who 
manufactured pottery products in 9 potteries. Workers were 
exposed to dust containing from 1 to 39% quartz and having an 
average particle diameter of 1.2 micrometers. The following 
table summarizing data from the report is taken from the 
NIOSH Criteria Document on crystalline silica:97
RELATION OF DUST CONCENTRATION AND 
LENGTH OF EMPLOYMENT IN  THE 
POTTERY INDUSTRY TO SILICOSIS*
D ust C oncentration Y ears in P o tte ry  Industry  
(million partic les 
per cubic foot) 0-9 10-19 20-29 30-39 O v er40
0-3.9:
Ca9es of silicosis - 1 1 . .
W orkers exposed 481 223 65 21 8
P ercentage 0 0.4 1.5 0 0
-7.9:
Cases of silicosis 1 6 26 27 29
W orkers exposed 321 198 110 53 34
P ercen tage 0.3 3 24 51 85
-15.9:
Cases of silicosis - 8 5 10 10
W orkers exposed 176 119 25 17 14
P ercentage 0 7 20 59 71
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O v e r  1 6 :
Cases of silicosis 13 33 10 5 4
W orkers exposed 363 174 21 7 5
Percentage 4 19 48 71 80
(Flinn et al., 1939 and NIOSH, 1974) 
♦Includes 1st, 2nd, and 3rd stage cases.
Flinn et al- suggested that new cases of silicosis would not 
develop if the dust concentration in potteries could be brought 
below 4 mppcf.
Rajhans and Budlovsky9* reported a study of 1,166 production 
workers in 10 brick and tile plants in Ontario in which no cases 
of silicosis were found. Workers had been exposed for 1 to 30 
years to mean workplace dust concentrations ranging from 12 
to 1,026 mppcf. Average respirable dust concentrations ranged 
from 1.05 to 4.26 milligrams per cubic meter and had a free 
silica content of approximately 13%. Rajhan and Budlovsky 
suggested that progression of the silicotic process Was inhibited 
by the 14% alumina content in the clays and tiles used to 
manufacture brick and tile. In an earlier study in 3 British brick 
plants, Keatinge and Potter" reported similar findings and 
concluded that excessive occupational hazards were not 
associated with brick making.
Theriault et al. 100.101.102 reported a comprehensive study of 
approximately 800 workers from 13 occupational groups in 49 
granite sheds. Granite dust and quartz were reported to cause 
significant decreases in FVC, FEVip and total lung volume but 
not in residual volume. Of 784 workers, 233 had X-rays classed 
as abnormal which showed opacities compatible with 
pneumoconiosis.10:1 Workers with abnormal X-rays had been 
exposed to an average of 2.3 times more dust than workers 
having normal X-rays. Theriault et al. concluded that 
pulmonary function measurements are more sensitive 
indicators of the effect of granite dust than chest 
roentgenograms.
In a 1-year study of 869 workers in 5 diatomite plants, Cooper 
and Cralley104 suggested that nearly all presumptive abnormal 
chest roentgenograms found in 156 workers were associated
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with exposure to calcined diatomite containing 15 to 61% 
cristobalite. The extent and severity of pneumoconiosis also 
appeared to correlate with length of exposure. For all plant 
operations, airborne dust concentrations ranged from 1 to 66 
mppcf, and the median particle size was 1.1 micrometers.
Evidence of Exposure
Sampling and Analysis
The NIOSH approved air sampling method uses mechanical 
filtration. Three methods previously used are:
1. Impingement,
2. cascade impactor, and
3. electrostatic precipitator
The NIOSH approved methods for samples analysis are:
1. Gravimetric plus X-ray diffraction,
2. gravimetric plus colorimetric analysis, and
3. gravimetric plus infrared spectrophotometry.
Three methods previously used are:
1. Electron microscopic,
2. exo-electron emission, and
3. differential thermoanalysis.
The above methods are not intended to be exclusive, but other 
methods should be justified.
Allowable Exposure Limits
Standards adapted by the Occupational Safety and Health 
Administration (OSHA) have recommended that limits for 
dusts containing greater than one percent of silicon dioxide 
(SiO )̂ are to be calculated from the following formula:
• quartz (respirable mass fraction)
(microscopic counting)
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25lr____  million particles per cubic foot
% SiOz + 5
• quartz (respirable mass fraction)
(gravimetric analysis)
10**____  milligrams per cubic meter
% Si02 + 2
•  quartz (total dust)
(gravimetric analysis)
____ 52_____  milligrams per cubic meter
% Si02 + 2
• cristobalite
1/2 the value calculated from the mass or count formula 
for quartz
•  tridymite
1/2 the value calculated from the mass or count formula 
for quartz
*The percent of crystalline silica in the formula is the amount 
determined from airborne samples except in those instances 
in which other methods have been shown to be applicable.
**Both concentration and percent quartz for the application of 
this limit are to be determined from the fraction passing a 
size selector with the following characteristics.
AERODYNAMIC DIAMETER






(NOTE: NIOSH has recommended a reduction in the standard 
to 50 micrograms per cubic meter as respirable free silica based 








Diagnostic criteria for occupational silicosis are based on 
meeting the following:
1. Confirmed history of occupational exposure to free silica 
of:
a. a particle size capable of producing the disease 
(pathologic)
b. sufficient intensity of exposure
c. sufficient duration of exposures
2. X-ray findings as outlined above (in accordance with 
ILO U/C International Classification of Radiographs 
of Pneumoconioses 1971)
3. clinical findings compatible with silicosis as outlined 
above
4. lung function test results that are indicative of respira­
tory dysfunction associated with the formation of 
fibrous tissue within the tissue spaces (interstitial 
fibrosis)
Lung biopsy and lung sections collected after death remain the 
only unequivocal methods of making a definitive diagnosis.
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S u l f u r  D i o x i d e
Introduction
Sulfur dioxide, a colorless gas at room temperature with a 
distinctive, irritating odor, can also exist as a liquid and is 
soluble in water and organic solvents. It is produced in the 
smelting of sulfide ores and in the processing of sulfur- 
containing fuels. In large cities and areas surrounding smelters 
and oil refineries, sulfur dioxide is a major contributor to 
atmospheric pollution.
Because sulfur dioxide is very soluble, it mainly affects the 
upper respiratory tract: nose, throat, trachea (windpipe), and 
bronchi. These tissues may swell and block the passage of air. 
After acute exposure, the alveoli (air sacs) are also injured, and 
pulmonary edema (filling of the lungs with fluid) can result, 
which may be fatal.
The average individual is able to detect 0.3 to 1 part per million 
(ppm) mainly by taste, 3 ppm by odor, and 6 ppm by immediate 
sharp irritation of the nose and throat. Concentrations of 20 
ppm can cause an immediate irritation to the eyes (Daum and 
Stellman, 1973).
Severe acute gassing accidents are rare because sulfur dioxide is 
so intensely irritating that workers run for their lives to 
escape from its effects. Workers in atmospheres fairly 
heavily contaminated by sulfur dioxide do acquire a degree of 
tolerance.
The long-term effects of low concentrations of sulfur dioxide are 
not known, though nasopharyngitis (chronic irritation of the 
nose and throat), changes in the senses of taste and smell, and 
increased fatigue have been documented. Chronic irritation of 
the trachea due to exposure to sulfur dioxide may cause chronic 
bronchitis and emphysema.
Eye injury varies according to whether the gaseous or liquid 
form of sulfur dioxide is involved. When only the gas is 
employed, as in magnesium foundries, ocular reactions are 
mild probably due to the warning characteristics of the gas 
which enable the worker to avoid excessive exposure. Even
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in acute gaseous exposures, severe enough to almost be 
fatal to the worker, the severe conjunctivitis (inflammation 
of the membrane that lines the eyelids and the front 
of the eyeball) that occurb resolves completely and leaves 
no ocular damage.
The accidental spraying of liquefied sulfur dioxide into the eyes 
of workers on refrigeration machines may cause permanent 
reduction of visual acuity (sharpness of vision) from its 
clouding effect on the cornea. Blindness can result.
Inhaled sulfur dioxide may cause thiamine deficiency-like 
symptoms. In women, menstrual disorders may be observed.
The following is a listing of common names for sulfur dioxide 
followed by a listing of occupations with potential exposure to 
sulfur dioxide:
Common Names
fermenticide liquid sulfurous anhydride
sulfer oxide sulfurous oxide
Sulfur oxide sulphur dioxide
sulfurous acid anhydride
Occupations with Potential Exposures to Sulfur Dioxide
alkali-salt makers 
automotive workers 
beet sugar bleachers 
blast furnace workers 





carbolic acid makers 
cellulose makers 
coke oven workers 
copper smelters 
diesel engine operators 










ore smelter workers 
organic sulfonate makers 
paper makers 
petroleum refinery workers 
pottery workers 
preservative makers 
protein makers (edible) 




dye makers sodium sulfite makers
exterminators storage battery chargers
feather workers straw bleachers
fertilizer makers sugar refiners
firemen sulfite makers
flour bleachers sulfur dioxide workers
flue cleaners sulfurers (malt and hops)
food bleachers sulfuric acid makers
foundry workers tannery workers
fruit preservers textile bleachers
fumigant makers thermometer makers (vapor)
fumigators thionyl chloride makers
furnace operators tunnel workers
galvanizers vegetable preservers
gelatin bleachers vulcanizers
glass makers wicker ware bleachers
glue bleachers wine makers
grain bleachers wood bleachers




Medical Evaluation and Differential 
Diagnosis
(See also Decision-Making Process)
The following should be considered:
—Any history of past disease of the eye or the- 
cardiopulmonary system (of the heart and/or lungs) 
should be carefully evaluated to determine if present 
symptoms are, in fact, associated with a previous disease 
or injury.
—a respiratory questionnaire, such as that in Appendix C, 
can be useful in evaluating the extent and importance of 







Exposure to sulfur dioxide may be from:
—Air pollution,
—hobbies invloved with auto mechanics and exposure to 
exhaust gases from cars equipped with catalytic 
converters, and 
—working as a volunteer fireman.
Signs and Sym ptom s
Acute Exposures
—irritation of nose and throat,
—burning sensation in the eyes,
—secretion and discharge of tears (lacrimation),







—rales, high pitched type,
—prolonged expiratory phase, and 
—bronchial asthma.
In severe exposure, the above progresses to:
—Chemical bronchopneumonia (inflammation of the 
terminal bronchioles and alveoli) and 
—bronchiolitis obliterans (irritation of the bronchioles 
that results in their closure).
Hypersensitive individuals will develop urticarial skin 
eruption (characterized by pale evanescent wheals or hives 
associated with severe itching) and swelling of the eyelids.
Signs and symptoms that liquid sulfur dioxide can cause in the 
eye are:
—Comeal burns (may be painless) and
Nonoccupational Exposure
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—corneal opacification which may result in partial 
or complete loss of vision, depending upon the 
severity of exposure.
Chronic Exposure
Symptoms which will be experienced initially include: 
—Upper respiratory tract irritation,
—cough,
—nose bleeds (epistaxis),
—chest tightness, and 
—expectoration of blood (hemotysis).







—chronic irritation of the nose and throat (nasopharyn­
gitis),
—alteration in senses of smell and taste,
—increased sensitivity to other irritants,
—fatigue,
—labored or difficult breathing (dyspnea) on exertion, and 
—prolongation of common colds.
Laboratory and Clinical Examinations
Additional data that will assist in arriving at a correct 
diagnosis are:
Urine
—increased acidity due to increased excretion of sulfate
Pulmonary Function
—increased airway resistance 
—decreased maximum expiration flow 
—decreased 1 second forced expiratory volume (FEVi)
—decreased forced vital capacity (FVC)
—decreased specific airway conduction 




—may show reticulation, nodulation, and enlarged hilar 
shadows after long-term exposure 
—X-ray findings compatible with bronchiectasis, pul­
monary edema, emphysema, bronchiolitis obliterans, 
asthma
An additional test result which will assist in arriving at a 
correct diagnosis is:
—inhibition of thyroid function
Epidemiology
Studies of workers exposed to sulfur dioxide in their work 
environment have suggested association with chronic 
nonspecific pulmonary disease. However, no quantitative 
exposure-effect relationships have been derived from the 
published reports of occupational exposure, and mixed exposures 
have been the general rule.105 This should be taken into 
consideration when evaluating the following material:
Smith et al.106 reported a study of 113 copper smelter workers 
who were exposed to concentrations of sulfur dioxide ranging 
from 1.6 to 45 ppm with the highest concentrations occurring 
close to the production source. Combination dust and gas 
masks were used intermittently when a worker experienced or 
expected irritation. Over the 2-year study period, the workers 
showed an excessive loss of pulmonary function averaging 74.5 
milliliter loss of forced vital capacity (FVC) and 84.0 milliliter 
loss of 1 second forced expiratory volume (FEVi) per year. 
Workers with FEVi below normal on initial measurements 
(based on their age and height) showed evidence of even greater 
loss of pulmonary function related to sulfur dioxide exposure. It 
was concluded that sulfur dioxide exposures greater than 1 
ppm are associated with an accelerated loss of pulmonary 
function that could lead to chronic pulmonary disease if high 
exposures were continued for a sufficient period of time.
Kehoe et al.107 reported a study of the effect of prolonged 
exposure to sulfur dioxide on 100 workers who manufactured 
electric refrigerators. At the time of the study, atmospheric 
concentrations of sulfur dioxide averaged from 20 to 30 ppm 
with a range of 5 to 70 ppm. (5 years before the study,
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concentrations averaged 80 to 100 ppm.) Average length of 
employment exposure was 3.8 years, and 47 workers had 4 to 12 
years employment exposure. A control group of 100 men, age- 
matched with the exposed group, was selected from parts of the 
same plant where there was no known exposure to sulfur 
dioxide or other known noxious gases, fumes, or dust. An 
incidence of slight chronic nasopharyngitis significantly 
higher than normal was found in exposed workers, and many 
of these workers suffered partial loss of sense of taste and smell. 
The susceptibility to ordinary colds was no higher than normal 
but their average duration was 2 to 3 times longer than the 
average for the control group. Other significant differences 
between the 2 groups were dyspnea on exertion and increased 
fatigue from work.
Skalpe 108 reported a study of 54 workers at 4 different pulp 
mills that was initiated by the observation that pulp mill 
workers very often complained of chronic cough. The workers 
were exposed to concentrations of sulfur dioxide ranging from 2 
to 36 ppm but were reported to occasionally have much heavier 
exposure due to special procedures than was indicated by the 
analysis. The control group, 56 unexposed workers from the 
same industry and district, had no significant differences in 
age or in frequency of smokers. A significantly higher frequency 
of cough, expectoration, and dyspnea on exertion was found in 
the exposed group with the difference being greatest in age 
groups under 50 years. The average maximal expiratory flow 
rate was significantly lower (the difference in means, 42 liters 
per minute, was twice the standard error) in the exposed group 
than in the control group in the age groups under 50- there was 
no difference in values in the age group over 50. Vital capacity 
values showed no significant difference between the groups.
Skalpe stated that the probable explanation for the high 
frequency of respiratory disease symptoms in the age group 
under 50 was because respiratory disease is rare in this age 
group. Therefore, the effect of small external insults would be 
easier to detect than in the older age group where respiratory 
disease from other causes is more common, so that a small 
addition would be less noticeable.
In a mortality study of8,047 copper smelter workers exposed to 
arsenic trioxide and sulfur dioxide, Lee and Fraumeni1"9 
hypothesized that an interaction between exposure to high 
levels of arsenic trioxide and to sulfur dioxide (or other
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unidentified chemicals in the work environment) may be 
responsible for the excessive number of respiratory cancer 
deaths among smelter workers.
Evidence of Exposure
Sampling and Analysis
The NIOSH approved air sampling method uses mechanical 
filtration in series with impingement. Two previous methods 
used are:
1. Continuous automatic reading instruments and
2. a series of two scrubbers (impingers).
Direct-reading detector tubes are still in use for spot sampling 
and analysis.
The NIOSH approved method for air sample analysis is 
titration using an indicator to determine the end point.
Previous impingement sample analysis methods also used 
titration plus an indicator.
These methods for sampling and analysis are not intended to 
be exclusive. However, it is recommended that other methods 
be justified.
Allowable Exposure Limits
The Occupational Safety and Health Administration 
(OSHA) has recommended limiting exposure to sulfur dioxide 
to 5 ppm of air by volume based on an 8-hour time-weighted 
average exposure. (NOTE: NIOSH has proposed a reduction in 
the standard to 2 ppm based on an 8-hour time-weighted 




It is difficult to attribute observed symptoms specifically to 
sulfur dioxide exposure since it is frequently associated with 
other atmospheric contaminants in industry.
Diagnosis of occupational disease due to sulfur dioxide 
exposure rests on meeting the following composite pictures:
1. Confirmed history of occupational exposure to sulfur 
dioxide,
2. clinical findings comparable to those outlined above,
3. lung function test results indicating- lung impairment, 
and
4. increased urinary sulfate ion concentration is not 
diagnostic but may indicate degree of exposure.
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T o l u e n e  D i i s o c y a n a t e
Introduction
Toluene diisocyanate (TDI) is a liquid used in the 
manufacture of polyurethane. The liquid, vapor, and aerosol 
forms are powerful irritants to all tissue.
Skin contact with liquid toluene diisocyanate causes 
inflammation which may lead to a chemical dermatitis. Liquid 
in the eyes causes severe irritation with lacrimation (watering 
of the eyes). A chemical conjunctivitis with swelling of the 
cornea can result from exposure to the vapor.
The vapor is a potent respiratory irritant and sensitizer. In 
some cases where sensitization has occurred, violent 
respiratory symptoms can develop on exposure to very low 
concentrations. It is not now known if all or only some people 
may become sensitized.
The irritating effects of TDI include rhinitis (inflammation of 
the mucous membrane lining the nose), pharyngitis (inflam­
mation of the pharynx), bronchitis, and in severe exposure, 
inflammation of the bronchioles. Occasionally the onset is with 
an attack of asthma. Usually the signs and symptoms of chest 
involvement subside when the exposure ceases. However, there 
is evidence that lung ventilatory capacity may be impaired in 
TDI foam workers even though they were symptomless and the 
maximum permissible concentrations had not been exceeded. 
Cigarette smokers and those with chronic lung disease show 
greater impairment.
Medical surveillance with frequent lung function tests, because 
of respiratory tract involvement, and eosinophil counts 
because of the allergenic properties of toluene diisocyanate are 
useful.
Occupations with Potential Exposures to Toluene 
Diisocyanate
abrasion resistant rubber nylon makers
makers organic chemical symthesizers
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adhesive workers plastic foam makers
aircraft burners plasticizer workers
foundry workers (core making) polyurethane foam makers 
insulation workers polyurethane foam users
isocyanate resin workers polyurethane sprayers
lacquer workers ship burners







Medical Evaluation and Differential 
Diagnosis
(See also Decision-Making Process)
In the Medical History, the following should be considered:
1. Persons with any history of the following are at in­
creased risk from inhalation of toluene diisocyanater 
—Cigarette smoking
—respiratory allergy 




2. a respiratory questionnaire, such as that in Appendix C, 
can be useful in evaluating the extent and importance of 






As part of the Occupational History, the results of any pre- 
employment and/or periodic lung function tests, as well as 
blood count and chemistry tests, should be evaluated.
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Signs and Sym ptom s
1. Primary irritation to which all exposed persons are 
susceptible to some degree and
2. sensitization reaction, which occurs at much lower 
exposures in persons who have become sensitized to TDI 
during earlier exposure.
Primary Irritation
Inhaled toluene diisocyanate vapor causes:




—paroxysmal cough (cough which may occur in 
sudden, periodic attacks), and 
—chest pain may occur.
If the TDI vapor concentration is high enough, the effects may 
progress to a chemical bronchitis with the following:
—Severe bronchospasm,
—feeling of tightness in chest, and 
—rales and rhonchi.
This high dose-response may follow a clinical course similar to 
that of broncho-pneumonia from bacterial infection. In 
addition, the following may occur:
—Pulmonary edema (excess fluid in the lungs),
—headache»
—insomnia, and
—neurological and psychiatric symptoms.
Sensitization Reaction
—onset (usually without realization) of respiratory 
problems which become progressively worse with 
continuous exposure to TDI 
—shortness of breath occurring at night (nocturnal 
dyspnea) and /o r nocturnal cough followed by 
development of asthmatic bronchitis
The reactions encountered with inhalation of TDI vapor are:
179
—exposure of sensitized persons to TDI, even at low levels, 
can promote a severe asthmatic attack, and may cause 
death
In some instances, workers with only minimal respiratory 
symptoms or no apparent effects for several weeks at low level 
exposure may suddenly develop an acute asthmatic attack.
Acute respiratory effects from TDI exposure are often 
completely reversible, but continued exposure of affected 
workers to TDI vapor may result in:
—Asthmatic bronchitis,
—broncho-pneumonia, and
—chronic bronchitis, emphysema, and cor pulmonale 
(right heart failure).
Laboratory and Clinical Examinations
Additional tests that will assist in arriving at a correct 
diagnosis are:
Lung Function Tests
—there is a decrease in the forced expiratory volume at one 
second (FEVi)
—forced vital capacity (FVC) is decreased
Chest X-ray—findings are nonspecific. Corresponding 
changes will be seen if there is a broncho-pneumonia or 
pulmonary edema (excessive fluids in the lungs):
—absolute eosinophil count often is increased 
—white blood count may be slightly increased 
—lymphocyte transformation test is positive in sensitized 
persons
Epidemiology
When considering exposure to TDI, both the primary irritant 
effects and sensitization must be considered. There is sufficient 
information to conclude that the primary irritant effects of TDI 
are dose-related. However, once people are sensitized to TDI, 
there appears to be little or no dose-response relationship,110 
and any further exposure may be extremely dangerous. This 
should be kept in mind when considering the following data:
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There is a report of a study of 12 workers in an automobile plant 
making polyurethane foam crashpads.110 For the first 3 weeks 
the workers were exposed to air concentrations of TDI not 
exceeding 0.01 ppm. The next week, air concentrations of TDI 
rose to 0.03-0.07 ppm. At the latter exposure, all workers 
complained of respiratory symptoms including coryzal 
symptoms, continuous coughing, sore throat, dyspnea, fatigue, 
and night sweats. Subsequently, air concentration of TDI were 
reduced to 0.01 -0.03 ppm. For the next 3Vi months there were no 
further respiratory symptoms or complaints, and none of the 
workers appeared to have any permanent effects or became 
sensitized from the exposure.
Walworth and Virchow111 report a study of workers’ health for
2Vi years in a polyurethane foam plant producing slabs. The 
average values of air concentrations of TDI were given as a 
range of 0.00-2-6 ppm with a time-weighted average level 
estimated in the range of 0.00-0.15 ppm (monthly). 83 workers 
developed illnesses attributed to TDI. 54 showed upper 
respiratory infection, 11 had tracheitis, 9 had bronchitis, and 9 
had bronchial asthma. Most illnesses, it was reported, started 
between the third and fourth week of exposure. The report 
indicates evidence of sensitization.
Elkins’12 published a report on a 5-year study of TDI exposure 
in 14 plants. The author concluded that 0.01 ppm for TDI was 
“a not unreasonable limit.” Elkin’s data is summarized in the 
table found on page 183.
Glass and Thom11:1 report a study in 3 plants in New Zealand. 
In one plant where polyurethane foam was produced in a batch 
molding process, atmospheric TDI concentrations ranged from
0.003-0.0123 ppm and 3 cases of respiratory sensitization were 
reported in one year. In the second plant (similar to the first), 
TDI concentrations in airrangedfrom0.005-0.100 ppm and two 
mild cases of coryzal symptoms, one case of possible 
sensitization, and one case of acute asthma attack on heavy 
exposure (with no evidence of sensitization) were reported. In 
the third plant, polyurthane foam was produced in the 
continuous slab process. Air concentrations of TDI ranged 
from 0.000-0.018 ppm in the third plant. Two cases of mild 
coryzal symptoms with no evidence of sensitization were 




Williamson114 reported a study of 18 workers exposed to air 
concentrations of TDI generally below 0.02 ppm except for a 
brief exposure (not more than 10 minutes) to at least 0.2 ppm 
after a spill. Over a 14-month period, no differences in 
ventilatory measurements were detected within a work-shift 
from Monday to Friday. It was reported that none of the men 
suffered illness attributed to TDI or developed TDI 
sensitization during this study.
Maxon11'1 reported a study of 7 workers exposed to TDI in a 
plastic varnish plant. Environmental data was minimal 
because only 3 measurements of TDI in air were made (0.08 
ppm, 0.10 ppm, and 0.12 ppm). Symptoms developed within Vi 
hour to 3 weeks following initial exposure. All workers had 
cough and dyspnea and 4 had hemotysis. There was evidence 
that 4 workers had become sensitized to TDI.
Bruchner et al.,Mi reported a study of 26 workers exposed to a 
range of 0.0-2.4 ppm isocyanates and a range of median values 
of 0.0-0.033 ppm over an 11-year period. The workers were 
engaged in research and development and production of 
isocyanates, presumably including TDI. 5 workers showed 
minimal symptoms of muscous membrane irritation, 16 
showed marked irritation of the respiratory tract, and 5 were 
sensitized. 4 of Lhe 5 sensitized workers showed a positive 
lymphocyte transformation test (an indication of an 
immunologic allergic sensitization) using TDI-human serum 
albumin conjugate as the antigen.
P eters117 reported a long-term study of ventilatory 
measurements on workers repeatly exposed to TDI. Initial 
atmospheric concentrations of TDI ranged from 0.0001-0.0030 
ppm and later concentrations ranged from 0.000-0.0120 ppm. 
After exposure to TDI on the first day of this study, decreases 
were reported in the forced vital capacity (KVC), HEV 1.0, peak 
flow rate (PFR), and flow rate at 50% and 25% of vital capacity 
of all 38 workers studied. At the end of the first week, FVC had 
returned to baseline but mean FEV 1.0 was still depressed and 
mean flow rates were even more depressed. A follow-up was 
made six months later on 28 of the workers still available. As a 
group, the 28 showed decrease in mean FEV 1.0, FEV 1.0/FVC, 
and in flow rates. 8 workers had cough and phlegm. Continued 
decline in FEV 1.0 was reported in the workers studies at six 
month intervals for a total of two years.
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ODu
SUMMARY OF TDI CONCENTRATIONS IN AIR AND 
CASES OF TDI INTOXICATION AT 14 PLANTS
AIR ANALYSIS NUMBER OF CASES
AVERAGE TDI
NUMBER CONCENTRA­ WORKERS ACCEPTED ABLE OR
PLANT YEAR OF TESTS TION (ppm) EXPOSED ESTABLISHED DISPUTED
1 1957 - - 2 1 1
2 1957-8 14 0.005 50 3 28
2 1960 33 0.028 100 14 25
2 1961-2 55 0.015 50 3 2
3 1958-60 12 0.009 25 - -
4 1958-62 21 0.004 40 5 15
5 1958-61 11 0.008 6 1 ?
6 1958-61 28 0.015 40 8 -
7 1961 4 0.001 (Less 4 -
8 1961 5 0.001* than) 5 1 -
9 1961 3 0.006 4 - -
10 1961 14 0.002** 3 2 -
11 1961 14 0,54 ** 4 4 -
12 1962 6 0.009 6 - 1
13 1962 4 Nil 20 - 1
14 1962 6 0.000 20 - -
TOTAL 230
* Probably not representative of exposure. 
**Not representative of exposure.
379 42 73
Elkins, H.B.; el al. 1962
Evidence of Exposure
Sampling and Analysis
The two most commonly used methods for the collection of air 
samples for toluene diisocyanate are:
1. The Ranta method and
2. the Marcali method.
These methods are not intended to be exclusive, but other 
methods should be justified.
There are also available a number of field instruments for the 
determination of TDI concentrations in air. Many of them are 
based on modifications of the Marcali sampling method.
Allowable Exposure Limits
The Occupational Safety and Health Administration 
(OSHA) limits exposure to toluene diisocyanate to 0.02 parts 
per million parts of air by volume. This is a Ceiling Limit which 
should never be exceeded. These allowable levels may not be 
safe for all persons.
Conclusion
Diagnostic criteria for occupational toluene diisocyanate 
poisoning are based on meeting the following:
1. Confirmed history of occupational exposure to TDI 
vapor,
2. clinical findings compatible with the respiratory 
syndrome as outlined above,
3. progressive decrease in lung capacity, and
4. progressive increase in eosinophil count.
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A P P E N D I X  B  
C A S E  H I S T O R I E S
This section contains two detailed examples of investigations 
of occupational disease claims, illustrating the application of 
the decision-making process. To illustrate the types of situations 
which may arise, the following brief examples are offered:
1. An obvious occupational disease—
A disease which occurs commonly in the workplace and a 
confirmed history of exposure to an agent causing the 
disease. Medical examination, X-ray, and lung function 
tests indicate probable silicosis, a disease of the lungs 
caused by inhalation of dust containing the mineral silica. 
The worker’s past and present job: hard-rock miner. 
Evidence is presented showing dust exposures in the mine 
in which he works and at his job are in excess of current 
standards. There is no question that this is an 
occupational disease.
2. An obvious nonoccupation disease—
A disease occurring commonly in the general population 
with no occupational agent exposure. Medical 
examination and laboratory tests diagnose tuberculosis. 
The worker’s past and present job: filing clerk. 
Investigation shows no other cases of tuberculosis in the 
office where the worker is employed. This is clearly a 
nonoccupational disease.
3. A possible occupational disease and an unknown exposure 
A worker has an anemia and is employed as a spray 
painter. If the anemia is an aplastic anemia, it could be 
caused by exposure to benzene, a solvent that may be 
present in some paints. Both the exact type of anemia and 
the chemical content of the paints used must be 
investigated to make a decision.
To illustrate this type of situation, where decision-making is 
more difficult, the following two case histories are offered:
Occupational Disease Case History
Complaint: Malaise, increasing fatigue, and “pins and 
needles" sensation in the feet.
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Evaluation of complaint: Past few days noticed a “pins and 
needles” sensation in his feet and some weakness of the lower 
legs. For several weeks or longer he has generally felt weak and 
tired and not himself In general he has not been feeling well for 
quite some time. He has had some weight loss but has not been 
eating well because of lack of appetite. For a time he has had 
intermittent periods of nausea and vomiting, but they “come 
and go.” Insomnia and rather frequent headaches have been 
occurring. Remaining systemic review is negative.
Medical History
General health has always been good. Tonsils and adenoids 
removed as a child; usual childhood diseases; occasional colds 
but nothing serious.
Personal History
Age 36, white male, married with children, boy 13 and girl 11. 
Drinks 8 to 10 ounces of alcohol a day and smokes one pack of 
cigarettes a day. Lived all his life in Brooklyn, New York. 
Graduated from high school at age 18. Mother and father and 
two siblings living and well—mother has diabetes. As a hobby 
he gardens and has many house plants, but does not use 
insecticides.
Occupational History
Present occupation: Handyman—works with five other 
people in a small shop where arts and crafts are made. The 
work entails mixing pigments and dyes used in printing 
textiles and for coloring enamels and glazes; generally keeps 
the shop clean and in order.
Previous occupations: Took two courses of arts and crafts, 
pottery-making and glazing in high school. Worked part-time 
as a grocery clerk while in school. After graduation worked for 
five years as a ship cutter; exposed to lead, asbestos and iron 
oxide.
Building superintendent, two years. No known exposures to 
agents but perhaps some polishes, detergents and disinfectants.
M edical Evaluation
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Painter, four years. Exposed to pigments found in paint such as 
lead, chromium and arsenic.
Gardener, three years. Exposed to insecticides and weed killers. 
Knows that some had pyrethrums, arsenic and parathion-like 
substances in them.
Present job, four years. Some of the pigments he mixes contain 
nickel, lead, arsenic, iron and other chemicals. He cleans with a 
vacuum cleaner, wears no protection and there is some dust.
He has no secondary job.
Clinical Evaluation
The examination revealed a well developed male who 
appeared tired. His face was pale and the skin over the trunk 
appeared somewhat pigmented. Examination of the head, eyes, 
ears and throat showed them to be normal. The nasal septum 
was inflamed. No adenopathy. The thyroid was normal. Chest 
expanded symmetrically and percussion and auscultation were 
normal.
The pulse was 78 and regular, the blood pressure was 128/82. 
Heart sounds were normal and no evidence of enlargement. 
There was slight tenderness on palpation of the right upper 
quadrant but the liver edge was not palpable.
External genitalia was normal. Peripheral circulation was 
normal. On examination of the extremities a hyperkeratosis of 
the palms of the hands and soles of the feet were found. There 
was decreased sensation to touch and vibration in the feet. 
Patella and ankle reflexes were decreased; those of the wrist 
and elbow were normal.
Laboratory Evaluation
CBC and Differential:
Chest X-Ray: 14” x 17”
Electrocardiogram:
SMA-12:
RBC 4.0 million/cubic mm
Hb. 12 g/100 ml
Hct. 40 percent






Thyroid function tests: Normal
Blood Lead: 0.03 mg/100 gms
Urinary Arsenic: 0.9 mg/liter
Epidemiologic Findings
The workplace was surveyed (see Table 1). It was found that 
the atmosphere contained levels of arsenic in excess of the 
Occupational Safety and Health Act (OSHA) standards. At 
breathing level, where the patient worked at mixing the 
pigments, arsenic levels often were much too high. Dust on the 
floor and walls contained arsenic and when cleaning, larger 
than recommended amounts of airborne arsenic were found. 
Even though pigment containing arsenic was not mixed daily, 
there was cumulative exposure.
The literature contains ample evidence to indicate that such 
exposure to arsenic dust could produce arsenic intoxication.
TABLE 1
ATMOSPHERIC METAL DUST AND 
FUME CONCENTRATIONS 
October 1, 1975 
ABC ARTS & CRAFTS 
ANYTOWN, U:S.A.
TIME RESULTS IN MILLIGRAMS PER 
SAMPLE START/ CUBIC METER OF AIR
NUMBER STOP Chrom-
LOCATION Arsenic Nickel Lead ium
OSHA Allowable
Limits 0.5 1 0.2 0.5
Operator’s Breathing 
Zone:
1 John Doe-General 0700/ 0.47 <0.001 <0.001 <0.001
Work in stockroom 1900
weighing pigments.
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2 John Doe-Weighing 0900/ 1.33 <0.001 0.021 0.007
and mixing 1100
pigments.
3 John Doe-Mixing 1100/ 1.21 <0.001 0.050 0.042
and packaging 1300
pigments; 30 minute 
lunch.
4 John Doe-Plant 1300/ 0.75 <0.001 0.027 0.003
cleanup 1500
Time-Weighted
Average Exposures: 0.94 <0.001 0.025 0.013
<Denotes less than.
It can be clearly seen from Table I that the employee’s exposure 
to arsenic was the only exposure evaluated which exceeded the 
allowable limit (in this case nearly twice the permitted 
exposure). Exposures to nickel, lead, and chromium were well 
within the eight hour time-weighted average limits and 
continued exposure at the levels evaluated should not result in 
any health hazards.
Contaminants in the Work Environment
Hyperpigmentation has been reported among employees 
exposed to arsenic concentrations ranging from 0.110-4.038 
milligrams per cubic meter of air (0.562 milligrams per cubic 
meter was the mean exposure). (Dinman, B.D. 1960. J. Occ. 
Med. 2:137.) This would conform with the clinical evaluation in 
this specific case where the average exposure to arsenic was
0.94 milligrams per cubic meter of air and hyperpigmentation 
was observed.
Laboratory findings indicated absorption of arsenic by urinary 
arsenic levels of 0.9 milligrams per liter. Toxicological data 
would also imply increased urinary arsenic levels at the 
atmospheric concentrations evaluated as indicated by the 
report of an average urinary arsenic level of 0.23 milligrams per 
liter in workers exposed to mean air concentrations of 0.562 
milligrams arsenic per cubic meter.
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The differential diagnosis would include lead poisoning, 
hypothyroidism, anemia and chronic arsenic poisoning; the 
laborato ry  findings rule out lead poisoning and 
hypothyroidism and indicate an absorption of arsenic. Anemia 
would not account for all of the symptoms and could be part of 
the pathology of arsenic intoxication.
This history of the complaint, the symptoms and signs along 
with the laboratory information and the abnormal exposure to 
arsenic in the workplace, and no evidence of nonoccupational 
exposure make the diagnosis of chronic arsenic intoxication, 
occupational in origin.
Nonoccupational Disease Case History
Complaint: Cough of five years duration and shortness of 
breath.
Medical Evaluation
Evaluation of complaint: About five years ago started to 
notice a cough that seems to occur during sleeping and at work. 
He may awaken and raise a mouthful of white, clear sputum. 
There is no cough on arising in the morning but during the 
course of the day may bring up 1 or 2 mouthfuls of white 
sputum—never colored or blood streaked.
He has no dyspnea but states that he does become aware of 
shortness of breath after climbing 7 or 8 stairs. He can walk 2 or
3 flights slowly but without stopping.
He sleeps without a pillow and has no swelling of the ankles. 
There is no chest pain or wheezing. He has no history of allergy 
and there are no other symptoms. The rest of the systemic 
review is noncontributory. He has never sought medical 
attention for the cough or shortness of breath during the five 
years that he has been aware of it.
Medical History
General health always has been good. Tonsillectomy and 
adenoidectomy at age 7. Usual childhood diseases, no 
accidents or serious illnesses. He received $2,000.00 from a
Conclusion
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previous employer for dermatitis of the hands (Workers 
Compensation Insurance). The cause of the dermatitis was 
never determined nor has it recurred.
Personal History
Age 40, white male, married with one son age 20. Lived in 
Pennsylvania all his life except while in the Navy when he was 
stationed in New York. Drinks an occasional beer, never 
smoked in any form. He quit high school at age 15 after two 
years. Mother age 62, father age 63, and a brother age 42; all 
living and well.
Occupational History
Present occupation: Foreman in a warehouse; warehouse 
adjacent to operation where paper towels, napkins and toilet 
tissue are printed. Duties consist of general supervision of the 
warehouse. Exposure to paper dust and ink and oil mist as well 
as exhaust from trucks at shipping platform.
Previous occupations: Age 14-16, sold newspapers (1949-1951).
Age 16-19, worked as a printer in a printing shop; in contact 
with paper dust and ink (1951-1954).
Age 19-21, Navy—stationed in New York and worked as a cook. 
No contact with any hazardous materials except some smoke 
from cooking (1954-1956).
Age 21-30, warehouseman in charge of ticketing—directing 
correct merchandise to proper retail stores. In contact with dust 
and some exhaust from trucks (1956-1965).
Age 30-40, present job—foreman in warehouse operation. The 
company makes and prints paper towels, napkins, toilet tissue, 
etc. Warehouse is adjacent to printing operation. There is some 
paper dust, ink and oil mist as well as exhaust from trucks.
He has no secondary occupation.
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C l in ic a l  E v a l u a t i o n
Examination revealed a white male, somewhat overweight, 
in no acute distress. Skin and hair appear normal. Neck veins 
not prominant, no cervical adenopathy. No abnormalities of 
ears, eyes and throat. Nasal septum deviated to the right. Chest 
is clear to percussion and auscultation. No murmurs or 
enlargement—A2 = P2. Blood pressure 180/120 right arm; 
170/110 left arm. PMI within midclavicular line. Abdomen—no 
masses or organs palpable. Slight tenderness in left lower 
quadrant on deep palpation. Right testicle not palpable, 
inquinal rings firm. No clubbing of the fingers. Small 
varicosities on left lower leg. No ankle edema. Axillary and 
inquinal nodes not enlarged. Rectal examination reveals a 
normal prostate, no masses or other abnormlaities palpable. 







There is no evidence in the scientific literature to indicate 
that working in this environment is hazardous. Others in the 
work area have occasional coughs—some with clear sputum 
production. These men all have negative clinical and 
laboratory findings. Epidemiologic evidence does exist to show 
that over 20 percent of the male and 9 percent of the female 
working population over 25 years of age in the United States 
have a chronic bronchitis (1970. N.E.J. Med. 270:894).
Contaminants in the Work Environment
The workplace was surveyed in 1973 (Table 2, a, b, c). 
Potential exposures are well within the allowable OSHA limits. 
The toxicity of carbon monoxide is well known, however, the 
levels of exposure in this case are far below toxic limits. Oil and 
ink mist have not been demostrated to cause specific disease
Heart size within normal 
limits; lung fields clear. 
Negative.
(Repeated 3 times) within 
normal limits.
All chemistries normal. 
Normal
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entities. With very high concentrations animals have 
developed a chemical pneumonitis. Paper dust has not been 
found to be toxic, and is considered a nuisance dust.
TABLE 2 (a)
ATMOSPHERIC OIL MIST 
PARTICULATE CONCENTRATIONS
October 10, 1973 











OSHA ALLOWABLE LIMIT 
Operator’s Breathing Zone:
5.0
















Time-Weigh ted Average Exposure 0.52
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T A B L E  2 (b)
ATMOSPHERIC PAPER DUST CONCENTRATIONS
October 10, 1973 











OSHA ALLOWABLE UMIT 
(Nuisance Particulates) 15
Operator’s Breathing Zone:








Time-Weighted Average Exposure 1.75
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ATMOSPHERIC CARBON MONOXIDE CONCENTRATIONS
October 10, 1973
XYZ VARIETY STORES 
SOMETOWN, NY
T A B L E  2(c)
SAMPLE TIME RESULTS AS
NUMBER LOCATION START/STOP PARTS PER
MILLION
OSHA ALLOWABLE UMIT 
Operator’s Breathing Zone:
1 Jack White - Paperwork 0810/0817
at desk.
2 Jack White ■ Operating 0842/0849
LPG Fueled Lift Truck.
3 Jack White - Loading 0955/1002
platform (all docks filled
with trucks).
4 Jack White - Same as 3 1131/1138
5 Jack White - Working 1159/1206
approx. center of whse.
6 Jack White - Paperwork 1310/1317
at desk.
7 Jack White - Approx. 1418/1425
center of Printing Dept.
8 Jack White - Operating 1430/1437











9 J a c k  W h ite  - S a m e  a s  8 1 5 0 1 /1 5 0 8 25
10 Jack White * Working 1547/1554 
approx. center of whse.
Approximate Time-Weighted Average Exposure 13
10
< Denotes less than.
Conclusion
In the face of normal X-ray and pulmonary function studies 
with no abnormal lung findings on clinical examination, 
normal blood count and blood chemistries, no adverse 
epidemiologic or toxicologic evidence and the ambient work 
environment well below the recommended levels, this case 
must be considered nonoccupational in origin. There is no 
evidence to indicate that the worker’s symptoms are 
occupational in origin.
He does, however, have hypertension. Sleeping flat and 
awakening to expectorate may signify a very early stage of 
hypertensive heart disease, and some orthopnea would be 
expected. Having symptoms for five years without ever seeking 
medical attention seems unusual. The conclusion in this case is 
that the disease is not bronchitis, but hypertension, and is 
nonoccupational-
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A P P E N D IX  C  
S A M P L E  R ESP IR A TO R Y  
Q U ES TIO N N A IR E
Use the actual wording of each question. Put X in the 
appropriate space after each question. When in doubt, record 
“NO.”
PREAMBLE: I am going to ask you some questions mainly 
about your chest. I should like you to answer ‘YES’ or ‘NO’ 
whenever possible.
YES NO N/A
1. Do you usually cough first thing in
the morning or on getting up? ___  ___
(Count a cough with first smoke or on 
first going out of doors. Exclude 
throat clearing or a single cough.)
2. Do you cough like this on most days 
for as much as three months each
year? ___  ___  ___
3. Do you cough at work? ___  ___
4. Do you usually bring up some phlegm
from your chest first thing in the 
morning or on getting up? ___  ___
(Count phelgm with the first smoke or 
on first going out of doors. Exclude 
phelgm from the nose. Count 
swallowed phlegm.)
5. Do you bring up phlegm like this on 
most days for as much as three
months each year? ___  ___  ___
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6. In the past three years, have you had 
a period of (increased) cough and 
phlegm lasting 3 weeks or more?
7. Have you had more than one such 
period?
8. Does your chest ever feel tight or your 
breathing become difficult?
9. Do you get this apart from colds?
(If YES: specify ... (Interviewer to code)
(a) With Exercise
(b) At Work
(c) Any Other Time
If disabled from walking by skeletal 
or other physical disability put ‘X’ 
here.
10. Are you troubled by shortness of 
breath, when hurrying on the levels or 
walking up a slight hill?
( I f ‘NO’ omit questions 11 and 12)
11. Do you get short of breath walking 
with other people of your own age on 
level ground?
(If ‘NO’ omit question 12)
12. Do you have to stop for breath when 
walking at your own pace on level 
ground?
13. Do you usually have a stuffy nose 
or catarrh at the back of your nose 
in the winter?
14. Do you have this in the summer?
(If ‘NO’ to both questions 13 and 14, 
go to question 16)
15. Do you have this on most days for as 
much as three months each year?
214
16. During the past 3 years have you had 
any chest illness which has kept you 
off work or from your usual activities 
for as much as a week?
17. Did you bring up more phlegm than 
usual in any of these illnesses?
18. Have you had more than one illness 
with phlegm like this in the last 3 
years?
HAVE YOU EVER HAD:
(Give relevant details after each 
positive answer.)












29. B y s s in o s is ?
30. Other chest troubles?
31. Have you ever smoked?______________ _____
(Record 'NO' if subject has never
smoked as much as one cigarette a 
day, or 1 oz. tobacco a month, for as 
long as one year)
32. Age when stopped ___  years. Was
this in the last month? ___  ___






(Average including weekends)___  ___
Oz. tobacco/week (handrolled)___  ___
Cigars/week (large) ___  ___
Cigars/week (small) ___  ___
Occupation (1st Interview Only)
(Record on lines the years in which subject has worked in any 
of these industries, e.g., 1960-1963)
YES NO
33. Have you ever worked in a dusty
job? _ ______________________________ _____
34. In a coal m ine---------------------------------- -------
35. In any other m ine?--------------------------- -------
216
36. In a quarry?_______________
37. In a foundry?______________
38. In a pottery? ______________
39. In a cotton, flax or hemp mill?
40. With asbestos? ____________
41. In any other dusty job? _____
If'YES’, specify ___________
42. Have you ever been exposed regularly 
to irritating gas or chemical fume9? 
If ‘YES’, give details of nature and 
duration_______________________
Occupation (Follow-Up only)
43. What is your present job? ______________
44. How long have you been doing i t ? _______
45. What was your previous job in the factory?
Taken with minor changes from Operating and Medical Codes 
of Practice for Safe Working with Toluene Diisocyanate, 




A P P E N D IX  D 
O C C U P A TIO N S  A N D  S E L E C T E D  










Acetic acid makers 
Acoustical product makers 




Airplane dope makers 








Aniline color makers 
Aniline makers 
Aniline workers 
Antimony ore smelters 
Antimony workers 
Aniline makers 
Aniline color makers 




































Artificial flower makers 




Artificial abrasive makers 


































Battery makers, dry 
Battery workers, storage
Arsenic



























Silica, nitrogen dioxide, sulfur 
dioxide, carbon monoxide, 
asbestos, lead 
Nitrogen dioxide 
Benzene, sulfur dioxide, carbon 















Beet sugar bleachers Sulfur dioxide
Belt scourers Benzene
Benzene hexachloride makers Benzene
Benzene workers Benzene
Bisque-kiln workers Silica, carbon monoxide
Blacksmiths Lead, carbon monoxide
Blast furnace workers Sulfur dioxide, carbon 
monoxide
Bleaching powder makers Arsenic
Blueprinters Nitrogen dioxide
Blast furnace gas users Carbon monoxide
Blockers (felt hat) Carbon monoxide
Boiler makers Mercury
Boiler operators Arsenic
Boiler water treaters Sulfur dioxide
Bone extractors Sulfur dioxide
Bookbinders Arsenic, lead
Bottle cap makers Lead
Boiler rooms Noise
Boiler room workers Carbon monoxide
Brakelining makers Benzene, asbestos
Brass cleaners Nitrogen dioxide
Brass founders Antimony, carbon monoxide
Brass makers Arsenic
Brass polishers Lead
Braziers Lead, nitrogen dioxide
Brewery workers Sulfur dioxide
Brick layers Lead, silica
Brick makers Lead, silica, sulfur dioxide
Bright dip workers Nitrogen dioxide
Britannia metal workers Antimony
Bronze cleaners Nitrogen dioxide
Bronze makers Arsenic





















Cap loaders, percussion 
Carbolic acid makers 
Carbon brush makers 
Carborundum makers 
Carders, cotton mil]
Carding machine operators, 
cotton mill 
Carpet makers 
Carroters, felt hat 
Cartridge makers 
Cast scrubbers, electroplating 
Casting cleaners, foundry 
Cattle dip workers 
Caustic soda makers 
Carbide makers 
Carbon monoxide workers 
Carders (asbestos)
Caulking compound makers 









Chemical equipment makers 



























































Cinnebar ore processors 
Cleaner operators, 
cotton mill 
Cleaner, cotton mill 
Clutch disc impregnators 
Clutch facing makers 
Coke oven tar chaser 
Coke oven workers










Coal tar refiners 
Coal tar workers 
Cobblers
Coke oven door cleaners, 
lu term an 
Coke oven door machine 
operators 
Coke oven larry car operators 
Coke oven lidmen, larrymen 
Coke oven maintenance 
men
Coke oven patcher 
















Coke oven emissions 
Benzene, coke oven emissions, 




Silica, asbestos, noise 
Nitrogen dioxide 
Antimony




















Colored glass maker 





















Dich loro benzene makers 
Diesel equipment operators 
Diesel engine operators
Diesel engine repairmen 
Dime this ulfate makers 
Diphenyl makers 









































Arsenic, benzene, mercury, 
sulfur dioxide 






C o k e  o v e n  e m is s io n s
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Dry cleaners





Earth moving equipment 
operators 
Electric apparatus makers 
Electric arc welders 
Electrolytic copper workers 
Electronic device makers 



























Antimony, arsenic, benzene, 
lead, mercury, nitrogen 









Antimony, arsenic, benzene, 














Arsenic, nitrogen dioxide 
Benzene
Antimony, benzene, lead, 
mercury, nitrogen dioxide 
Nitrogen dioxide 
Arsenic, sulfur dioxide 
Arsenic, lead, mercury, 
nitrogen dioxide, silica 
Arsenic, lead, mercury, 
nitrogen dioxide, silica 
Noise






































Fused quartz workers 





Arsenic, nitrogen dioxide, 




Lead, nitrogen dioxide, sulfur 
dioxide, asbestos, carbon 
monoxide 











Nitrogen dioxide, sulfur 
dioxide

























Gas shrinking operators 
Gas welders
Gas workers, illumination 
Gas station attendants 
Gasket makers 
Gasoline engine testers 
Gelatin bleachers 






Glaze dippers, pottery 










Grinders, cotton mill 
Grinding wheel makers 
Grindstrone workers 
Gun barrel browners 
Hair remover makers 
Hairdressers 
Handpickers, cotton 
Hard rock miners 
Hatters 
Heat treaters 






Arsenic, lead, sulfur dioxide 
Lead, carbon monoxide, 




Benzene, carbon monoxide 






































Hydrochloric acid workers 
Ice makers








Incandescent lamp makers 
Inert filter media workers 
Insulation workers 
Iron workers 
Ironing board cover 
makers 
Isocyanate resin workers 
Japan makers 
Japanners 
Jet fuel makers 
Jewelers 
Jewelry makers
Junk metal refiners 
Jute workers 
Kiln liners
Kraft recovery furnace 
workers 




Lake color makers 
Lamp makers, fluorescent 
Lamp makers, mercury arc 








Arsenic, sulfur dioxide 
Arsenic



























dioxide, silica, sulfur dioxide












Lead flooring makers 
Lead foil makers 
Lead hardeners 
Lead mill workers 
Lead miners 
Lead pipe makers 
Lead salt makers 
Lead shield makers 
Lead shot makers 
Lead shot workers 
Lead smelters 









Li no typers 
Linseed oil boilers 




Lift truck operators 
(propane and gasoline 
fueled)
Lime kiln workers 




















Antimony, arsenic, lead 
Antimony, arsenic, lead 














































































Mono process workers 
Musical light makers 
Nitrate workers 





















































Nitrous acid workers 
Nickel refiners 
Nickel smelters 
Nuclear reactor workers 
Nuclear technologists 
Nurses






Openers, cotton mill 
Optical equipment makers 
Ore smelters 
Ore smelting workers 
Organic chemical 
synthesizers












Patent leather makers 
Painters
Paper manufacture 
Paper products manufacture 
Pearl makers, imitation 
Pencil makers 
Percussion cap makers 
Perfume makers 
Pesticide workers
















Antimony, arsenic, benzene, 
nitrogen dioxide, carbon 











Antimony, arsenic, benzene, 
lead 
Arsenic, lead 














Petroleum refinery workers 
Pewter workers 











Phthalic acid makers 
Physicians 
Pickers, cotton mill 
Picklers
Picric acid makers 
Pigment makers 
Pipefitters
Plasma torch operators 












Polishing soap makers 
Pottery decorators 
Pottery glaze dippers 















































Polyurethane foam users 
Polyurethane sprayers 
Ore smelters 
Ore smelting workers 
Organic chemical 
synthesizers












Patent leather makers 
Painters
Paper manufacture 
Paper products manufacture 
Pearl makers, imitation 
Pencil makers 




Petroleum refinery workers 
Pewter workers 










Antimony, arsenic, benzene, 
nitrogen dioxide, carbon 











Antimony, arsenic, benzene, 
lead 
Arsenic, lead 

















Antimony, arsenic, benzene, 
mercury, nitrogen dioxide, 










Phthalic acid makers 
Physicians 
Pickers, cotton mill 
Picklers
Picric acid makers 
Pigment makers 
Pipefitters
Plasma torch operators 
Plastic cast bronzers 
Pottery kiln workers 
Power plant operators 
Porcelain workers 
Preservative makers 
Press box operators, 
cotton mill 
Pressure gage makers. 
Printers
Printing ink workers 
Protein makers, edible 
Protein makers, industrial 
Primary metal processing 
Printing 
Printers
Producer gas workers 
Pulps tone workers 
Putty makers 





































































Roving frame operators, 
cotton mill 
Roofing materials makers 
Rubber buffers 
Rubber cementers 
Rubber compound mixers 












Scouring soap workers 
Scrap metal workers 





Service station attendants 
Sewer workers 
Sheep dip workers 
Sheet metal workers 
Shellac makers 
Ship disman tiers 
























































Silica brick workers 














Sodium silicate workers 
Sodium sulfite makers 






Spindle pickers cotton 























































Storage battery chargers 
Storage battery workers 
Straw bleachers 
Street sweepers 















Sulfur dioxide workers 
Sulfurprs, malt and hops 
Sulfuric acid makers
Sulfuric acid workers 
Switch makers 





































Arsenic, nitrogen dioxide, 
sulfur dioxide 
Arsenic, sulfur dioxide 
Mercury 
Benzene























Thionyl chloride makers 
Tile makers 
Tin foil makers 
Tinners
Tobacco seedling treaters 
Tooth paste makers 
Toll collectors (highway) 







Tube mill liners 




Twisters, cotton mill 
Type cleaners 
Type founders 





Vacuum pump makers 
Vanadium compound 
makers 







Noise, cotton dust 
Tol. diisocyanate 































Arsenic, benzene, lead 
Sulfur dioxide
Lead, nitrogen dioxide, sulfur 









Warfare gas makers 
Water weed controllers 
Wax makers 
Warehouse workers 
Water gas workers 





Wicker ware bleachers 




Wire coating workers 
Wood bleachers 
Wood filler workers 
Wood preservative workers 






Zinc chloride makerb 
Zinc mill workers 
Zinc minerB 
Zinc refiners 

































Antimony, arsenic, lead 
Antimony, arsenic, lead 
Lead




A P P E N D IX  E  
G LO SS A R Y
Aberrations: Deviations from a normal course.
Acoustic, Acoustical: Containing, producing, or rising from, 
actuated by, related to, or associated with sound.
Acoustic Trauma: Hearing loss caused by sudden loud noise or 
by sudden blow.
Acuity; Pertaining to the sensitivity of the senses, such as 
hearing.
Acute: Sharp, severe; having rapid onset, severe symptoms, 
and a short course.
Addison's Disease: Disease resulting from deficiency in the 
secretion of adrenocortical hormones.
Adhesion: A holding together by new connective tissues 
produced by inflammation or injury.
Adsorption: The condensation of gases, liquids, or dissolved 
substances on the surfaces of solids.
Air Monitoring: The continuous sampling for, and measuring 
of, pollutants in the atmosphere.
Albuminuria: Presence of readily detectable amounts of 
albumin protein in the urine.
Allergy: An abnormal response of a hypersensitive person to 
chemical and physical stimuli.
Alopecia: Baldness or deficiency of hair, partial or complete, 
localized or generalized.
Alveolar: Concerning the air spaces within the lungs.
Alveoli: Air spaces within the lungs.
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Anemia: Deficiency in the hemoglobin and/or red blood cells.
Angina: Any disease characterized by attacks of choking or 
suffocation.
Anorexia: Loss of appetite.
Anuria: Urinary suppression or failure of kidney function.
Aplastic Anemia: Failure of bone marrow to produce red blood 
cells.
Arthralgia: Pain in a joint.
Asphyxia: Suffocation from lack of oxygen.
Asthenia: Lack or loss of strength: debility.
Asymptomatic: Without symptoms.
Ataxia: Muscular incoordination.
Atelectasis: A collapsed or airless condition of the lung or a 
segment of the lung.
Atrophy: Reduction in size.
Attenuation: Lessening.
Audiogram: A test and recording of hearing ability.
Audiometer: An instrument for measuring hearing ability.
Auricular Fibrillation: Extermely rapid incomplete contrac­
tions of the upper heart chambers (auricles of heart).
Basophilia: A pathological reaction of immature erythrocytes 
to basic dyes whereby the stained cells appear blue, gray, or 
contain bluish granules.
Basophilic Stippling: A spotted appearance of erythrocytes in 
Basophilia due to bluish granules.
A m b l y o p i a : R e d u c e d  o r  d im n e s s  o f  v is io n .
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Benign: Harmless.
Bilirubin: The orange-colored or yellowish bile pigment 
formed by the breakdown of heme (such as found in hemo­
globin) circulated in the plasma and taken up by liver cells.
Bioassay: Estimation of the strength of a drug on a test animal.
Biologic Monitoring: Periodic examination of blood, urine, or 
any other body substance to determine exposure to toxic 
materials.
Biopsy: Removal of small bits of living tissue from the body 
for study.
Blood Count: A count of the total number of blood cells 
circulating in the body. A complete blood count totals the 
number of different kinds of blood cells circulating in the 
body.
Blood Dyscrasia: An abnormality of the blood or blood forming 
system.
Body Burden: The amount of a harmful material in the body at 
a given time.
Bone Conduction Test: A hearing test conducted by placing a 
vibrating tuning fork on the bony portion of the head.
Bone Marrow: The soft tissue of bone which is a part of the 
blood forming system.
Brady cardie: Slow heart action.
Brain Dysfunction: Abnormal, inadequate, or impaired 
function of the brain.
Bronchial Tubes: Branches or subdivisions of the trachea 
(windpipe).
Bronchiectasis: Dilation, usually of the terminal bronchi, often 
associated with abnormal secretions.
Bronchiogenic: Originating in the bronchi.
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Bronchiolar: Pertaining to the bronchioles.
Bronchiole: One of the finer subdivisions of the bronchial tree.
Bronchiolitis Fibrosa Obliterans: The closing of the 
bronchioles with fibrous tissue due to irritation.
Bronchitis: Inflammation of the bronchial tubes.
Bronchoscope: An instrument used for visual examination of 
the interior of a bronchus.
Bronchoscopy: Examination of the bronchi through a 
bronchoscope.
Bronchospasm: Spasm of the bronchi or bronchioles.
Cancer: A malignant tumor characterized by proliferation of 
abnormal cells (carcinoma or sarcoma).
Caplan’s Syndrome: The appearance of large nodules in the 
lung, against the background of simple silicosis.
Carcinogen: Substance which is capable of causing cancer.
Carcinoma: New growth of malignant tumor.
Carcinomatous Lymphangitis: Inflammation of lymphatic 
channels or vessels due to cancer.
Cardiomyopathies: Diseases of the heart muscle.
Ceiling Limit: The maximum level of an environmental contam­
inant which should not be exceeded for any period of time.
Chelation: Combining of metallic ions with certain hetero­
cyclic ring structures so that the ion is held by chemical 
bonds from each of the participating rings, permitting 
elimination from the body.
Chemical Cartridge: The type of absorption unit used with a 
respirator for removal of low concentrations of solvent 
vapors and certain gases.
Chemosis: Swelling of the mucous membrane of the sclera.
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Chromatography: An analytical technique for the separation 
and identification of chemical compounds.
Chronic: Long, drawn out; designating a disease showing 
little change or of slow progression and long continuance.
Chronic Obstructive Lung Disease: Disease processes which 
cause decreased pulmonary ventilation (e.g., pulmonary 
emphysema, pulmonary fibrosis, chronic asthma, and 
chronic bronchiolitis).
Cirrhosis: Progressive fibrosis of the liver.
Coalescence: Fusion of two or more parts.
Colic: Spasm in any hollow or tubular soft organ such as 
the colon accompanied by pain.
Colorimetry: An analytical technique based on measuring 
color.
Coma: Prolonged unconsciousness.
Comedones: Blackheads or plugging of sebaceous gland of 
skin.
Compound: A chemical substance composed of two or more 
elements joined according to the laws of chemical combina­
tion. Each compound has its own characteristic properties 
different from those of its constituent elements.
Concomitant: Occurring at the same time.
Conductive Hearing Loss: Type of hearing loss not caused by 
noise exposure» but due to any disorder in the middle ear or 
external ear that prevents the sound from reaching the inner 
ear.
Conjunctiva: The membrane that lines the eyelids and covers 
the exposed surface of the sclera.
Conjunctivitis: Inflammation of the membrane that lines the 
eyelids and the front of the eyeball.
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Consolidation: The act of becoming solid. Used in connection 
with the solidification of the lungs due to engorgement of the 
lung tissues, as occurs in acute pneumonia.
Comtaminant: A material that is foreign to the normal 
medium.
Coproporphyrin: A porphyrin present in urine and feces.
Cor Pulmonale: Hypertrophy (enlargement) and failure of the 
right ventricle resulting from disorders of the lungs, 
pulmonary vessels, or chest wall which involve an increase 
in pulmonary arterial pressure.
Cornea: The transparent part of the eye.
CPS: Cycles per second (Hertz); a measurement of frequency 
of sound or any other cyclic phenomenon.
Crackles: A crackling sound heard in the lung during certain 
diseases.
Creatinine: 1-Methylglycocyamidine, the end product of 
creatine metabolism, a normal alkaline constituent of urine 
and blood.
Cutaneous: Pertaining to, or affecting the skin.
Cyanosis: Slightly bluish, greyish, slatelike, or dark purple 
discoloration of the skin due to the presence of abnormal 
amounts of reduced hemoglobin in the blood.
Cytology: Pertaining to the formation, structure, and function 
of cells.
Cytoscopy: Microscopic examination of cells for purpose of 
diagnosis.
dB(A): Sound level in decibels read on the A-scale of a sound 
level meter.
Dicibel (dB): A unit used to measure sound intensity.
Dermatitis: Inflammation of the skin from any cause.
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Differentail Blood Count: Determination of the number of 
(different) white blood cells in a cubic millimeter of blood.
Differential Diagnosis: Comparison of symptoms of two or 
more similar diseases to determine which disease the worker 
has.
Digital Clubbing: Rounding and swelling of the ends of the 
fingers.
Direct-Reading Instrument: An instrument which gives an 
immediate indication of concentration of an airborne 
contaminant by some means such as a meter or the changing 
color of a chemical.
Dysphagia; Inability to swallow or difficulty in swallowing.
Dyspnea: Labored or difficult breathing.
Edema: A swelling of body tissues.
Electrophoretic: A method of analyzing the movement of 
charged protein particles.
Emphysema: A lung disease in which the walls of the air sac 
(alveoli) have been stretched and broken down.
Emphysematous Bullae: Large blisters on lung surfaces filled 
with fluid caused by emphysema.
Eosin: An acid dye used for staining tissues for microscopic 
examination.
Eosinophil: A white blood cell containing granules that readily 
stain with the acid stain, eosin.
Epistaxis: Bleeding from the nose.
Epithelioma: Carcinoma of the epithelial cells of the skin.
Epitheliomatous Ulceration: An open sore or lesion originating 
in the epidermis of the skin or in a mucous membrane.
Erethism: Triad of gingivitis, tremor, and emotional 
instability.
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Erythroblasts: Any form of nucleated red corpuscles.
Erythrocyte: the mature red blood corpuscle.
Erythroleukemia: Malignant growth of both red- and white- 
blood cell forming tissues.
Erythropoiesis: The formation of red blood corpuscles.
Etiology: The study of the causes of disease.
Euphoria: An exaggerated feeling of well-being.
Exfoliative Dermatitis: Skin disorder characterized by 
erythema, the scaling off of dead skin, itching, and loss of 
hair.
Fasciculation: Small rapid movements of muscle fibers.
FEVi: Forced expiratory volume in one second; a test of 
pulmonary function.
Fibrosing Alvelolitis: Fibrous tissue which replaces normal 
lung tissue following inflammation of the alveoli.
Fibrosis: A thickening, associated with growth of fibrous 
tissue.
Fibrotic: Abnormal formation of fibrous tissue.
FVC: Forced vit^l capacity; a test of lung function.
Gangrenous: Death and decomposition of body tissue due to 
failure of blood supply, to injury, or to disease.
Gastritis: Inflammation of the lining of the stomach.
Gastrointestinal: Pertaining to the stomach and intestine.
Genitourinary: Pertaining to the genitals, the urinary organs, 
and their accessories.
Gingivitis: Inflammation of the gums characterized by . 
redness, swelling, and tendency to bleed.
E r y t h e m a :  R e d d e n in g  o f  th e  s k in .
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Hematemesis: Vomiting of blood.
Hematocrit: The volume of red blood cells.
Hematologic Toxins: Poisonous substances affecting the blood 
or blood-forming tissues.
Hematology: The study of blood and the blood-forming organs.
Hematuria: Blood in the urine.
Hemoglobin: The red coloring matter of the blood which carries 
the oxygen.
Hemolysis: Breakdown of red blood cells with liberation of 
hemoglobin.
Hemolytic Anemia: Anemia resulting from the excessive 
destruction of red blood cells.
Hemopoietic: Pertaining to the formation of blood in the body.
Hemoptysis: Spitting blood or blood-stained sputum.
Hemorrhage: Profuse bleeding.
Hemosiderosis: A condition characterized by the deposition of 
iron containing pigment, from the disintegration of 
hemoglobin into the liver and spleen.
Hepatic: Pertaining to the liver.
Hepatic Injury: Damage to the liver.
Hepatitis: Inflammation of the liver.
Hepatomegaly: Enlargement of the liver.
Hertz; Unit of frequency of sound.
Hilar Nodes: Nodes on the root of the lungs at level of fourth 
and fifth dorsal vertebrae.
G ly c o s u r ia : T h e  p re se n c e  o f  g lu c o se  in  th e  u r in e .
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Histological: Pertaining to the study of the microscopic 
structure of animal and plant tissue.
Hydrocephalus: Increased accumulation of cerebrospinal fluid 
within the ventricles of the brain.
Hyperaminoaciduria: An abnormal amount of amino acids in 
the urine.
Hyperemia: Congestion from an unusual amount blood.
Hyperhidrosis: Excessive sweating.
Hyperkeratosis: Overgrowth of the homy layer of the skin.
Hyperpigmentation: Development of increased skin pimen- 
tation.
Hyperplastic: Excessive proliferation of cells.
Hyperuricemia: Abnormal amount of uric acid in the blood.
Hypochromic Normocytic: A condition of the blood in which 
the red blood cells have a reduced hemoglobin content, but 
are normal in size.
Hypoplasia: Reduced development of tissue.
Hypoplastic: Reduced or defective production of cells.
industrial Hygiene: The science that deals with the recognition, 
evaluation, and control of potential health hazards in the 
industrial environment.
Inflammation: The reaction of body tissue to injury.
Inorganic: Term used to designate compounds that are not 
derived from hydrocarbons.
Insidious: Working or spreading harmfully without symptoms.
Interstitial: Pertaining to the small spaces between cells.
Intravenous Pyelogram: A roentgenogram of the kidney, 
ureter, and pelvis.
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Jaundice: A condition characterized by yellowness of skin 
and sclerae (white of eyes), mucous membranes, and body 
fluids due to deposition of bile pigment resulting from excess 
bilirubin in the blood.
Keratitis: Inflammation of the cornea.
Lacrimation: Secretion and discharge of tears.
Laryngitis: Inflammation of the larynx.
Larynx: Voice box.
Latent Period: The time which elapses between exposure and 
the first manifestation of symptoms.
Lesion: An injury, damage, or abnormal change in a tissue 
or organ.
Leukemia: A blood disease distinguished by a marked increase 
of white blood cells.
Leukemogen: Any substance or agent that produces or incites 
leukemia.
Leukocyte: A white blood cell.
Leukocytosis: An increase in the number of white blood cells.
Leukopenia: A reduction in the total number of white blood 
cells.
Lymphoblastic: A disease characterized by the presence of 
immature lymphocytes.
Malaise: A feeling of illness or depression.
Malignancy: A neoplasm or tumor that is cancerous.
Malignant: Virulent or harmful.
Maturation: The final stages of differentiation of 
cells, tissues, or organs.
Mean Corpuscular Volume: A measurement of the volume of 
red corpuscles.
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Medical Monitoring: Periodic evaluation of body functions to 
ascertain state of health.
Melanosis: Unusual deposit of black pigments in different 
parts of the body.
Melena: Black vomit due to action of intestinal juices on free 
blood.
Menorrhagia: Excessive bleeding during the menstrual period 
in number of days, amount of blood, or both.
Mesothelioma: A malignant tumor of the membrane which 
surrounds the internal organs of the body.
Metastasis: Spreading of cancer cells from one part of the body 
to another.
Methemoglobin: A form of hemoglobin wherein the ferrous iron 
has been oxidized to ferric iron.
Methemoglobinemia: A condition where more than 1% of the 
hemoglobin in the blood has been oxidized to the ferric form.
Mists: Liquid droplets suspended in air.
Morphological: Pertaining to the biological study of the form 
and structure of living organisms.
Mucopolysaccharides: A chief constituent of mucous. 
Mucopurulent: Consisting of mucous and pus.
Myalgia: Tenderness or pain in the muscles.
Myeloblastic: A condition where the bone marrow cell develops 
into a large cell in bone marrow from which blood cells are 
formed.
Myelofibrosis: Replacement of bone marrow by fibrous tissue.
Myeloid: Like marrow.
Myelopoieses: The development of bone marrow or formation of 
cells derived from bone marrow.
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Narcotic: Producing stupor or sleep.
Nasal Septum: A partition that divides the nasal cavity into 
two passages.
Nasopharyngitis: Inflamed condition of the pharynx directly 
behind the nasal cavity and above the soft palate.
Necrotic: Death of a portion of tissue.
Neoplasm: A new and abnormal formation of tissue, as a tumor 
or growth.
Nephritis: Inflammation in the kidneys.
Nephropathy: Any disease of the kidney.
Neuropathies: Any disease of the nerve.
NIOSH: National Institute for Occupational Saftey and 
Health.
Node: A small round or oval mass of lymphiod tissue.
Nodular Ulcers: An open sore in a small aggregation of cells.
Nodule: A small node.
Nuisance Dust: An innocuous dust.
Nystagmus: Constant involuntary cyclic movement of the 
eyeball in any direction.
Opacities: Areas or spots that are not transparent.
Oropharyngeal: Concerning the central portion of the pharynx 
lying between the soft palate and upper portion of the 
epiglottis.
OSHA: Occupational Safety and Health Administration or 
Occupational Safety and Health Act.
M y o c a r d ia l : C o n c e rn in g  h e a r t  m u sc le .
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Otologist; A physician who has specialized in surgery and 
diseases of the ear.
Ototoxic: Drugs which can affect hearing acuity.
Palpitation: Abnormal rhythm of the heart of which a person is 
acutely aware.
Pancytopenia: A reduction in all cellular elements of the blood.
Papillomas: Benign epithelial or endothelial tumors.
Paresthesia: Abnormal sensation such as numbness, prickling, 
or tingling.
Particulate Matter: A suspension of fine solid or liquid particles 
in air, such as dust, fog, fume, mist, smoke, or sprays.
Pathological: Abnormal or diseased.
Percutaneous: Effected through the skin.
Peripheral Neuritis: Inflammation of peripheral nerves.
Peritoneal: Concerning the serous membrane reflected over the 
viscera and lining the abdominal cavity.
Pernicious Anemia: Severe form of blood disease marked by 
progressive decrease in red blood corpuscles, muscular 
weakness, and gastrointestinal and neural disturbances.
Peroneal Nerve: Nerve on the fibular side of the leg.
Phelegm: Thick mucous from the respiratory passages.
Plantar Keratosis: A homy growth on the sole of the foot
Platelet: A round or oval disc, 2 to 4 micrometers in diamter, 
found in the blood of vertebrates, and are concerned with the 
clotting of blood.
Pleurisy: Inflammation of the lining of the lungs or chest cavity.
Pneumoconiosis: A condition of the respiratory tract due to the 
inhalation of dust particles.
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Polymorphonuclear: A white blood cell consisting of several 
parts or lobes connected by fine strands.
Polyneuritis: A nerve inflammation involving two or more 
nerves.
Porphobilinogen: A substance sometimes found in the urine of 
patients with acute porphyria.
ppm: Parts of vapor or gas per million parts of air (by volume).
Preexisting Disease: A disease known to exist before the onset 
of current symptoms.
Preleukemic: A condition in which a group of non diagnostic 
physical and blood abnormalities may indicate that leuke­
mia will develop later.
Presbycusis: Hearing loss due to age.
Prognosis: Prediction of the future course of a disease.
Prostration: Absolute exhaustion.
Protoporphyrin: A derivative of hemoglobin containing four 
pyrrole nuclei.
Pruritis: Severe itching.
Pulmonary: Concerning or involving the lungs.
Pulmonary Hemosiderosis: A condition characterized by the 
deposition of iron containing pigment in the lungs.
Purpura: Hemorrhage into the akin or mucous membranes.
Pustular: Characterized by small elevations of the skin filled 
with pus.
Pyelography: X-ray examination of the rena] pelvis and ureter.
Radiomimetic Substance: A substance which imitates the 
biological effects of ionizing radiation.
P n e u m o n i t i s : I n f la m m a t io n  o f  th e  lu n g s .
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Rafter Sample: A sample of dust taken from a rafter or other 
settling place. Representative of but not identical to dust 
suspended in air.
Remission: Lessening severity or abatement of symptoms or 
signs.
Reticulocytosis: Increase in number of red blood cells contain­
ing a network of granules or filaments in circulating blood.
Reticuloendothelial System: Cells scattered throughout the 
body which have the power to ingest bacteria and colloidal 
particles.
Rhinitis: Inflammation of the nasal mucosa.
Rhinorrhea: Thin watery discharge from the nose.
Sanguinolent: Containing, or tinged with, blood.
Sarcoidosis: A chronic granulomatous disease of unknown 
etiology characterized by the formation of tubercle-like 
lesions in the organs such as skin, lymph nodes, lungs, and 
bone marrow.
Scalene Node: A particular group of lymph nodes in the neck.
Scotomas: Is land-like gaps in the visual fields.
Serum: The watery portion of the blood after coagulation.
Sideroblasts: A ferritin-containing nucleated red blood cor­
puscle in the bone marrow.
Siderocyte: A red blood cell containing iron in a form other 
than hematin.
Skin Absorption: Penetration of the unbroken skin by a substance.
Sputum Cytology: Examination of the sputum cells.
Stomatitis: Inflammation of the mouth.
Striated: Skeletal muscle, consisting of fibers marked by cross­
wise series of streaks.
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Subcutaneous: Beneath or to be introduced beneath the skin.
Substernal: Beneath the breastbone.
Supervene: The development of an additional condition as a 
complication to an existing disease.
Syncope: Fainting.
Synergism: Producing a total effect greater than the sum of 
separate effects.
Systemic: Spread throughout the body.
Tachycardia: Rapid heart action, usually defined as over 100 
beats per minute.
Tachypnea: Rapid breathing.
Threshold Limit Value (TLV): An atmospheric exposure level 
under which most people can work without harmful effects.
Thrombocytopenia: Decrease in number of the blood platelets.
Time-Weighted Average (Exposure): An average of several 
samples taken at various times during a working day. Usually 
more representative of the true exposure to a person for 
evaluation of long term effects from a harmful agent.
Tinnitis: A ringing sound in the ears.
Toxic Nephrosis: Kidney failure due to toxic degeneration of 
the kidney or renal tubules.
Toxicology: Study of the effects of toxic or poisonous substances.
Trachea: Cylindrical tube from the larynx to the bronchial 
tubes.
Tracheitis: Inflammation of the trachea.
Tracheobronchial: Trachea or bronchial tubes.
Tracheobronchitis: Inflammation of the mucous membrane 
that lines the trachea or bonchi.
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Tumor: A swelling or enlargement, may also refer to a spon­
taneous growth of new tissue.
Ulcerative: Causing ulcers.
Urinary: Pertaining to urine, its production, function, or 
excretion.
Urobilinogen: A colorless derivative of bilirubin from which it 
is formed by the action of intestinal bacteria.
Urticaria: A vascular skin reaction characterized by the 
eruption of pale evanescent wheals which are associated 
with severe itching.
Vascular: Blood vessels.
VC: Vital capacity; a test of lung function.
Ventricular Arrhythmias: A rhythmic disturbance arising in 
the ventricles or the lower chambers of the heart that pump 
blood into the arteries leading to the lungs and body.
Vertigo: Dizziness.
Viscera: Internal organs enclosed within a cavity such as the 
abdominal or thoracic cavities.
T r a u m a :  A n  in ju r y  o r  a  w o u n d .
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A P P E N D IX  F  
S A M P L E  O SH A  R E G U L A T IO N S  
FO R  M A N D A T O R Y  P H Y S IC A L  
EX A M IN A TIO N S  A N D  M E D IC A L  





The employer shall provide or make available at his 
cost, medical examinations relative to exposure to 
asbestos required by this paragraph.
(2) Preplacement
The employer shall provide or make available to each of 
his employees, within 30 calendar days following his 
first employment in an occupation exposed to airborne 
concentrations of asbestos fibers, a comprehensive 
medical examination, which shall include, as a 
minimum, a chest roentgenogram (posterior-anterior 
14 X 17 inches), a history to elicit symptomatology of 
respiratory disease, and pulmonary function tests to 
include forced vital capacity (FVC) and forced 
expiratory volume at 1 second (FEVi.o).
(3) Annual examinations
On or before January 31, 1973, and at least annually 
thereafter, every employer shall provide, or make 
available, comprehensive medical examinations to 
each of his employees engaged in occupations exposed 
to airborne concentrations of asbestos fibers. Such 
annual examination shall include, as a minimum, a 
chest roentgenogram (posterior-anterior 14 X 17 inches), 
a history to elicit symptomatology of respiratory 
disease, and pulmonary function tests to include forced 
vital capacity (FVC) and forced expiratory volume at 1 
second (FEVi.o).
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(4) Termination of employment
The employer shall provide, or make available, within 
30 calendar days before or after the termination of 
employment of any employee engaged in an occupation 
exposed to airborne concentrations of asbestos fibers, 
a comprehensive medical examination which shall 
include, as a minimum, a chest roentgenogram 
(posterior-anterior 14 X 17 inches), a history to elicit 
symptomatology of respiratory disease, and pulmonary 
function tests to include forced vital capacity (FVC) 
and forced expiratory volume for 1 second (FEVi.o)-
(5) Recent examinations
No medical examination is required of any employee, if 
adequate records show that the employee has been 




Employers of employees examined pursuant to this 
paragraph shall cause to be maintained complete 
and accurate records of all such medical exami­
nations. Records shall be retained by employers for 
at least 20 years.
(ii) Access
The contents of the records of the medical exami­
nations required by this paragraph shall be made 
available, for inspection and copying, to the 
Assistant Secretary of Labor for Occupational 
Safety and Health, the Director of NIOSH, to 
authorized physicians and medical consultants of 
either of them, and, upon the request of an 
employee or former employee, to his physician. 
Any physician who conducts a medical exami­
nation required by this paragraph shall furnish to 
the employer of the examined employee all the 
inform ation specifically required by this 
paragraph, and any other medical information 
related to occupational exposure to asbestos fibers.
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II . V IN Y L  C H L O R ID E
(B) Medical Surveillance
A program of medical surveillance shall be instituted for 
each employee exposed, without regard to the use of 
respirators, to vinyl chloride in excess of the action level. 
The program shall provide each such employee with an 
opportunity for examinations and tests in accordance with 
this paragraph. All medical examinations and procedures 
shall be performed by or under the supervision of a licensed 
physician, and shall be provided without cost to the 
employee.
(1) At the time of initial assignment, or upon institution of 
medical surveillance;
(i) A general physical exam ination shall be 
performed, with specific attention to detecting 
enlargement of liver, spleen or kidneys, or dysfunc­
tion in these organs, and for abnormalities in skin, 
connective tissues and the pulmonary system.
(ii) A medical history shall be taken, including the 
following topics:
(A) Alcohol intake;
(B) Past history of hepatitis;
(C) Work history and past exposure to potential 
hepatotoxic agents, including drugs and 
chemicals;
(D) Past history of blood transfusions; and
(E) Past history of hospitalizations.




(C) Serum glutamic oxalacetic transam inase 
(SGOT);
(D) Serum glutamic pyruvic transam inase  
(SGPT); and
(E) Gamma glustamyl transpeptidase.
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(2) Examinations provided in accordance with this 
paragraph shall be performed at least:
(i) Every 6 months for each employee who has been 
employed in vinyl chloride or polyvinyl chloride 
manufacturing for 10 years or longer; and
(ii) Annually for all other employees.
(3) Each employee exposed to an emergency shall be 
afforded appropriate medical surveillance.
(4) A statement of each employee’s suitability for 
continued exposure to vinyl chloride including use of 
protective equipment and respirators, shall be obtained 
from the examining physician promptly after any 
examination. A copy of the physician’s statement shall 
be provided each employee.
(5) If any employee’s health would be materially impaired 
by continued exposure, such employee shall be 
withdrawn from possible contact with vinyl chloride.
(6) Laboratory analyses for all biological specimens 
included in medical examinations shall be performed in 
laboratories licensed under 42 CFR Part 74.
(7) If the examining physician determines that alternative 
medical examinations to those required by paragraph
(B) (1) of this section will provide at least equal 
assurance of detecting medical conditions pertinent to 
the exposure to vinyl chloride, the employer may accept 
such alternative examinations as meeting the require­
ments of paragraph (B) (1) of this section. If the 
employer obtains a statement from the examining 
physician setting forth the alternative examinations 
and the rationale for substitution. This statement shall 
be available upon request for examination and copying 
to authorized representatives of the Assistant Secretary 
and the Director.
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S U P P L E M E N T A R Y  M E D IC A L  IN F O R M A T IO N
When required teste under paragraph (B)(1) of this section 
show abnormalities, the tests should be repeated as soon as 
practicable, preferably within 3 to 4 weeks. If tests remain 
abnormal, consideration should be given to withdrawal of the 
employee from contact with vinyl chloride, while a more 
comprehensive examination is made.
Additional tests which may be useful:
A. For kidney dysfunction: urine examination for albumin, 
red blood cells, and exfoliative abnormal cells.
B. Pulmonary system: Forced vital capacity, forced expira­
tory volume at 1 second, and chest roentgenogram 
(posterior-anterior, 14 X 17 inches).
C. Additional serum tests: Lactic acid dehydrogenase, lactic 
acid dehydrogenase isoenzyme, protein determination, and 
protein electrophoresis.
D. For a more comprehensive examination on repeated 
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At no cost to the employee, a program of medical surveil­
lance shall be established and implemented for employees 
considered for assignment to enter regulated areas, and for 
authorized employees.
(1) Examinations
(i) Before an employee is assigned to enter a regulated 
area, a preassignment physical examination by a 
physician shall be provided. The examination 
shall include the personal history of the employee, 
family and occupational background, including 
genetic and environmental factors.
(ii) Authorized employees shall be provided periodic 
physical examinations, not less often than annu­
ally, following the preassignment examination.
(iii) In all physical examinations, the examining 
physician shall consider whether there exist 
conditions of increased risk, including reduced 
immunological competence, those undergoing 
treatment with steroids or cytotoxic agents, 
pregnancy and cigarette smoking.
(2) Records
(i) Employers of employees examined pursuant to 
this paragraph shall cause to be maintained 
complete and accurate records of all such medical 
examinations. Records shall be maintained for the 
duration of the employee’s employment. Upon 
termination of the employee’s employment, 
including retirement or death, or in the event that 
the employer ceases business without a successor, 
records, or notarized true copies thereof, shall be 
forwarded by registered mail to the Director.
(ii) Records required by this paragraph shall be 
provided upon request to authorized representa­
tives of the Assistant Secretary or the Director; and 
upon request of any employee or former employee, 
to a physician designated by the employee, or to a 
new employer.
(C ) M ed ica l S u rv e il la n c e
264
(iii) Any physician who conducts a medical exami­
nation required by this paragraph shall furnish to 
the employer a statement of the employee’s 
suitability for employment in the specific 
exposure.
MEDICAL HISTORY EMPHASIS ITEMS
1. Previous exposures to benzene and any other hematologic 
toxin; blood dyscrasias including genetically related 
hemoglobin alterations, bleeding abnormalities and 
abnormalities in the function of formed blood elements; 
renal disease; liver disease; alcoholic intake and infection.
2. Respiratory symptoms, i.e, breathlessness, cough, sputum 
production and wheezing.
3. Nausea, vomiting, visual disturbances and use of alcohol 
and barbiturates.
4. G. I. symptoms and mental status. Review alcohol 
consumption.
5. Skin or pulmonary sensitization or a skin or mucous 
membrane condition that may promote response to 
chromic acid.
6. Potential skin or pulmonary sensitization, a skin or 
mucous membrane condition that may be exacerbated by 
chromium (VI), Bmoking habits and history of liver or 
kidney disease.
7. Presence and degree of respiratory symptoms (breathless­
ness, cough, sputum production and wheezing.
8. Respiratory allergy, chronic obstructive lung disease, 
cardio-pulmonary symptoms, smoking. (Respiratory 
questionnaire included).
9. Respiratory disease.
10. Respiratory and renal disease.
11. Musculoskeletal, pulmonary and G. I. symptoms and 
kidney dysfunction.
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12. Emphasis on signs or symptoms of unacceptable mercury 
absorption such as loss of weight, sleeplessness, tremors, 
personality change or other evidence of CNS involvement.
13. Occurrence of headache, dizziness, fatigue, pain in the 
limbs and irritation of the skin and eyes.
14. Respiratory symptoms, i.e., breathlessness, cough, 
sputum production, wheezing and tightness in the chest. 
Smoking history.
15. Head aches, nausea,6r G.I. disturbance, dizziness, alcohol 
comsumption. Particular attention to eye mucous 
membrane or skin irritation.
16. Preexisting disorders of the skin, respiratory tract, liver, 
and kidneys.
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